data_2o13_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2o13 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 3.1400000000000001 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.26 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 3.2999999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.94999999999999996 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 3.4100000000000001 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.8700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 1.3500000000000001 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.4100000000000001 110.835 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 1.51 114.319 -167.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.6599999999999999 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.923 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.6099999999999999 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.6100000000000001 108.284 168.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 2.25 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.3 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 3.1099999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.923 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.91000000000000003 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.98999999999999999 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.6000000000000001 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.676 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 2.0699999999999998 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.22 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.24 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 3.3900000000000001 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.677 ' HB3' ' H ' ' A' ' 168' ' ' CYS . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.5800000000000001 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.625 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.55 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 1.0 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.81999999999999995 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.7999999999999998 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.98 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.432 HD23 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.3799999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.7200000000000002 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 3.1000000000000001 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.603 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.6000000000000001 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.673 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 2.1000000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.6599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.669 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 3.3300000000000001 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.6699999999999999 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.75 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.51 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.677 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.57999999999999996 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.48 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.51 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 2.0600000000000001 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.55 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.7799999999999998 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.77 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 5.21 111.199 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 3.1400000000000001 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.26 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.731 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.94999999999999996 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.765 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 3.4100000000000001 110.638 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.8700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.55 HG22 ' NE2' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 1.3500000000000001 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.4100000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.6599999999999999 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.6099999999999999 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.6100000000000001 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 2.25 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.3 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 3.1099999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.91000000000000003 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.555 ' CZ3' HD23 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.90000000000000002 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.81 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.7 m170 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.98999999999999999 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.515 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.6000000000000001 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 2.0699999999999998 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.81 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.22 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.24 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 3.3900000000000001 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.5800000000000001 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.597 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.55 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 1.0 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.81999999999999995 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.7999999999999998 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.98 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.478 HD22 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.3799999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.7200000000000002 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 3.1000000000000001 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.6000000000000001 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 2.1000000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.6599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 3.3300000000000001 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.6699999999999999 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.75 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.51 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.478 ' SG ' HD22 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.57999999999999996 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.48 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.51 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.781 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 2.0600000000000001 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.55 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.7799999999999998 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.77 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 5.21 111.711 -178.508 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 3.1400000000000001 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.26 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.766 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 3.2999999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.94999999999999996 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.448 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 3.4100000000000001 111.726 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.8700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 1.3500000000000001 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.4100000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 1.51 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.6599999999999999 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.842 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.6099999999999999 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.6100000000000001 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 2.25 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.3 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.44 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 3.1099999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.842 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.91000000000000003 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.44 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.90000000000000002 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.632 ' CD2' HG23 ' A' ' 127' ' ' VAL . 44.7 m170 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.98999999999999999 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.6000000000000001 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 2.0699999999999998 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.766 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.22 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.584 ' CZ ' HG22 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.24 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.568 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 3.3900000000000001 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.5800000000000001 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.55 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 1.0 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.81999999999999995 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.7999999999999998 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.568 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.98 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.747 HD22 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.3799999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.7200000000000002 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 3.1000000000000001 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.6000000000000001 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.706 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 2.1000000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.6599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.736 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 3.3300000000000001 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.6699999999999999 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.75 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.51 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.747 ' SG ' HD22 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.57999999999999996 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.48 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.51 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.65 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.736 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 2.0600000000000001 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.55 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.54 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.7799999999999998 111.868 -176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.77 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 5.21 111.522 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 3.1400000000000001 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.26 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 3.2999999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.94999999999999996 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 3.4100000000000001 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.8700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.687 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 1.3500000000000001 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.4100000000000001 110.79 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 1.51 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.6599999999999999 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.852 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.6099999999999999 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.6100000000000001 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 2.25 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.3 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 3.1099999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.852 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.91000000000000003 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.465 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.90000000000000002 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.687 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.98999999999999999 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.6000000000000001 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 2.0699999999999998 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.22 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.24 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.847 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 3.3900000000000001 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.88 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.5800000000000001 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.653 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.55 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 1.0 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.81999999999999995 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.622 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.7999999999999998 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.98 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.3799999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.7200000000000002 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.6000000000000001 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.513 ' HA ' HD12 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 2.1000000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.6599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 3.3300000000000001 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.6699999999999999 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.465 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.75 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.88 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.51 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.474 ' HA ' HD22 ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.57999999999999996 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.48 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.51 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.964 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.666 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 2.0600000000000001 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.55 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.964 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.7799999999999998 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.666 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.77 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 5.21 112.761 175.083 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.864 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 3.1400000000000001 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.26 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 3.2999999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.94999999999999996 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 3.4100000000000001 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.8700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 1.3500000000000001 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.4100000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 1.51 114.212 -170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.6599999999999999 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.879 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.6099999999999999 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.6100000000000001 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 2.25 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.3 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 3.1099999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.879 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.91000000000000003 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.90000000000000002 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.846 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.98999999999999999 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HG2' HG11 ' A' ' 133' ' ' VAL . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.6000000000000001 110.406 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 2.0699999999999998 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.846 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.24 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 3.3900000000000001 108.619 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.93 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.5800000000000001 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.55 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 1.0 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.81999999999999995 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.7999999999999998 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.98 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.3799999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.7200000000000002 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 3.1000000000000001 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.6000000000000001 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 2.1000000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.6599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 3.3300000000000001 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.6699999999999999 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.75 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.93 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.51 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.61 ' HA ' HD22 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.57999999999999996 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.48 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.51 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 2.0600000000000001 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.55 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.7799999999999998 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.77 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 5.21 112.179 -177.491 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 3.1400000000000001 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.26 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 3.2999999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.94999999999999996 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 3.4100000000000001 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.8700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 1.3500000000000001 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.814 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.4100000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 1.51 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.6599999999999999 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.814 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.996 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.6099999999999999 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.6100000000000001 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 2.25 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.3 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 3.1099999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.996 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.91000000000000003 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.90000000000000002 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.834 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.98999999999999999 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.6000000000000001 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 2.0699999999999998 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.834 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.22 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.564 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.24 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 3.3900000000000001 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.5800000000000001 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.55 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 1.0 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.81999999999999995 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.945 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.7999999999999998 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.98 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.3799999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.7200000000000002 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 3.1000000000000001 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.528 ' N ' HD21 ' A' ' 158' ' ' ASN . 0.1 OUTLIER -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.6000000000000001 110.116 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 2.1000000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.6599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 164' ' ' GLY . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 3.3300000000000001 110.545 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 162' ' ' LYS . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.6699999999999999 112.348 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.75 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.851 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.51 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.456 ' HA ' HD23 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.57999999999999996 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.48 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.51 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 2.0600000000000001 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.55 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.7799999999999998 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.77 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 5.21 110.831 178.092 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 3.1400000000000001 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.26 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.524 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 3.2999999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.94999999999999996 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 3.4100000000000001 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.8700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 1.3500000000000001 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.504 ' CE1' ' HB1' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.4100000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 1.51 113.582 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.6599999999999999 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.541 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.769 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.6099999999999999 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.6100000000000001 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 2.25 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.3 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.543 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 3.1099999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.984 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.91000000000000003 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.543 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.90000000000000002 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.98999999999999999 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.6000000000000001 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 2.0699999999999998 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.22 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.24 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 3.3900000000000001 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.848 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.5800000000000001 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.55 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.81999999999999995 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.7999999999999998 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.734 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.98 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.3799999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.7200000000000002 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 3.1000000000000001 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.6000000000000001 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 2.1000000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.6599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.5 ' HZ1' ' HH ' ' A' ' 172' ' ' TYR . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 3.3300000000000001 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.6699999999999999 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.472 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.75 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.51 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.57999999999999996 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.48 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.51 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.5 ' HH ' ' HZ1' ' A' ' 162' ' ' LYS . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 2.0600000000000001 110.67 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.55 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.7799999999999998 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.77 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 5.21 115.229 179.83 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 3.1400000000000001 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.26 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 3.2999999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.94999999999999996 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 3.4100000000000001 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.8700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 1.3500000000000001 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.404 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.4100000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.743 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 1.51 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.6599999999999999 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.6099999999999999 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.6100000000000001 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 2.25 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.3 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 3.1099999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.91000000000000003 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.98999999999999999 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.6000000000000001 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 2.0699999999999998 112.248 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.22 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.437 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.24 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 3.3900000000000001 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 1.019 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.5800000000000001 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.501 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.55 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 1.0 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.81999999999999995 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.7999999999999998 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.98 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.3799999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 157' ' ' THR . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.7200000000000002 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 155' ' ' GLU . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 3.1000000000000001 112.409 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.6 HD21 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.6000000000000001 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 2.1000000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.6599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.591 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 3.3300000000000001 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.6699999999999999 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' HD13 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.75 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.51 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.57999999999999996 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.498 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.48 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.51 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 2.0600000000000001 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.55 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.7799999999999998 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.77 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 5.21 112.751 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 3.1400000000000001 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.26 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 3.2999999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.94999999999999996 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.545 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 3.4100000000000001 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.8700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.4100000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 1.51 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.6599999999999999 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.938 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.6099999999999999 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.6100000000000001 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 2.25 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.3 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 3.1099999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.803 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.91000000000000003 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.90000000000000002 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.98999999999999999 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.938 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.6000000000000001 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 2.0699999999999998 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.22 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.24 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 3.3900000000000001 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 1.011 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.5800000000000001 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.55 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 1.0 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.81999999999999995 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.7999999999999998 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.923 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.98 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.3799999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.412 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.7200000000000002 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.412 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 3.1000000000000001 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.6000000000000001 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 2.1000000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.6599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.568 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 3.3300000000000001 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.6699999999999999 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.553 HD23 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.75 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.51 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.57999999999999996 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.48 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 2.0600000000000001 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.55 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.682 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.7799999999999998 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.77 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 5.21 110.648 -177.576 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 3.1400000000000001 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.26 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.506 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 3.2999999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.94999999999999996 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 3.4100000000000001 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.8700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 1.3500000000000001 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.4100000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 1.51 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.6599999999999999 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.848 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.6099999999999999 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.6100000000000001 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 2.25 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.3 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 3.1099999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.848 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.91000000000000003 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.433 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.90000000000000002 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.98999999999999999 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.907 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.6000000000000001 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 2.0699999999999998 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.24 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 3.3900000000000001 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.5800000000000001 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.55 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 1.0 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.81999999999999995 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.613 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.7999999999999998 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.98 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.3799999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.7200000000000002 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 3.1000000000000001 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.921 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.6000000000000001 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 2.1000000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.6599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.543 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.6699999999999999 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.75 108.18 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.892 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.51 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.613 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.57999999999999996 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.921 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.48 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.51 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 2.0600000000000001 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.55 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.7799999999999998 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.77 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 5.21 113.665 -178.101 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 3.1400000000000001 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.26 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 3.2999999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.94999999999999996 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 3.4100000000000001 110.403 -170.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.8700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 1.3500000000000001 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.4100000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 1.51 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.6599999999999999 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.448 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.6099999999999999 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.6100000000000001 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 2.25 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.3 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 3.1099999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.742 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.91000000000000003 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.47 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.90000000000000002 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.772 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 18.2 m170 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.98999999999999999 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.6000000000000001 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 2.0699999999999998 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.22 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.24 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 3.3900000000000001 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 1.033 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.5800000000000001 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.57 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.55 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.889 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 1.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.81999999999999995 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.889 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.7999999999999998 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.98 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.3799999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.7200000000000002 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 3.1000000000000001 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.6000000000000001 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 2.1000000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.6599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 3.3300000000000001 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.6699999999999999 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.75 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 1.033 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.51 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.523 ' HA ' HD22 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.57999999999999996 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.48 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.51 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.659 ' HA ' HD22 ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.55 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.7799999999999998 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.659 HD22 ' HA ' ' A' ' 172' ' ' TYR . 9.9 p30 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.77 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 5.21 112.743 178.344 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.519 ' CB ' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 3.1400000000000001 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.26 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 3.2999999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.94999999999999996 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 3.4100000000000001 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.8700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 1.3500000000000001 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.4100000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 1.51 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.6599999999999999 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.893 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.6099999999999999 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.6100000000000001 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 2.25 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.3 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 3.1099999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.91000000000000003 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.493 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.90000000000000002 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.98999999999999999 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.6000000000000001 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 2.0699999999999998 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.22 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.652 ' CZ ' HG23 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.24 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.958 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 3.3900000000000001 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.82 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.5800000000000001 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.492 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.55 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 1.0 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.81999999999999995 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.447 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.7999999999999998 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.958 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.98 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.3799999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.7200000000000002 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 3.1000000000000001 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.566 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.6000000000000001 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.682 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 2.1000000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.6599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.498 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 3.3300000000000001 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.6699999999999999 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.75 109.051 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.82 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.51 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.57999999999999996 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.566 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.48 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.51 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 2.0600000000000001 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.655 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.55 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.7799999999999998 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.77 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 5.21 113.583 -166.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 3.1400000000000001 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.26 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.729 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 3.2999999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.94999999999999996 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 3.4100000000000001 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.8700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.92 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 1.3500000000000001 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.4100000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 1.51 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.6599999999999999 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.659 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.576 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.6099999999999999 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 2.25 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.3 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 3.1099999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.92 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.91000000000000003 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.90000000000000002 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.98999999999999999 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.6000000000000001 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 2.0699999999999998 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.729 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.22 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.24 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 3.3900000000000001 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.5800000000000001 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.524 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.55 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 1.0 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.667 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.7999999999999998 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.98 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.3799999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.7200000000000002 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 3.1000000000000001 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.6000000000000001 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 2.1000000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.6599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.56 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 3.3300000000000001 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.6699999999999999 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.75 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.916 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.699 ' SG ' HD23 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.57999999999999996 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.48 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.51 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 2.0600000000000001 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.55 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.7799999999999998 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.77 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.56 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 5.21 110.385 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 3.1400000000000001 109.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.26 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 3.2999999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.94999999999999996 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.698 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 3.4100000000000001 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.8700000000000001 110.842 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 1.3500000000000001 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.4100000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 1.51 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.6599999999999999 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.868 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.6099999999999999 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.6100000000000001 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 2.25 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.3 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 3.1099999999999999 110.022 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.868 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.91000000000000003 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.427 ' O ' HG13 ' A' ' 127' ' ' VAL . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.90000000000000002 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.721 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.98999999999999999 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.6000000000000001 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' THR . . . . . 0.612 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 2.0699999999999998 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.22 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.24 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.714 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 3.3900000000000001 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.5800000000000001 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.55 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 1.0 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.81999999999999995 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.7999999999999998 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.661 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.98 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.3799999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.7200000000000002 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 3.1000000000000001 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.6000000000000001 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 2.1000000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.6599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 3.3300000000000001 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.6699999999999999 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.75 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.57999999999999996 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.48 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.51 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 2.0600000000000001 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.55 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.7799999999999998 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.77 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 5.21 110.79 -175.361 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 3.1400000000000001 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.26 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.581 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 3.2999999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.94999999999999996 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 3.4100000000000001 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.8700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 1.3500000000000001 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.4100000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 1.51 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.6599999999999999 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.999 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.6099999999999999 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.6100000000000001 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 2.25 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.3 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.486 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 3.1099999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.999 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.91000000000000003 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.486 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.90000000000000002 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.827 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.98999999999999999 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.6000000000000001 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 2.0699999999999998 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.22 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.553 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 3.3900000000000001 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.5800000000000001 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.55 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 1.0 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.81999999999999995 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.7999999999999998 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.98 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.553 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.3799999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.7200000000000002 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 3.1000000000000001 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.6 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.6000000000000001 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 2.1000000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 3.3300000000000001 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.6699999999999999 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.75 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.51 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.57999999999999996 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.48 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.51 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 2.0600000000000001 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.55 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.7799999999999998 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.77 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 5.21 110.217 -178.805 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 3.1400000000000001 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.26 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 3.2999999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.94999999999999996 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 3.4100000000000001 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 1.3500000000000001 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.4100000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 1.51 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.6599999999999999 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.873 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.6099999999999999 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.6100000000000001 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 2.25 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.3 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 3.1099999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.873 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.91000000000000003 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.464 ' O ' HG11 ' A' ' 127' ' ' VAL . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.90000000000000002 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.98999999999999999 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.6000000000000001 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 2.0699999999999998 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.22 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.24 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 3.3900000000000001 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.908 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.5800000000000001 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.55 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.848 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 1.0 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.81999999999999995 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.848 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.7999999999999998 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.809 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.98 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.3799999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.7200000000000002 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 3.1000000000000001 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . 0.594 HD22 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.6000000000000001 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 2.1000000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.6599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 3.3300000000000001 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.6699999999999999 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.433 ' CD ' ' HH ' ' A' ' 167' ' ' TYR . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.75 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.908 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.51 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.594 ' HB3' HD22 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.57999999999999996 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.48 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.51 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 2.0600000000000001 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.55 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.7799999999999998 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.77 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 5.21 110.285 178.842 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 3.1400000000000001 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.26 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 3.2999999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.94999999999999996 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 3.4100000000000001 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.8700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.805 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.4100000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 1.51 113.907 -168.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.6599999999999999 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.965 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.6099999999999999 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.6100000000000001 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 2.25 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.3 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.438 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 3.1099999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.965 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.91000000000000003 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.90000000000000002 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.98999999999999999 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.6000000000000001 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 2.0699999999999998 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.22 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.24 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 3.3900000000000001 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.956 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.5800000000000001 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.622 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.55 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 1.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.81999999999999995 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.7999999999999998 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.98 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.68 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.3799999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.7200000000000002 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 3.1000000000000001 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.6000000000000001 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 2.1000000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.6599999999999999 108.941 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 3.3300000000000001 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.6699999999999999 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.591 HD23 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.75 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.956 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.51 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.68 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.57999999999999996 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.48 110.541 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.51 110.325 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 2.0600000000000001 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.55 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.579 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.7799999999999998 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.77 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 5.21 110.818 -177.261 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 3.1400000000000001 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.26 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.428 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 3.2999999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.94999999999999996 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 3.4100000000000001 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.8700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 1.3500000000000001 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.4100000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.472 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 1.51 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.6599999999999999 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.699 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.6099999999999999 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.6100000000000001 108.478 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 2.25 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.3 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 3.1099999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.699 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.91000000000000003 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.98999999999999999 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.6000000000000001 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 2.0699999999999998 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.22 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.24 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.803 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 3.3900000000000001 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.5800000000000001 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.55 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 1.0 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.81999999999999995 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.7999999999999998 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.803 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.98 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.591 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.3799999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.7200000000000002 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 3.1000000000000001 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.6000000000000001 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 2.1000000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 3.3300000000000001 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.6699999999999999 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.75 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 1.05 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.51 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.57999999999999996 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.48 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.51 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 2.0600000000000001 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.55 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.7799999999999998 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.77 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 5.21 112.59 -178.961 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 3.1400000000000001 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.26 112.455 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 3.2999999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.94999999999999996 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.558 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 3.4100000000000001 110.063 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.8700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 1.3500000000000001 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.4100000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 1.51 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.6599999999999999 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.6099999999999999 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.6100000000000001 108.577 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' MET . . . . . 0.614 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 2.25 113.35 -168.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.3 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 3.1099999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.615 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.91000000000000003 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.576 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.90000000000000002 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 28.8 m80 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.98999999999999999 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.6000000000000001 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 2.0699999999999998 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.22 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.24 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 3.3900000000000001 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.5800000000000001 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.55 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.81999999999999995 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.7999999999999998 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.3799999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.7200000000000002 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 3.1000000000000001 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.6000000000000001 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 2.1000000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.6599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.798 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 3.3300000000000001 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.6699999999999999 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . 0.477 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.497 HD23 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.75 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.723 ' SG ' HD22 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.57999999999999996 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.48 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.51 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . 0.798 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 2.0600000000000001 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.55 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.7799999999999998 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.77 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 5.21 111.661 -175.655 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 3.1400000000000001 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.26 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 3.2999999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.94999999999999996 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 3.4100000000000001 110.054 -170.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.8700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 1.3500000000000001 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.4100000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 1.51 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.6599999999999999 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.6099999999999999 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.6100000000000001 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 2.25 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.3 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.424 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 3.1099999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.91000000000000003 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HG21 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.90000000000000002 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 36.5 m80 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.98999999999999999 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.6000000000000001 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 2.0699999999999998 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.22 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.24 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 3.3900000000000001 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.5800000000000001 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.699 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.55 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.902 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 1.0 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.81999999999999995 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.902 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.7999999999999998 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.98 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.3799999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.7200000000000002 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 3.1000000000000001 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.6000000000000001 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.958 ' HB ' HD13 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 2.1000000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.6599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 3.3300000000000001 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.6699999999999999 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LEU . . . . . 0.958 HD13 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.75 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.51 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' CYS . . . . . 0.584 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.57999999999999996 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.48 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.51 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 2.0600000000000001 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.55 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.7799999999999998 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.77 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 5.21 114.209 177.608 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 3.1400000000000001 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.26 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 3.2999999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.94999999999999996 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 3.4100000000000001 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.536 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.8700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 1.3500000000000001 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.4100000000000001 110.835 177.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 1.51 114.319 -167.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.6599999999999999 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.923 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.6099999999999999 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.402 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.6100000000000001 108.284 168.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 2.25 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.3 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 3.1099999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.923 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.91000000000000003 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.419 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.90000000000000002 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.5 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.98999999999999999 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.6000000000000001 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.676 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 2.0699999999999998 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.5 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.22 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.673 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.24 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.676 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 3.3900000000000001 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.677 ' HB3' ' H ' ' A' ' 168' ' ' CYS . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.5800000000000001 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.625 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.55 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.744 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 1.0 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.81999999999999995 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.744 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.7999999999999998 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.98 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.432 HD23 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.3799999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.7200000000000002 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 3.1000000000000001 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.603 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.6000000000000001 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.673 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 2.1000000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.6599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.669 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 3.3300000000000001 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.6699999999999999 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.75 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.51 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.677 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.57999999999999996 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.48 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.51 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 2.0600000000000001 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.55 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.7799999999999998 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.77 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.493 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 5.21 111.199 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 3.1400000000000001 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.26 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.731 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 3.2999999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.94999999999999996 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.765 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 3.4100000000000001 110.638 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.8700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.55 HG22 ' NE2' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 1.3500000000000001 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.4100000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.6599999999999999 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.515 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.457 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.6099999999999999 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.6100000000000001 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 2.25 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.462 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.3 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.448 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 3.1099999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.456 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.91000000000000003 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.555 ' CZ3' HD23 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.90000000000000002 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.81 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.7 m170 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.98999999999999999 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.515 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.6000000000000001 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 2.0699999999999998 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.81 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.22 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.24 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 3.3900000000000001 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.999 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.5800000000000001 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.597 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.55 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 1.0 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.81999999999999995 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.871 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.7999999999999998 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.98 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.478 HD22 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.3799999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.7200000000000002 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 3.1000000000000001 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.6000000000000001 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.492 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 2.1000000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.6599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.426 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 3.3300000000000001 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.6699999999999999 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.592 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.75 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.999 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.51 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.478 ' SG ' HD22 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.57999999999999996 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.48 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.51 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.781 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 2.0600000000000001 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.55 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.7799999999999998 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.77 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 5.21 111.711 -178.508 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 3.1400000000000001 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.55 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.26 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.766 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 3.2999999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.94999999999999996 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.448 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 3.4100000000000001 111.726 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.8700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.741 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 1.3500000000000001 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.4100000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 1.51 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.6599999999999999 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.842 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.6099999999999999 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.41 HG23 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.6100000000000001 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 2.25 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.3 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.44 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 3.1099999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.842 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.91000000000000003 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.44 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.90000000000000002 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.632 ' CD2' HG23 ' A' ' 127' ' ' VAL . 44.7 m170 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.98999999999999999 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.6000000000000001 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 2.0699999999999998 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.766 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.22 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.584 ' CZ ' HG22 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.24 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.568 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 3.3900000000000001 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.5800000000000001 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.65 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.55 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 1.0 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.81999999999999995 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' HZ3' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.7999999999999998 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.568 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.98 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.747 HD22 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.3799999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.7200000000000002 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 3.1000000000000001 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.672 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.6000000000000001 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.706 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 2.1000000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.6599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.736 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 3.3300000000000001 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.6699999999999999 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.75 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.51 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.747 ' SG ' HD22 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.57999999999999996 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.48 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.51 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.65 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.736 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 2.0600000000000001 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.55 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.54 ' HZ2' ' HB2' ' A' ' 174' ' ' LYS . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.7799999999999998 111.868 -176.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.77 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.568 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 5.21 111.522 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 3.1400000000000001 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.26 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.491 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 3.2999999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.94999999999999996 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 3.4100000000000001 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.8700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.687 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 1.3500000000000001 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.4100000000000001 110.79 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 1.51 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.6599999999999999 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.852 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.6099999999999999 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.6100000000000001 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 2.25 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.3 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 3.1099999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.852 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.91000000000000003 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.465 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.90000000000000002 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.687 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.98999999999999999 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.6000000000000001 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 2.0699999999999998 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.22 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.485 ' HB2' HG22 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.24 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.847 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 3.3900000000000001 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.88 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.5800000000000001 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.653 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.55 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 1.0 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.81999999999999995 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.622 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.7999999999999998 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.847 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.98 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.595 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.3799999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.7200000000000002 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 3.1000000000000001 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.403 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.6000000000000001 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.513 ' HA ' HD12 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 2.1000000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.6599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.544 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 3.3300000000000001 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.6699999999999999 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.465 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.75 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.88 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.51 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.474 ' HA ' HD22 ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.57999999999999996 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.48 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.51 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.964 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.666 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 2.0600000000000001 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.55 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.964 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.7799999999999998 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.666 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.77 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 5.21 112.761 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.864 ' HZ3' ' HB3' ' A' ' 119' ' ' LYS . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 3.1400000000000001 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.26 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.447 ' HA ' ' HE ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 3.2999999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.94999999999999996 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 3.4100000000000001 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.8700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 1.3500000000000001 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.4100000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 1.51 114.212 -170.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.6599999999999999 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.879 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.6099999999999999 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.6100000000000001 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 2.25 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.3 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 3.1099999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.879 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.91000000000000003 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.90000000000000002 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.846 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.98999999999999999 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HG2' HG11 ' A' ' 133' ' ' VAL . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.6000000000000001 110.406 176.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 2.0699999999999998 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.846 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.22 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.24 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 3.3900000000000001 108.619 -173.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.93 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.5800000000000001 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.55 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 1.0 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.81999999999999995 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.7999999999999998 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.98 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.61 HD22 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.3799999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.428 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.7200000000000002 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.428 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 3.1000000000000001 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.6000000000000001 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 2.1000000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.6599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 3.3300000000000001 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.6699999999999999 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.75 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.93 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.51 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.61 ' HA ' HD22 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.57999999999999996 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.48 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.51 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 2.0600000000000001 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.55 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.7799999999999998 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.77 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 5.21 112.179 -177.491 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 3.1400000000000001 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.26 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 3.2999999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.94999999999999996 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 3.4100000000000001 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.8700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.528 HG21 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 1.3500000000000001 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.814 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.4100000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 1.51 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.6599999999999999 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.814 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.996 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.6099999999999999 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.6100000000000001 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 2.25 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.3 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 3.1099999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.996 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.91000000000000003 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.90000000000000002 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.834 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.98999999999999999 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.6000000000000001 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 2.0699999999999998 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.834 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.22 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.564 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.24 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 3.3900000000000001 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.851 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.5800000000000001 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.519 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.55 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.945 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 1.0 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.81999999999999995 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.945 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.7999999999999998 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.98 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.456 HD23 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.3799999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.7200000000000002 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 3.1000000000000001 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.528 ' N ' HD21 ' A' ' 158' ' ' ASN . 0.1 OUTLIER -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.6000000000000001 110.116 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 2.1000000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.6599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.438 ' C ' ' H ' ' A' ' 164' ' ' GLY . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 3.3300000000000001 110.545 176.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.438 ' H ' ' C ' ' A' ' 162' ' ' LYS . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.6699999999999999 112.348 -177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.564 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.75 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.851 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.51 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.456 ' HA ' HD23 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.57999999999999996 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.48 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.51 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 2.0600000000000001 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.55 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.7799999999999998 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.77 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 5.21 110.831 178.092 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 3.1400000000000001 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.524 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.26 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.524 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 3.2999999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.94999999999999996 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 3.4100000000000001 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.8700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.984 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 1.3500000000000001 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.504 ' CE1' ' HB1' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.4100000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 1.51 113.582 -169.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' HB1' ' CE1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.6599999999999999 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.541 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.769 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.6099999999999999 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.513 HG21 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.6100000000000001 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.523 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 2.25 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.3 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.543 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 3.1099999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.984 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.91000000000000003 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.543 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.90000000000000002 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.559 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.98999999999999999 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.541 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.6000000000000001 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.463 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 2.0699999999999998 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.559 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.22 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.593 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.24 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.734 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 3.3900000000000001 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.848 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.5800000000000001 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.623 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.55 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.76 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 1.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.81999999999999995 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.76 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.7999999999999998 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.734 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.98 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.686 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.3799999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.7200000000000002 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 3.1000000000000001 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.6000000000000001 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.593 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 2.1000000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.6599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.5 ' HZ1' ' HH ' ' A' ' 172' ' ' TYR . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 3.3300000000000001 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.6699999999999999 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.472 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.75 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.848 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.51 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.686 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.57999999999999996 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.48 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.51 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.5 ' HH ' ' HZ1' ' A' ' 162' ' ' LYS . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 2.0600000000000001 110.67 178.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.55 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.7799999999999998 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.77 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 5.21 115.229 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 3.1400000000000001 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.505 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.26 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 3.2999999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.94999999999999996 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 3.4100000000000001 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.8700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.728 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 1.3500000000000001 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.404 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.4100000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.743 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 1.51 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.6599999999999999 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.743 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.6099999999999999 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.6100000000000001 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 2.25 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.3 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 3.1099999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.91000000000000003 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.783 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.98999999999999999 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.6000000000000001 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 2.0699999999999998 112.248 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.783 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.22 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.437 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.24 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 3.3900000000000001 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 1.019 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.5800000000000001 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.501 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.55 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.584 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 1.0 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.81999999999999995 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.584 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.7999999999999998 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.98 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.52 HD21 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.3799999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.42 ' C ' ' H ' ' A' ' 157' ' ' THR . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.7200000000000002 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 155' ' ' GLU . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 3.1000000000000001 112.409 -175.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.6 HD21 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.6000000000000001 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 2.1000000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.6599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.591 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 3.3300000000000001 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.6699999999999999 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.485 ' HB3' HD13 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.75 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 1.019 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.51 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.6 ' HB3' HD21 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.57999999999999996 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.498 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.48 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.51 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 2.0600000000000001 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.55 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.7799999999999998 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.77 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 5.21 112.751 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 3.1400000000000001 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.26 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.568 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 3.2999999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.94999999999999996 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.545 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 3.4100000000000001 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.8700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.803 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 1.3500000000000001 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.4100000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 1.51 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.6599999999999999 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.938 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.737 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.6099999999999999 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.441 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.6100000000000001 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.442 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 2.25 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.3 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 3.1099999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.803 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.91000000000000003 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.568 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.90000000000000002 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.766 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.98999999999999999 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.938 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.6000000000000001 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 2.0699999999999998 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.766 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.22 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.456 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.24 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.923 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 3.3900000000000001 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 1.011 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.5800000000000001 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.596 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.55 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.801 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 1.0 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.81999999999999995 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.801 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.7999999999999998 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.923 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.98 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.708 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.3799999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.412 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.7200000000000002 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.412 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 3.1000000000000001 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.6000000000000001 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 2.1000000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.6599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.568 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 3.3300000000000001 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.6699999999999999 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.553 HD23 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.75 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 1.011 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.51 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.57999999999999996 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.48 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.488 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.51 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 2.0600000000000001 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.55 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.682 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.7799999999999998 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.77 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 5.21 110.648 -177.576 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 3.1400000000000001 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.506 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.26 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.506 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 3.2999999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.94999999999999996 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 3.4100000000000001 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.8700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.732 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 1.3500000000000001 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.4100000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.76 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 1.51 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.6599999999999999 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.848 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.6099999999999999 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.6100000000000001 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 2.25 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.3 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.537 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 3.1099999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.848 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.91000000000000003 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.433 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.90000000000000002 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.98999999999999999 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.907 ' HB3' ' HZ3' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.6000000000000001 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 2.0699999999999998 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.22 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.498 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.24 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 3.3900000000000001 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.892 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.5800000000000001 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.55 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 1.0 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.81999999999999995 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.613 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.7999999999999998 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.487 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.98 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.3799999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.7200000000000002 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 3.1000000000000001 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.921 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.6000000000000001 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 2.1000000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.6599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.543 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 3.3300000000000001 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.6699999999999999 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.75 108.18 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.892 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.51 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.613 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.57999999999999996 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.921 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.48 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.51 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.504 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 2.0600000000000001 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.55 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.7799999999999998 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.77 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 5.21 113.665 -178.101 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 3.1400000000000001 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.537 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.26 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.537 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 3.2999999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.94999999999999996 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.412 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 3.4100000000000001 110.403 -170.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.8700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 1.3500000000000001 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.4100000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 1.51 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.6599999999999999 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.448 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.742 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.6099999999999999 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.6100000000000001 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 2.25 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.3 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 3.1099999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.742 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.91000000000000003 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.47 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.90000000000000002 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.772 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 18.2 m170 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.98999999999999999 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.554 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.6000000000000001 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 2.0699999999999998 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.772 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.22 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.24 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.435 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 3.3900000000000001 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 1.033 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.5800000000000001 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.57 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.55 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.889 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 1.0 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.81999999999999995 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.889 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.7999999999999998 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.554 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.98 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.3799999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.7200000000000002 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 3.1000000000000001 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.6000000000000001 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 2.1000000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.6599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 3.3300000000000001 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.6699999999999999 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.75 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 1.033 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.51 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.523 ' HA ' HD22 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.57999999999999996 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.48 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.51 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.659 ' HA ' HD22 ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 2.0600000000000001 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.55 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.7799999999999998 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.659 HD22 ' HA ' ' A' ' 172' ' ' TYR . 9.9 p30 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.77 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 5.21 112.743 178.344 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.519 ' CB ' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 3.1400000000000001 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.26 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 3.2999999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.94999999999999996 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 3.4100000000000001 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.519 ' HA ' ' CB ' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.8700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.446 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 1.3500000000000001 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.4100000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 1.51 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.6599999999999999 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.893 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.6099999999999999 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.533 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.6100000000000001 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 2.25 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.3 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 3.1099999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.893 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.91000000000000003 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.493 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.90000000000000002 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.51 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.98999999999999999 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.6000000000000001 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 2.0699999999999998 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.51 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.22 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.652 ' CZ ' HG23 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.24 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.958 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 3.3900000000000001 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.82 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.5800000000000001 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.492 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.55 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 1.0 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.81999999999999995 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.447 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.7999999999999998 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.958 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.98 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.3799999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . 0.434 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.7200000000000002 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 3.1000000000000001 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.566 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.6000000000000001 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.682 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 2.1000000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.6599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.498 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 3.3300000000000001 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.6699999999999999 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.464 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.401 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.75 109.051 175.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.82 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.51 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.57999999999999996 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.566 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.48 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.51 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.495 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 2.0600000000000001 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.655 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.55 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.7799999999999998 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.77 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.655 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 5.21 113.583 -166.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.655 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 3.1400000000000001 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.534 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.26 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.729 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 3.2999999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.94999999999999996 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 3.4100000000000001 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.655 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.8700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.92 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 1.3500000000000001 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.659 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.4100000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 1.51 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.6599999999999999 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.659 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.576 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.6099999999999999 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.527 HG22 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.6100000000000001 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 2.25 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.3 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 3.1099999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.92 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.91000000000000003 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.90000000000000002 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.98999999999999999 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.6000000000000001 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.499 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 2.0699999999999998 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.729 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.22 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.554 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.24 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.499 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 3.3900000000000001 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.916 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.5800000000000001 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.524 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.55 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 1.0 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.667 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.7999999999999998 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.98 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.3799999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.7200000000000002 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 3.1000000000000001 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.6000000000000001 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 2.1000000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.6599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.56 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 3.3300000000000001 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.6699999999999999 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.75 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.916 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.51 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.699 ' SG ' HD23 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.57999999999999996 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.48 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.51 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 2.0600000000000001 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.55 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.7799999999999998 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.77 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.56 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 5.21 110.385 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 3.1400000000000001 109.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.42 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.26 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 3.2999999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.94999999999999996 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.698 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 3.4100000000000001 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.8700000000000001 110.842 178.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 1.3500000000000001 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.4100000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 1.51 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.6599999999999999 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.868 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.6099999999999999 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.6100000000000001 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 2.25 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.3 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 3.1099999999999999 110.022 178.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.868 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.91000000000000003 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.427 ' O ' HG13 ' A' ' 127' ' ' VAL . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.90000000000000002 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.721 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.98999999999999999 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.6000000000000001 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . 0.612 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 2.0699999999999998 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.721 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.22 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.464 ' CZ ' HG23 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.24 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.714 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 3.3900000000000001 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.679 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.5800000000000001 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.638 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.55 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.567 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 1.0 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.81999999999999995 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.71 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.7999999999999998 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.661 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.98 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.714 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.3799999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.7200000000000002 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 3.1000000000000001 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.6000000000000001 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.464 HG23 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 2.1000000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.6599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 3.3300000000000001 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.6699999999999999 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.75 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.679 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.51 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.619 ' SG ' HD22 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.57999999999999996 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.48 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.51 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 2.0600000000000001 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.55 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.7799999999999998 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.77 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 5.21 110.79 -175.361 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 3.1400000000000001 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.26 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.581 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 3.2999999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.94999999999999996 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 3.4100000000000001 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.8700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.626 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 1.3500000000000001 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.4100000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 1.51 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.6599999999999999 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.999 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.6099999999999999 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.6100000000000001 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 2.25 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.3 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.486 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 3.1099999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.999 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.91000000000000003 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.486 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.90000000000000002 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.827 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.98999999999999999 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.49 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.6000000000000001 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 2.0699999999999998 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.827 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.22 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.553 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.24 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 3.3900000000000001 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.5800000000000001 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.518 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.55 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 1.0 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.81999999999999995 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.7999999999999998 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.98 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.553 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.3799999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.7200000000000002 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 3.1000000000000001 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.6 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.6000000000000001 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 2.1000000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.6599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 3.3300000000000001 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.6699999999999999 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.458 ' N ' HD21 ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.75 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.51 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.54 ' SG ' HD22 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.57999999999999996 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . 0.6 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.48 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.51 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 2.0600000000000001 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.55 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.7799999999999998 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.77 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 5.21 110.217 -178.805 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.671 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 3.1400000000000001 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.26 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 3.2999999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.94999999999999996 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 3.4100000000000001 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.671 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.8700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.765 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 1.3500000000000001 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.4100000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 1.51 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.6599999999999999 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.873 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.6099999999999999 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.6100000000000001 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.418 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 2.25 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.3 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.621 ' HZ3' ' HB3' ' A' ' 138' ' ' LYS . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 3.1099999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.873 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.91000000000000003 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.464 ' O ' HG11 ' A' ' 127' ' ' VAL . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.90000000000000002 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.751 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.98999999999999999 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.6000000000000001 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 2.0699999999999998 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.751 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.22 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.476 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.24 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.809 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 3.3900000000000001 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.908 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.5800000000000001 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.55 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.848 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 1.0 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.81999999999999995 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.848 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.7999999999999998 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.809 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.98 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.3799999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.7200000000000002 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 3.1000000000000001 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . 0.594 HD22 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.6000000000000001 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 2.1000000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.6599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 3.3300000000000001 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.6699999999999999 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.433 ' CD ' ' HH ' ' A' ' 167' ' ' TYR . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.75 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.908 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.51 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.594 ' HB3' HD22 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.57999999999999996 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.48 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.51 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 2.0600000000000001 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.55 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.7799999999999998 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.77 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 5.21 110.285 178.842 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.628 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 3.1400000000000001 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.26 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 3.2999999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.94999999999999996 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 3.4100000000000001 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.628 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.8700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.805 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 1.3500000000000001 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.4100000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 1.51 113.907 -168.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.6599999999999999 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.965 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.6099999999999999 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.6100000000000001 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 2.25 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.3 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.438 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 3.1099999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.965 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.91000000000000003 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.597 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.90000000000000002 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.606 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.98999999999999999 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.6000000000000001 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 2.0699999999999998 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.606 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.22 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.492 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.24 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 3.3900000000000001 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.956 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.5800000000000001 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.622 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.55 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.67 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 1.0 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.81999999999999995 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.67 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.7999999999999998 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.98 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.68 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.3799999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.7200000000000002 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 3.1000000000000001 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.6000000000000001 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.459 HG22 ' CZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 2.1000000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.6599999999999999 108.941 170.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 3.3300000000000001 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.6699999999999999 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.591 HD23 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.75 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.956 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.51 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.68 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.57999999999999996 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.48 110.541 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.51 110.325 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 2.0600000000000001 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.55 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.579 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.7799999999999998 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.77 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 5.21 110.818 -177.261 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 3.1400000000000001 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.26 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.428 ' HA ' ' HD2' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 3.2999999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.94999999999999996 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 3.4100000000000001 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.74 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.8700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 1.3500000000000001 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.4100000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 1.51 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.6599999999999999 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.699 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.6099999999999999 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.6100000000000001 108.478 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 2.25 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.3 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.402 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 3.1099999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.699 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.91000000000000003 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.402 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.90000000000000002 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.98999999999999999 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.437 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.6000000000000001 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 2.0699999999999998 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.22 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.547 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.24 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.803 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 3.3900000000000001 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 1.05 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.5800000000000001 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.55 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.603 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 1.0 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.81999999999999995 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.603 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.7999999999999998 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.803 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.98 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.591 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.3799999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.7200000000000002 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 3.1000000000000001 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.6000000000000001 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 2.1000000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.6599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 3.3300000000000001 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.6699999999999999 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.75 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 1.05 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.51 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.591 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.57999999999999996 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.48 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.51 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 2.0600000000000001 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.55 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.7799999999999998 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.77 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 5.21 112.59 -178.961 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 3.1400000000000001 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.26 112.455 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.593 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 3.2999999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.94999999999999996 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.558 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 3.4100000000000001 110.063 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.8700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 1.3500000000000001 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.4100000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 1.51 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.6599999999999999 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.615 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.6099999999999999 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.6100000000000001 108.577 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.614 ' HE2' ' HD2' ' A' ' 132' ' ' LYS . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 2.25 113.35 -168.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.3 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.576 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 3.1099999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.615 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.91000000000000003 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.576 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.90000000000000002 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.595 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 28.8 m80 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.98999999999999999 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.6000000000000001 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 2.0699999999999998 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.595 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.22 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.24 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 3.3900000000000001 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.5800000000000001 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.55 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 1.0 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.81999999999999995 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.7999999999999998 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.98 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.723 HD22 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.3799999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.7200000000000002 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 3.1000000000000001 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.6000000000000001 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 2.1000000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.6599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.798 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 3.3300000000000001 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.423 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.6699999999999999 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . 0.477 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.497 HD23 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.75 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.587 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.51 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.723 ' SG ' HD22 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.57999999999999996 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.48 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.51 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . 0.798 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 2.0600000000000001 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.55 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.7799999999999998 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.77 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 5.21 111.661 -175.655 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 3.1400000000000001 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.26 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.421 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 3.2999999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.94999999999999996 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.768 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 3.4100000000000001 110.054 -170.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.8700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 1.3500000000000001 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.4100000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.472 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 1.51 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.6599999999999999 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.527 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.6099999999999999 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.484 HG21 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.6100000000000001 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 2.25 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.3 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.424 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 3.1099999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.91000000000000003 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.484 ' HB2' HG21 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.90000000000000002 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 36.5 m80 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.98999999999999999 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.6000000000000001 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 2.0699999999999998 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.22 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PHE . . . . . 0.583 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.24 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.559 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 3.3900000000000001 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' CYS . . . . . 0.821 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.5800000000000001 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.699 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.55 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.902 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 1.0 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.81999999999999995 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.902 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.7999999999999998 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.98 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.584 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.3799999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.7200000000000002 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 3.1000000000000001 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.6000000000000001 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.958 ' HB ' HD13 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 2.1000000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.6599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 3.3300000000000001 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.6699999999999999 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . 0.958 HD13 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.75 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.51 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' CYS . . . . . 0.584 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.57999999999999996 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.48 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.51 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 2.0600000000000001 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.55 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.7799999999999998 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.77 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 5.21 114.209 177.608 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 2.7599999999999998 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.0 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 2.8199999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.88 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 2.9900000000000002 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.3700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 0.80000000000000004 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.402 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.0800000000000001 110.835 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 0.94999999999999996 114.319 -167.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.21 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.932 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.1800000000000002 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.02 108.284 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 1.78 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.04 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 2.6899999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.932 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.71999999999999997 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.78000000000000003 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.71999999999999997 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.1899999999999999 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.683 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 1.47 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.1399999999999999 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.1299999999999999 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 2.7799999999999998 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.02 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.02 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 0.87 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.76000000000000001 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.3700000000000001 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.46 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.5800000000000001 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 2.6699999999999999 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.602 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.2999999999999998 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.678 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 1.5900000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.1599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 2.9500000000000002 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.46 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.25 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.52000000000000002 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.1200000000000001 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.02 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 1.78 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.05 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.3599999999999999 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.6499999999999999 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 4.3200000000000003 111.199 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 2.7599999999999998 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.0 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.777 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.88 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 2.9900000000000002 110.638 -174.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.3700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.767 HG22 ' CE1' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 0.80000000000000004 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.0800000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 0.94999999999999996 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.21 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.507 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.1800000000000002 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.02 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 1.78 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.04 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 2.6899999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.71999999999999997 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.556 ' CZ3' HD21 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.78000000000000003 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 56.7 m-70 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.1899999999999999 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 1.47 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.813 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.1299999999999999 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 2.7799999999999998 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.02 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.02 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 0.87 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.76000000000000001 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.3700000000000001 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.46 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.1299999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.5800000000000001 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 2.6699999999999999 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.2999999999999998 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 1.5900000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.1599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 2.9500000000000002 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.46 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.25 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.995 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.23 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.52000000000000002 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.1200000000000001 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.02 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.799 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 1.78 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.05 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.3599999999999999 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.6499999999999999 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 4.3200000000000003 111.711 -178.508 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 2.7599999999999998 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.0 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.792 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 2.8199999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.88 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 2.9900000000000002 111.726 -172.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.3700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.759 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.80000000000000004 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.0800000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 0.94999999999999996 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.21 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.1800000000000002 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 1.78 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.04 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.444 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 2.6899999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.71999999999999997 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.46 ' CH2' ' HG2' ' A' ' 121' ' ' PRO . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.78000000000000003 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.535 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 10.1 m-70 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.71999999999999997 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.1899999999999999 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 1.47 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.594 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.1299999999999999 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 2.7799999999999998 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.912 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.02 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.02 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.87 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.76000000000000001 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.3700000000000001 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.46 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.1299999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.5800000000000001 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 2.6699999999999999 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.2999999999999998 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 1.5900000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.732 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 2.9500000000000002 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.25 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.912 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.23 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.52000000000000002 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.1200000000000001 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.02 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.732 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.05 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.3599999999999999 111.868 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.6499999999999999 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 4.3200000000000003 111.522 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 2.7599999999999998 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.0 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 2.8199999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.88 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 2.9900000000000002 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.3700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.71 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 0.80000000000000004 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.0800000000000001 110.79 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 0.94999999999999996 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.21 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.1800000000000002 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.02 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 1.78 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.04 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 2.6899999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.71999999999999997 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.461 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.78000000000000003 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.71 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.71999999999999997 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.1899999999999999 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 1.47 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.1299999999999999 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.872 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 2.7799999999999998 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.918 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.02 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.02 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 0.87 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.76000000000000001 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.3700000000000001 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.872 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.46 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.1299999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.5800000000000001 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 2.6699999999999999 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.2999999999999998 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 1.5900000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.1599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.551 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 2.9500000000000002 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.46 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.461 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.25 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.918 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.1200000000000001 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.02 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.988 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 1.78 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.05 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.988 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.3599999999999999 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.6499999999999999 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 4.3200000000000003 112.761 175.083 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 2.7599999999999998 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.0 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 2.8199999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.88 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 2.9900000000000002 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.3700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 0.80000000000000004 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.0800000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 0.94999999999999996 114.212 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.21 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.1800000000000002 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.02 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 1.78 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 145' ' ' PHE . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.04 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 2.6899999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.862 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.71999999999999997 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.1899999999999999 110.406 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 1.47 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.1399999999999999 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.1299999999999999 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 2.7799999999999998 108.619 -173.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.02 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 0.87 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.76000000000000001 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.3700000000000001 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.46 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.1299999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.5800000000000001 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 2.6699999999999999 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.2999999999999998 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.1599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 2.9500000000000002 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.46 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.23 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.643 ' HA ' HD21 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.52000000000000002 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.1200000000000001 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.02 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 1.78 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.05 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.3599999999999999 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.6499999999999999 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 4.3200000000000003 112.179 -177.491 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 2.7599999999999998 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.0 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 2.8199999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.88 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 2.9900000000000002 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.3700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.80000000000000004 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.815 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.0800000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 0.94999999999999996 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.21 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.815 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.951 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.1800000000000002 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.02 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 1.78 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.04 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 2.6899999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.951 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.71999999999999997 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.78000000000000003 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.839 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.71999999999999997 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.1899999999999999 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 1.47 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.839 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.1399999999999999 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.571 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.1299999999999999 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 2.7799999999999998 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.891 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.02 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.02 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.959 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 0.87 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.76000000000000001 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.959 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.3700000000000001 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.46 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.5800000000000001 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 2.6699999999999999 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.2999999999999998 110.116 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 1.5900000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.1599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 2.9500000000000002 110.545 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.46 112.348 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.25 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.891 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.23 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.459 ' HA ' HD21 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.52000000000000002 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.1200000000000001 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.02 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 1.78 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.05 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.3599999999999999 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.6499999999999999 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.831 178.092 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 2.7599999999999998 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.0 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 2.8199999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.88 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 2.9900000000000002 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.3700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.992 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 0.80000000000000004 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.0800000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 0.94999999999999996 113.582 -169.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' H ' ' HD1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.21 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.792 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.1800000000000002 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.02 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 1.78 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.04 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.548 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 2.6899999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.992 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.71999999999999997 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.548 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.78000000000000003 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.71999999999999997 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.1899999999999999 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 1.47 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.1399999999999999 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.1299999999999999 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 2.7799999999999998 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.02 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.636 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.02 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 0.87 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.76000000000000001 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.3700000000000001 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.742 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.46 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.696 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.1299999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.5800000000000001 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 2.6699999999999999 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.2999999999999998 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 1.5900000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.1599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 2.9500000000000002 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.46 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.25 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.23 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.696 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.52000000000000002 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.1200000000000001 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.02 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 1.78 110.67 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.05 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.3599999999999999 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.6499999999999999 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 4.3200000000000003 115.229 179.83 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 2.7599999999999998 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.0 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 2.8199999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.88 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 2.9900000000000002 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.3700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 0.80000000000000004 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.0800000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 0.94999999999999996 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.21 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.1800000000000002 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 1.78 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.04 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 2.6899999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.74 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.71999999999999997 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.71999999999999997 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.1899999999999999 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.409 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.47 112.248 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.1399999999999999 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.1299999999999999 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 2.7799999999999998 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.02 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.02 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 0.87 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.76000000000000001 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.3700000000000001 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.46 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.1299999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.5800000000000001 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 2.6699999999999999 112.409 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.2999999999999998 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 1.5900000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.1599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.608 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 2.9500000000000002 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.46 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.25 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.23 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' HB3' HD22 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.52000000000000002 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.1200000000000001 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.02 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 1.78 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.05 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.3599999999999999 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.6499999999999999 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 4.3200000000000003 112.751 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 2.7599999999999998 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.0 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 2.8199999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.88 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 2.9900000000000002 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.0800000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 0.94999999999999996 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.21 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.966 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 1.78 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.04 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 2.6899999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.797 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.71999999999999997 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.78000000000000003 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.765 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.71999999999999997 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.966 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.1899999999999999 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 1.47 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.765 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.1399999999999999 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.938 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 2.7799999999999998 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.02 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.604 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.02 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 0.87 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.76000000000000001 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.3700000000000001 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.938 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.46 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.1299999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.5800000000000001 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 2.6699999999999999 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.2999999999999998 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 1.5900000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.577 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 2.9500000000000002 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.46 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD21 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.25 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 1.001 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.23 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.1200000000000001 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.02 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 1.78 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.05 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.699 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.3599999999999999 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.6499999999999999 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 4.3200000000000003 110.648 -177.576 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.0 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 2.8199999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.88 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 2.9900000000000002 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.3700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 0.80000000000000004 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.0800000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 0.94999999999999996 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.21 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.1800000000000002 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.02 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 1.78 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.04 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 2.6899999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.82 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.71999999999999997 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.71999999999999997 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.1899999999999999 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 1.47 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.1399999999999999 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.1299999999999999 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 2.7799999999999998 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.883 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.02 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.02 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 0.87 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.76000000000000001 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.627 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.3700000000000001 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.46 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.1299999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.5800000000000001 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 2.6699999999999999 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.95 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.2999999999999998 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 1.5900000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.1599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.461 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.46 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.25 108.18 -175.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.883 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.23 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.52000000000000002 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.95 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.1200000000000001 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.02 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 1.78 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.05 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.3599999999999999 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.6499999999999999 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 4.3200000000000003 113.665 -178.101 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.0 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 2.8199999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.88 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 2.9900000000000002 110.403 -170.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.524 HG22 ' CE1' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 0.80000000000000004 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.0800000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 0.94999999999999996 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.47 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.706 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.1800000000000002 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.02 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 1.78 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.04 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 2.6899999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.706 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.71999999999999997 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.78000000000000003 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 17.5 m-70 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.71999999999999997 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.1899999999999999 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 1.47 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.1299999999999999 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 2.7799999999999998 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.02 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.584 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.02 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.897 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 0.87 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.76000000000000001 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.897 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.3700000000000001 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.46 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.1299999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.5800000000000001 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 2.6699999999999999 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.2999999999999998 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 1.5900000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 2.9500000000000002 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.25 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.23 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.52000000000000002 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.1200000000000001 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.02 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.464 ' HA ' ' OD1' ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 1.78 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.05 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.3599999999999999 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 172' ' ' TYR . 2.5 p-10 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.6499999999999999 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 4.3200000000000003 112.743 178.344 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 2.7599999999999998 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.0 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 2.8199999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.88 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 2.9900000000000002 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.3700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 0.80000000000000004 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.0800000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 0.94999999999999996 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.21 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.884 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.1800000000000002 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.02 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 1.78 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.04 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 2.6899999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.884 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.71999999999999997 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.78000000000000003 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.71999999999999997 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 1.47 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.1399999999999999 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.642 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.1299999999999999 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.949 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 2.7799999999999998 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.02 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.02 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 0.87 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.76000000000000001 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.3700000000000001 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.949 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.46 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.1299999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.5800000000000001 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.45 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 2.6699999999999999 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.677 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.2999999999999998 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 1.5900000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.1599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.475 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 2.9500000000000002 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.46 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.25 109.051 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.23 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.52000000000000002 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.677 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.1200000000000001 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.02 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.494 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 1.78 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.662 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.05 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.3599999999999999 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.6499999999999999 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.662 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 4.3200000000000003 113.583 -166.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 2.7599999999999998 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.0 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.755 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 2.8199999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.88 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 2.9900000000000002 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.3700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.93 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.0800000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.94999999999999996 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.21 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.65 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.1800000000000002 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.02 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 1.78 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.04 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 2.6899999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.93 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.71999999999999997 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.78000000000000003 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.71999999999999997 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.1899999999999999 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 1.47 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.755 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.1399999999999999 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.576 ' HB2' HG21 ' A' ' 133' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.1299999999999999 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 2.7799999999999998 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.947 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.02 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 0.87 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.76000000000000001 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.3700000000000001 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.46 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.1299999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.5800000000000001 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.2999999999999998 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 1.5900000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.1599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.46 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.25 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.23 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.52000000000000002 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.1200000000000001 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.02 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 168' ' ' CYS . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 1.78 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.05 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.3599999999999999 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.57 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 4.3200000000000003 110.385 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 2.7599999999999998 109.908 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.0 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.433 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 2.8199999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.88 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.696 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 2.9900000000000002 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.3700000000000001 110.842 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.484 HG22 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 0.80000000000000004 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.0800000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 0.94999999999999996 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.21 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.838 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.1800000000000002 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.02 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 1.78 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.04 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 2.6899999999999999 110.022 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.838 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.71999999999999997 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.78000000000000003 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.71999999999999997 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.1899999999999999 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' THR . . . . . 0.624 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 1.47 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.1399999999999999 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.1299999999999999 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 2.7799999999999998 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.718 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.02 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.649 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.02 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 0.87 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.76000000000000001 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.722 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.3700000000000001 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.67 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.46 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.742 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.1299999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.5800000000000001 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 2.6699999999999999 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.2999999999999998 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 1.5900000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.584 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 2.9500000000000002 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.46 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.25 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.23 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.623 ' SG ' HD21 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.52000000000000002 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.1200000000000001 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.02 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 1.78 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.05 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.3599999999999999 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.6499999999999999 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 4.3200000000000003 110.79 -175.361 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 2.7599999999999998 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.0 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.606 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 2.8199999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.88 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 2.9900000000000002 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.3700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 0.80000000000000004 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.0800000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 0.94999999999999996 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.21 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.954 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.1800000000000002 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.02 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 1.78 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.04 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 2.6899999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.954 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.71999999999999997 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.495 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.78000000000000003 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.832 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.71999999999999997 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.1899999999999999 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 1.47 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.832 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.565 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.1299999999999999 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 2.7799999999999998 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 1.081 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.02 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.02 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 0.87 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.76000000000000001 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.3700000000000001 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.46 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.5800000000000001 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 2.6699999999999999 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.589 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.2999999999999998 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 1.5900000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.1599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 2.9500000000000002 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.46 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.25 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 1.081 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.23 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.52000000000000002 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.1200000000000001 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.02 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 1.78 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.05 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.3599999999999999 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.6499999999999999 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 4.3200000000000003 110.217 -178.805 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 2.7599999999999998 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.0 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 2.8199999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.88 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 2.9900000000000002 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.697 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.3700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 0.80000000000000004 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.0800000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 0.94999999999999996 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.21 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.1800000000000002 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.02 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 1.78 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.04 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 2.6899999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.71999999999999997 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.466 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.78000000000000003 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.71999999999999997 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.1899999999999999 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 1.47 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.1399999999999999 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.1299999999999999 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.817 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 2.7799999999999998 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.937 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.02 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.02 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 0.87 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.76000000000000001 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.3700000000000001 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.817 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.46 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.1299999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.5800000000000001 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 2.6699999999999999 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASN . . . . . 0.618 HD21 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 1.5900000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 2.9500000000000002 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.46 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.25 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.937 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.23 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HB3' HD21 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.52000000000000002 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.1200000000000001 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.02 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 1.78 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.05 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.3599999999999999 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.6499999999999999 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 4.3200000000000003 110.285 178.842 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 2.7599999999999998 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.0 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 2.8199999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.88 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 2.9900000000000002 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.3700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.0800000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 0.94999999999999996 113.907 -168.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.21 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.957 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.1800000000000002 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.02 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 1.78 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.04 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 2.6899999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.957 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.71999999999999997 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.78000000000000003 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.71999999999999997 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.1899999999999999 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.47 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.1399999999999999 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.498 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.1299999999999999 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 2.7799999999999998 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.972 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.02 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.02 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 0.87 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.76000000000000001 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.3700000000000001 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.46 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.1299999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.5800000000000001 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 2.6699999999999999 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.2999999999999998 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 1.5900000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 169' ' ' LYS . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 108.941 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 2.9500000000000002 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.46 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.6 HD21 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.25 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.972 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.23 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.52000000000000002 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 160' ' ' THR . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.1200000000000001 110.541 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.02 110.325 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.78 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.05 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.3599999999999999 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.6499999999999999 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 4.3200000000000003 110.818 -177.261 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.0 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 2.8199999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.88 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 2.9900000000000002 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.0800000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.493 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 0.94999999999999996 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.21 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.1800000000000002 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 140' ' ' TRP . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.02 108.478 165.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 1.78 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.04 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 2.6899999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.71999999999999997 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.71999999999999997 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.1899999999999999 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 1.47 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.1399999999999999 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.1299999999999999 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.821 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 2.7799999999999998 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.02 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.02 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 0.87 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.76000000000000001 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.3700000000000001 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.46 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.1299999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.5800000000000001 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 2.6699999999999999 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.2999999999999998 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 1.5900000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.1599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 2.9500000000000002 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.46 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.25 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.23 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.52000000000000002 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.1200000000000001 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.02 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 1.78 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.05 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.3599999999999999 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.6499999999999999 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 4.3200000000000003 112.59 -178.961 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 2.7599999999999998 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 119' ' ' LYS . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.0 112.455 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.598 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 2.8199999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.88 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 2.9900000000000002 110.063 -172.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.3700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.0800000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 0.94999999999999996 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.21 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.1800000000000002 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 140' ' ' TRP . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.02 108.577 167.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 1.78 113.35 -168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.04 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 2.6899999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.71999999999999997 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.585 ' HZ3' ' HG2' ' A' ' 122' ' ' ARG . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.1 m-70 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.71999999999999997 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 1.47 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.1399999999999999 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.1299999999999999 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 2.7799999999999998 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.02 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.02 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 0.87 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.76000000000000001 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.46 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.731 HD21 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.5800000000000001 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 2.6699999999999999 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.2999999999999998 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 1.5900000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.1599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.803 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 2.9500000000000002 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.46 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . 0.493 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.25 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.23 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.52000000000000002 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.1200000000000001 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.02 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' TYR . . . . . 0.803 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.78 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.05 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.3599999999999999 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.6499999999999999 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 4.3200000000000003 111.661 -175.655 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 2.7599999999999998 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.0 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 2.8199999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.88 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 2.9900000000000002 110.054 -170.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.3700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.712 HG22 ' CE1' ' A' ' 141' ' ' HIS . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 0.80000000000000004 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.0800000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 0.94999999999999996 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.21 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.1800000000000002 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.02 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 1.78 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.04 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 2.6899999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.71999999999999997 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.517 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.78000000000000003 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 77.8 m-70 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.71999999999999997 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.1899999999999999 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 1.47 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.1399999999999999 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.1299999999999999 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 2.7799999999999998 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.02 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.712 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.02 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.916 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 0.87 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.76000000000000001 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.916 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.3700000000000001 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.46 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.1299999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.5800000000000001 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 2.6699999999999999 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.2999999999999998 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 1.5900000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.1599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 2.9500000000000002 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.46 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.849 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.23 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' CYS . . . . . 0.59 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.52000000000000002 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.1200000000000001 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.02 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.05 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.3599999999999999 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.6499999999999999 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 4.3200000000000003 114.209 177.608 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 2.7599999999999998 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.0 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 2.8199999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.88 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 2.9900000000000002 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.3700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 0.80000000000000004 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.402 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.0800000000000001 110.835 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 0.94999999999999996 114.319 -167.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.21 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.932 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.1800000000000002 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.02 108.284 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 1.78 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.04 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 2.6899999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.932 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.71999999999999997 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.78000000000000003 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.71999999999999997 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.1899999999999999 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.683 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 1.47 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.1399999999999999 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.1299999999999999 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 2.7799999999999998 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.02 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.02 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 0.87 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.76000000000000001 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.3700000000000001 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.46 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.5800000000000001 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 2.6699999999999999 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.602 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.2999999999999998 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.678 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 1.5900000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.1599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 2.9500000000000002 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.46 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.25 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.52000000000000002 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.1200000000000001 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.02 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 1.78 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.05 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.3599999999999999 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.6499999999999999 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 4.3200000000000003 111.199 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 2.7599999999999998 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.0 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.777 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.88 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.779 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 2.9900000000000002 110.638 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.3700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.567 HG22 ' NE2' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 0.80000000000000004 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.0800000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 0.94999999999999996 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.21 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.507 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.1800000000000002 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.02 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 1.78 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.04 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 2.6899999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.71999999999999997 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.556 ' CZ3' HD21 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.78000000000000003 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.7 m170 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.1899999999999999 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 1.47 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.813 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.1299999999999999 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 2.7799999999999998 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.02 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.02 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 0.87 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.76000000000000001 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.3700000000000001 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.46 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.1299999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.5800000000000001 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 2.6699999999999999 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.2999999999999998 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 1.5900000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.1599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 2.9500000000000002 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.46 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.25 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.995 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.23 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.52000000000000002 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.1200000000000001 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.02 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.799 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 1.78 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.05 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.3599999999999999 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.6499999999999999 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 4.3200000000000003 111.711 -178.508 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 2.7599999999999998 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.0 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.792 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 2.8199999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.88 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.456 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 2.9900000000000002 111.726 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.3700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.759 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.80000000000000004 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.0800000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 0.94999999999999996 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.21 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.1800000000000002 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 1.78 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.04 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 2.6899999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.71999999999999997 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.46 ' CH2' ' HG2' ' A' ' 121' ' ' PRO . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.78000000000000003 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.654 ' CD2' HG22 ' A' ' 127' ' ' VAL . 44.7 m170 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.71999999999999997 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.1899999999999999 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 1.47 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.594 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.1299999999999999 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 2.7799999999999998 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.912 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.02 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.02 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.87 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.76000000000000001 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.3700000000000001 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.46 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.1299999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.5800000000000001 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 2.6699999999999999 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.2999999999999998 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 1.5900000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.732 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 2.9500000000000002 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.25 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.912 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.23 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.52000000000000002 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.1200000000000001 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.02 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.732 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.05 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.3599999999999999 111.868 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.6499999999999999 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 4.3200000000000003 111.522 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 2.7599999999999998 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.0 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 2.8199999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.88 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 2.9900000000000002 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.3700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.71 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 0.80000000000000004 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.0800000000000001 110.79 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 0.94999999999999996 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.21 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.1800000000000002 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.02 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 1.78 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.04 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 2.6899999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.71999999999999997 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.461 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.78000000000000003 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.71 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.71999999999999997 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.1899999999999999 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 1.47 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.1299999999999999 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.872 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 2.7799999999999998 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.918 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.02 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.02 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 0.87 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.76000000000000001 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.3700000000000001 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.872 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.46 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.1299999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.5800000000000001 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 2.6699999999999999 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.2999999999999998 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 1.5900000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.1599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.551 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 2.9500000000000002 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.46 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.25 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.918 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.1200000000000001 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.02 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.988 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 1.78 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.05 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.988 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.3599999999999999 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.6499999999999999 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 4.3200000000000003 112.761 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 2.7599999999999998 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.0 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 2.8199999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.88 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 2.9900000000000002 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.3700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 0.80000000000000004 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.0800000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 0.94999999999999996 114.212 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.21 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.1800000000000002 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.02 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 1.78 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 145' ' ' PHE . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.04 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 2.6899999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.862 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.71999999999999997 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.1899999999999999 110.406 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 1.47 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.1399999999999999 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.1299999999999999 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 2.7799999999999998 108.619 -173.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.02 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 0.87 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.76000000000000001 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.3700000000000001 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.46 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.1299999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.5800000000000001 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 2.6699999999999999 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.2999999999999998 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.1599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 2.9500000000000002 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.46 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.23 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.643 ' HA ' HD21 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.52000000000000002 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.1200000000000001 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.02 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 1.78 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.05 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.3599999999999999 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.6499999999999999 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 4.3200000000000003 112.179 -177.491 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 2.7599999999999998 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.0 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 2.8199999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.88 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 2.9900000000000002 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.3700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.80000000000000004 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.815 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.0800000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 0.94999999999999996 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.21 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.815 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.951 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.1800000000000002 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.02 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 1.78 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.04 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 2.6899999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.951 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.71999999999999997 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.78000000000000003 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.839 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.71999999999999997 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.1899999999999999 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 1.47 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.839 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.1399999999999999 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.571 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.1299999999999999 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 2.7799999999999998 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.891 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.02 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.02 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.959 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 0.87 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.76000000000000001 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.959 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.3700000000000001 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.46 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.5800000000000001 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 2.6699999999999999 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.2999999999999998 110.116 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 1.5900000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.1599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 2.9500000000000002 110.545 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.46 112.348 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.25 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.891 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.23 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.459 ' HA ' HD21 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.52000000000000002 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.1200000000000001 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.02 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 1.78 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.05 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.3599999999999999 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.6499999999999999 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.831 178.092 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 2.7599999999999998 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.0 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 2.8199999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.88 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 2.9900000000000002 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.3700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.992 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 0.80000000000000004 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.0800000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 0.94999999999999996 113.582 -169.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' H ' ' HD1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.21 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.792 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.1800000000000002 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.02 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 1.78 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.04 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.548 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 2.6899999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.992 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.71999999999999997 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.548 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.78000000000000003 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.71999999999999997 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.1899999999999999 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 1.47 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.1399999999999999 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.1299999999999999 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 2.7799999999999998 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.02 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.636 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.02 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 0.87 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.76000000000000001 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.3700000000000001 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.742 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.46 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.696 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.1299999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.5800000000000001 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 2.6699999999999999 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.2999999999999998 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 1.5900000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.1599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 2.9500000000000002 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.46 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.25 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.23 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.696 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.52000000000000002 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.1200000000000001 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.02 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 1.78 110.67 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.05 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.3599999999999999 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.6499999999999999 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 4.3200000000000003 115.229 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 2.7599999999999998 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.0 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 2.8199999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.88 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 2.9900000000000002 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.3700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 0.80000000000000004 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.0800000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 0.94999999999999996 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.21 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.1800000000000002 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 1.78 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.04 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 2.6899999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.74 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.71999999999999997 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.71999999999999997 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.1899999999999999 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.409 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.47 112.248 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.1399999999999999 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.1299999999999999 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 2.7799999999999998 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.02 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.02 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 0.87 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.76000000000000001 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.3700000000000001 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.46 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.1299999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.5800000000000001 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 2.6699999999999999 112.409 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.2999999999999998 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 1.5900000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.1599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.608 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 2.9500000000000002 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.46 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.25 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.23 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' HB3' HD22 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.52000000000000002 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.1200000000000001 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.02 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 1.78 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.05 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.3599999999999999 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.6499999999999999 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 4.3200000000000003 112.751 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 2.7599999999999998 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.0 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 2.8199999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.88 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 2.9900000000000002 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.0800000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 0.94999999999999996 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.21 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.966 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 1.78 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.04 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 2.6899999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.797 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.71999999999999997 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.78000000000000003 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.765 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.71999999999999997 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.966 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.1899999999999999 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 1.47 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.765 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.1399999999999999 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.938 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 2.7799999999999998 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.02 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.604 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.02 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 0.87 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.76000000000000001 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.3700000000000001 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.938 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.46 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.1299999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.5800000000000001 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 2.6699999999999999 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.2999999999999998 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 1.5900000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.577 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 2.9500000000000002 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.46 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD21 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.25 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 1.001 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.23 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.1200000000000001 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.02 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 1.78 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.05 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.699 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.3599999999999999 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.6499999999999999 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 4.3200000000000003 110.648 -177.576 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.0 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 2.8199999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.88 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 2.9900000000000002 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.3700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 0.80000000000000004 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.0800000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 0.94999999999999996 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.21 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.1800000000000002 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.02 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 1.78 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.04 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 2.6899999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.82 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.71999999999999997 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.71999999999999997 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.1899999999999999 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 1.47 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.1399999999999999 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.1299999999999999 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 2.7799999999999998 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.883 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.02 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.02 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 0.87 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.76000000000000001 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.627 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.3700000000000001 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.46 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.1299999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.5800000000000001 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 2.6699999999999999 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.95 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.2999999999999998 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 1.5900000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.1599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.461 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.46 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.25 108.18 -175.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.883 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.23 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.52000000000000002 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.95 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.1200000000000001 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.02 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 1.78 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.05 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.3599999999999999 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.6499999999999999 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 4.3200000000000003 113.665 -178.101 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.0 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 2.8199999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.88 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 2.9900000000000002 110.403 -170.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 0.80000000000000004 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.0800000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 0.94999999999999996 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.47 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.706 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.1800000000000002 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.02 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 1.78 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.04 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 2.6899999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.706 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.71999999999999997 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.78000000000000003 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 18.2 m170 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.71999999999999997 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.1899999999999999 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 1.47 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.1299999999999999 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 2.7799999999999998 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.02 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.584 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.02 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.897 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 0.87 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.76000000000000001 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.897 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.3700000000000001 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.46 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.1299999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.5800000000000001 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 2.6699999999999999 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.2999999999999998 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 1.5900000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 2.9500000000000002 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.25 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.23 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.52000000000000002 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.1200000000000001 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.02 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.464 ' HA ' ' OD1' ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 1.78 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.05 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.3599999999999999 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.464 ' OD1' ' HA ' ' A' ' 172' ' ' TYR . 2.5 p-10 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.6499999999999999 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 4.3200000000000003 112.743 178.344 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 2.7599999999999998 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.0 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 2.8199999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.88 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 2.9900000000000002 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.3700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 0.80000000000000004 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.0800000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 0.94999999999999996 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.21 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.884 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.1800000000000002 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.02 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 1.78 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.04 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 2.6899999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.884 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.71999999999999997 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.78000000000000003 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.71999999999999997 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 1.47 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.1399999999999999 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.642 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.1299999999999999 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.949 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 2.7799999999999998 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.02 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.02 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 0.87 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.76000000000000001 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.3700000000000001 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.949 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.46 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.1299999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.5800000000000001 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.45 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 2.6699999999999999 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.677 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.2999999999999998 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 1.5900000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.1599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.475 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 2.9500000000000002 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.46 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.25 109.051 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.23 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.52000000000000002 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.677 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.1200000000000001 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.02 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.494 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 1.78 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.662 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.05 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.3599999999999999 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.6499999999999999 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.662 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 4.3200000000000003 113.583 -166.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 2.7599999999999998 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.0 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.755 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 2.8199999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.88 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 2.9900000000000002 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.3700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.93 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.0800000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.94999999999999996 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.21 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.65 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.1800000000000002 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.02 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 1.78 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.04 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 2.6899999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.93 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.71999999999999997 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.78000000000000003 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.71999999999999997 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.1899999999999999 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 1.47 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.755 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.1399999999999999 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.576 ' HB2' HG21 ' A' ' 133' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.1299999999999999 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 2.7799999999999998 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.947 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.02 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 0.87 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.76000000000000001 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.3700000000000001 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.46 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.1299999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.5800000000000001 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.2999999999999998 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 1.5900000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.1599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.46 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.25 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.23 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.52000000000000002 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.1200000000000001 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.02 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 168' ' ' CYS . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 1.78 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.05 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.3599999999999999 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.57 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 4.3200000000000003 110.385 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 2.7599999999999998 109.908 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.0 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.433 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 2.8199999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.88 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.696 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 2.9900000000000002 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.3700000000000001 110.842 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.484 HG22 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 0.80000000000000004 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.0800000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 0.94999999999999996 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.21 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.838 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.1800000000000002 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.02 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 1.78 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.04 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 2.6899999999999999 110.022 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.838 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.71999999999999997 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.78000000000000003 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.71999999999999997 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.1899999999999999 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.624 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 1.47 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.1399999999999999 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.1299999999999999 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 2.7799999999999998 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.718 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.02 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.649 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.02 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 0.87 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.76000000000000001 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.722 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.3700000000000001 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.67 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.46 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.742 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.1299999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.5800000000000001 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 2.6699999999999999 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.2999999999999998 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 1.5900000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.584 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 2.9500000000000002 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.46 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.25 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.23 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.623 ' SG ' HD21 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.52000000000000002 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.1200000000000001 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.02 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 1.78 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.05 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.3599999999999999 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.6499999999999999 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 4.3200000000000003 110.79 -175.361 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 2.7599999999999998 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.0 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.606 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 2.8199999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.88 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 2.9900000000000002 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.3700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 0.80000000000000004 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.0800000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 0.94999999999999996 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.21 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.954 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.1800000000000002 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.02 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 1.78 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.04 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 2.6899999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.954 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.71999999999999997 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.495 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.78000000000000003 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.832 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.71999999999999997 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.1899999999999999 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 1.47 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.832 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.565 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.1299999999999999 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 2.7799999999999998 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 1.081 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.02 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.02 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 0.87 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.76000000000000001 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.3700000000000001 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.46 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.5800000000000001 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 2.6699999999999999 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.589 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.2999999999999998 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 1.5900000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.1599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 2.9500000000000002 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.46 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.25 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 1.081 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.23 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.52000000000000002 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.1200000000000001 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.02 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 1.78 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.05 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.3599999999999999 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.6499999999999999 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 4.3200000000000003 110.217 -178.805 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 2.7599999999999998 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.0 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 2.8199999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.88 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 2.9900000000000002 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.697 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.3700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 0.80000000000000004 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.0800000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 0.94999999999999996 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.21 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.1800000000000002 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.02 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 1.78 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.04 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 2.6899999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.71999999999999997 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.466 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.78000000000000003 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.71999999999999997 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.1899999999999999 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 1.47 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.1399999999999999 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.1299999999999999 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.817 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 2.7799999999999998 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.937 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.02 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.02 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 0.87 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.76000000000000001 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.3700000000000001 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.817 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.46 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.1299999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.5800000000000001 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 2.6699999999999999 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . 0.618 HD21 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 1.5900000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 2.9500000000000002 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.46 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.25 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.937 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.23 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HB3' HD21 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.52000000000000002 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.1200000000000001 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.02 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 1.78 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.05 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.3599999999999999 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.6499999999999999 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 4.3200000000000003 110.285 178.842 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 2.7599999999999998 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.0 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 2.8199999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.88 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 2.9900000000000002 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.3700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.0800000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 0.94999999999999996 113.907 -168.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.21 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.957 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.1800000000000002 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.02 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 1.78 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.04 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 2.6899999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.957 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.71999999999999997 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.78000000000000003 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.71999999999999997 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.1899999999999999 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.47 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.1399999999999999 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.498 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.1299999999999999 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 2.7799999999999998 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.972 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.02 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.02 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 0.87 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.76000000000000001 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.3700000000000001 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.46 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.1299999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.5800000000000001 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 2.6699999999999999 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.2999999999999998 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 1.5900000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 169' ' ' LYS . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 108.941 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 2.9500000000000002 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.46 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.6 HD21 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.25 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.972 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.23 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.52000000000000002 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 160' ' ' THR . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.1200000000000001 110.541 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.02 110.325 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.78 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.05 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.3599999999999999 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.6499999999999999 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 4.3200000000000003 110.818 -177.261 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.0 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 2.8199999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.88 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 2.9900000000000002 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.0800000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.493 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 0.94999999999999996 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.21 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.1800000000000002 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 140' ' ' TRP . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.02 108.478 165.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 1.78 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.04 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 2.6899999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.71999999999999997 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.71999999999999997 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.1899999999999999 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 1.47 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.1399999999999999 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.1299999999999999 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.821 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 2.7799999999999998 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.02 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.02 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 0.87 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.76000000000000001 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.3700000000000001 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.46 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.1299999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.5800000000000001 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 2.6699999999999999 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.2999999999999998 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 1.5900000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.1599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 2.9500000000000002 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.46 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.25 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.23 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.52000000000000002 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.1200000000000001 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.02 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 1.78 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.05 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.3599999999999999 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.6499999999999999 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 4.3200000000000003 112.59 -178.961 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 2.7599999999999998 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 119' ' ' LYS . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.0 112.455 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.598 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 2.8199999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.88 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.561 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 2.9900000000000002 110.063 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.3700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.0800000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 0.94999999999999996 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.21 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.1800000000000002 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 140' ' ' TRP . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.02 108.577 167.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 1.78 113.35 -168.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.04 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 2.6899999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.71999999999999997 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.585 ' HZ3' ' HG2' ' A' ' 122' ' ' ARG . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 28.8 m80 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.71999999999999997 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 1.47 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.1399999999999999 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.1299999999999999 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 2.7799999999999998 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.02 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.02 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 0.87 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.76000000000000001 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.46 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.731 HD21 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.5800000000000001 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 2.6699999999999999 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.2999999999999998 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 1.5900000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.1599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.803 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 2.9500000000000002 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.46 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . 0.493 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.25 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.23 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.52000000000000002 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.1200000000000001 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.02 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' TYR . . . . . 0.803 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.78 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.05 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.3599999999999999 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.6499999999999999 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 4.3200000000000003 111.661 -175.655 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 2.7599999999999998 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.0 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 2.8199999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.88 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.771 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 2.9900000000000002 110.054 -170.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.3700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 0.80000000000000004 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.0800000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 0.94999999999999996 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.21 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.1800000000000002 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.02 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 1.78 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.04 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 2.6899999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.71999999999999997 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.517 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.78000000000000003 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 36.5 m80 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.71999999999999997 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.1899999999999999 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 1.47 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.1399999999999999 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.1299999999999999 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 2.7799999999999998 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.02 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.712 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.02 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.916 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 0.87 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.76000000000000001 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.916 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.3700000000000001 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.46 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.1299999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.5800000000000001 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 2.6699999999999999 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.2999999999999998 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 1.5900000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.1599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 2.9500000000000002 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.46 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.849 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.23 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' CYS . . . . . 0.59 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.52000000000000002 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.1200000000000001 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.02 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.05 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.3599999999999999 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.6499999999999999 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 4.3200000000000003 114.209 177.608 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 2.7599999999999998 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.0 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 2.8199999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.88 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 2.9900000000000002 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.3700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 0.80000000000000004 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.402 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.0800000000000001 110.835 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 0.94999999999999996 114.319 -167.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.21 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.932 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.1800000000000002 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.02 108.284 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 1.78 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.04 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 2.6899999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.932 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.71999999999999997 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.78000000000000003 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.71999999999999997 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.1899999999999999 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.683 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 1.47 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.1399999999999999 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.1299999999999999 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 2.7799999999999998 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.02 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.02 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 0.87 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.76000000000000001 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.3700000000000001 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.46 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.5800000000000001 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 2.6699999999999999 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.602 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.2999999999999998 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.678 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 1.5900000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.1599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 2.9500000000000002 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.46 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.25 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.52000000000000002 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.1200000000000001 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.02 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 1.78 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.05 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.3599999999999999 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.6499999999999999 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 4.3200000000000003 111.199 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 2.7599999999999998 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.0 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.777 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.88 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.779 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 2.9900000000000002 110.638 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.3700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.567 HG22 ' NE2' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 0.80000000000000004 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.0800000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 0.94999999999999996 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.21 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.507 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.1800000000000002 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.02 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 1.78 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.04 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 2.6899999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.71999999999999997 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.556 ' CZ3' HD21 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.78000000000000003 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.7 m170 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.1899999999999999 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 1.47 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.813 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.1299999999999999 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 2.7799999999999998 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.02 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.02 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 0.87 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.76000000000000001 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.3700000000000001 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.46 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.1299999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.5800000000000001 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 2.6699999999999999 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.2999999999999998 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 1.5900000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.1599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 2.9500000000000002 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.46 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.25 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.995 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.23 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.52000000000000002 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.1200000000000001 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.02 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.799 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 1.78 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.05 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.3599999999999999 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.6499999999999999 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 4.3200000000000003 111.711 -178.508 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 2.7599999999999998 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.0 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.792 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 2.8199999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.88 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.456 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 2.9900000000000002 111.726 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.3700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.759 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.80000000000000004 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.0800000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 0.94999999999999996 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.21 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.1800000000000002 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 1.78 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.04 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.444 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 2.6899999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.71999999999999997 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.46 ' CH2' ' HG2' ' A' ' 121' ' ' PRO . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.78000000000000003 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.654 ' CD2' HG22 ' A' ' 127' ' ' VAL . 44.7 m170 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.71999999999999997 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.1899999999999999 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 1.47 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.594 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.1299999999999999 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 2.7799999999999998 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.912 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.02 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.02 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.87 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.76000000000000001 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.3700000000000001 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.46 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.1299999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.5800000000000001 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 2.6699999999999999 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.2999999999999998 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 1.5900000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.732 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 2.9500000000000002 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.25 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.912 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.23 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.52000000000000002 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.1200000000000001 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.02 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.732 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.05 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.3599999999999999 111.868 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.6499999999999999 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 4.3200000000000003 111.522 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 2.7599999999999998 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.0 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 2.8199999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.88 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 2.9900000000000002 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.3700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.71 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 0.80000000000000004 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.0800000000000001 110.79 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 0.94999999999999996 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.21 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.1800000000000002 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.02 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 1.78 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.04 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 2.6899999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.71999999999999997 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.461 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.78000000000000003 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.71 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.71999999999999997 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.1899999999999999 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 1.47 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.1299999999999999 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.872 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 2.7799999999999998 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.918 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.02 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.02 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 0.87 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.76000000000000001 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.3700000000000001 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.872 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.46 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.1299999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.5800000000000001 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 2.6699999999999999 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.2999999999999998 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 1.5900000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.1599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.551 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 2.9500000000000002 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.46 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.461 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.25 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.918 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.1200000000000001 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.02 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.988 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 1.78 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.05 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.988 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.3599999999999999 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.6499999999999999 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 4.3200000000000003 112.761 175.083 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 2.7599999999999998 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.0 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 2.8199999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.88 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 2.9900000000000002 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.3700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 0.80000000000000004 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.0800000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 0.94999999999999996 114.212 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.21 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.1800000000000002 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.02 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 1.78 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 145' ' ' PHE . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.04 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 2.6899999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.862 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.71999999999999997 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.1899999999999999 110.406 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 1.47 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.1399999999999999 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.1299999999999999 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 2.7799999999999998 108.619 -173.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.02 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 0.87 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.76000000000000001 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.3700000000000001 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.46 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.1299999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.5800000000000001 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 2.6699999999999999 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.2999999999999998 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.1599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 2.9500000000000002 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.46 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.23 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.643 ' HA ' HD21 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.52000000000000002 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.1200000000000001 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.02 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 1.78 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.05 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.3599999999999999 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.6499999999999999 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 4.3200000000000003 112.179 -177.491 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 2.7599999999999998 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.0 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 2.8199999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.88 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 2.9900000000000002 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.3700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.80000000000000004 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.815 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.0800000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 0.94999999999999996 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.21 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.815 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.951 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.1800000000000002 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.02 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 1.78 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.04 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 2.6899999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.951 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.71999999999999997 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.78000000000000003 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.839 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.71999999999999997 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.1899999999999999 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 1.47 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.839 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.1399999999999999 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.571 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.1299999999999999 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 2.7799999999999998 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.891 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.02 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.02 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.959 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 0.87 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.76000000000000001 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.959 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.3700000000000001 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.46 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.5800000000000001 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 2.6699999999999999 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.2999999999999998 110.116 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 1.5900000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.1599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 2.9500000000000002 110.545 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.46 112.348 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.25 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.891 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.23 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.459 ' HA ' HD21 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.52000000000000002 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.1200000000000001 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.02 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 1.78 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.05 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.3599999999999999 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.6499999999999999 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.831 178.092 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 2.7599999999999998 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.0 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 2.8199999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.88 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 2.9900000000000002 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.3700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.992 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 0.80000000000000004 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.0800000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 0.94999999999999996 113.582 -169.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.542 ' H ' ' HD1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.21 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.792 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.1800000000000002 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.02 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 1.78 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.04 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.548 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 2.6899999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.992 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.71999999999999997 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.548 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.78000000000000003 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.71999999999999997 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.1899999999999999 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 1.47 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.1399999999999999 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.1299999999999999 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 2.7799999999999998 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.02 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.636 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.02 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 0.87 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.76000000000000001 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.3700000000000001 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.742 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.46 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.696 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.1299999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.5800000000000001 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 2.6699999999999999 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.2999999999999998 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 1.5900000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.1599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 2.9500000000000002 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.46 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.25 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.23 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.696 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.52000000000000002 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.1200000000000001 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.02 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 1.78 110.67 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.05 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.3599999999999999 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.6499999999999999 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 4.3200000000000003 115.229 179.83 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 2.7599999999999998 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.0 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 2.8199999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.88 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 2.9900000000000002 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.3700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 0.80000000000000004 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.0800000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 0.94999999999999996 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.21 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.1800000000000002 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 1.78 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.04 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 2.6899999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.74 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.71999999999999997 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.71999999999999997 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.1899999999999999 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.409 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.47 112.248 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.1399999999999999 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.1299999999999999 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 2.7799999999999998 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.02 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.02 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 0.87 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.76000000000000001 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.3700000000000001 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.46 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.1299999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.5800000000000001 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 2.6699999999999999 112.409 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.2999999999999998 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 1.5900000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.1599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.608 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 2.9500000000000002 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.46 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.25 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.23 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' HB3' HD22 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.52000000000000002 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.1200000000000001 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.02 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 1.78 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.05 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.3599999999999999 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.6499999999999999 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 4.3200000000000003 112.751 -179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 2.7599999999999998 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.0 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 2.8199999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.88 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 2.9900000000000002 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.0800000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 0.94999999999999996 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.21 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.966 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 1.78 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.04 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 2.6899999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.797 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.71999999999999997 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.78000000000000003 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.765 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.71999999999999997 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.966 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.1899999999999999 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 1.47 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.765 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.1399999999999999 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.938 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 2.7799999999999998 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.02 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.604 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.02 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 0.87 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.76000000000000001 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.3700000000000001 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.938 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.46 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.1299999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.424 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.5800000000000001 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 2.6699999999999999 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.2999999999999998 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 1.5900000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.577 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 2.9500000000000002 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.46 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.532 HD21 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.25 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 1.001 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.23 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.1200000000000001 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.02 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 1.78 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.05 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.699 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.3599999999999999 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.6499999999999999 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 4.3200000000000003 110.648 -177.576 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.0 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 2.8199999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.88 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 2.9900000000000002 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.3700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 0.80000000000000004 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.0800000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 0.94999999999999996 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.21 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.1800000000000002 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.02 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 1.78 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.04 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 2.6899999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.82 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.71999999999999997 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.71999999999999997 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.1899999999999999 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 1.47 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.1399999999999999 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.1299999999999999 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 2.7799999999999998 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.883 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.02 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.02 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 0.87 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.76000000000000001 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.627 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.3700000000000001 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.46 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.1299999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.5800000000000001 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 2.6699999999999999 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.95 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.2999999999999998 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 1.5900000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.1599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.461 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.46 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.25 108.18 -175.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.883 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.23 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.52000000000000002 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.95 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.1200000000000001 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.02 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 1.78 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.05 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.3599999999999999 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.6499999999999999 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 4.3200000000000003 113.665 -178.101 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.0 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 2.8199999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.88 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 2.9900000000000002 110.403 -170.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 0.80000000000000004 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.0800000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 0.94999999999999996 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.47 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.706 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.1800000000000002 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.02 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 1.78 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.04 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 2.6899999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.706 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.71999999999999997 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.78000000000000003 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 18.2 m170 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.71999999999999997 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.1899999999999999 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 1.47 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.1299999999999999 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 2.7799999999999998 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.02 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.584 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.02 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.897 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 0.87 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.76000000000000001 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.897 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.3700000000000001 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.46 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.1299999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.5800000000000001 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 2.6699999999999999 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.2999999999999998 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 1.5900000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 2.9500000000000002 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.25 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.23 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.52000000000000002 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.1200000000000001 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.02 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' HD21 ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 1.78 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.05 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.3599999999999999 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 172' ' ' TYR . 9.9 p30 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.6499999999999999 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 4.3200000000000003 112.743 178.344 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 2.7599999999999998 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.0 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 2.8199999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.88 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 2.9900000000000002 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.3700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 0.80000000000000004 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.0800000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 0.94999999999999996 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.21 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.884 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.1800000000000002 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.02 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 1.78 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.04 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 2.6899999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.884 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.71999999999999997 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.78000000000000003 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.71999999999999997 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 1.47 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.1399999999999999 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.642 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.1299999999999999 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.949 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 2.7799999999999998 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.02 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.02 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 0.87 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.76000000000000001 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.3700000000000001 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.949 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.46 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.1299999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.5800000000000001 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.45 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 2.6699999999999999 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.677 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.2999999999999998 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 1.5900000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.1599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.475 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 2.9500000000000002 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.46 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.25 109.051 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.23 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.52000000000000002 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.677 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.1200000000000001 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.02 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.494 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 1.78 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.662 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.05 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.3599999999999999 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.6499999999999999 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.662 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 4.3200000000000003 113.583 -166.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 2.7599999999999998 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.0 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.755 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 2.8199999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.88 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 2.9900000000000002 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.3700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.93 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.0800000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.94999999999999996 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.21 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.65 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.1800000000000002 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.02 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 1.78 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.04 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 2.6899999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.93 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.71999999999999997 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.78000000000000003 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.71999999999999997 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.1899999999999999 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 1.47 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.755 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.1399999999999999 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.576 ' HB2' HG21 ' A' ' 133' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.1299999999999999 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 2.7799999999999998 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.947 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.02 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 0.87 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.76000000000000001 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.3700000000000001 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.46 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.1299999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.5800000000000001 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.2999999999999998 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 1.5900000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.1599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.46 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.25 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.23 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.52000000000000002 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.1200000000000001 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.02 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 168' ' ' CYS . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 1.78 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.05 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.3599999999999999 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.57 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 4.3200000000000003 110.385 -178.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 2.7599999999999998 109.908 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.0 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.433 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 2.8199999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.88 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.696 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 2.9900000000000002 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.3700000000000001 110.842 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.484 HG22 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 0.80000000000000004 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.0800000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 0.94999999999999996 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.21 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.838 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.1800000000000002 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.02 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 1.78 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.04 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.4 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 2.6899999999999999 110.022 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.838 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.71999999999999997 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.78000000000000003 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.71999999999999997 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.1899999999999999 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . 0.624 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 1.47 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.1399999999999999 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.1299999999999999 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 2.7799999999999998 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.718 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.02 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.649 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.02 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 0.87 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.76000000000000001 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.722 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.3700000000000001 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.67 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.46 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.742 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.1299999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.5800000000000001 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 2.6699999999999999 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.2999999999999998 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 1.5900000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.584 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 2.9500000000000002 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.46 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.25 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.23 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.623 ' SG ' HD21 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.52000000000000002 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.1200000000000001 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.02 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 1.78 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.05 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.3599999999999999 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.6499999999999999 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 4.3200000000000003 110.79 -175.361 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 2.7599999999999998 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.0 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.606 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 2.8199999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.88 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 2.9900000000000002 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.3700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 0.80000000000000004 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.0800000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 0.94999999999999996 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.21 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.954 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.1800000000000002 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.02 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 1.78 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.04 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 2.6899999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.954 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.71999999999999997 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.495 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.78000000000000003 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.832 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.71999999999999997 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.1899999999999999 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 1.47 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.832 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.565 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.1299999999999999 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 2.7799999999999998 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 1.081 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.02 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.02 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 0.87 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.76000000000000001 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.3700000000000001 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.46 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.5800000000000001 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 2.6699999999999999 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.589 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.2999999999999998 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 1.5900000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.1599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 2.9500000000000002 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.46 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.25 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 1.081 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.23 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.52000000000000002 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.1200000000000001 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.02 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 1.78 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.05 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.3599999999999999 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.6499999999999999 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 4.3200000000000003 110.217 -178.805 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 2.7599999999999998 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.0 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 2.8199999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.88 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 2.9900000000000002 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.697 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.3700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 0.80000000000000004 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.0800000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 0.94999999999999996 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.21 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.1800000000000002 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.02 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 1.78 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.04 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 2.6899999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.71999999999999997 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.466 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.78000000000000003 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.71999999999999997 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.1899999999999999 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 1.47 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.1399999999999999 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.1299999999999999 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.817 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 2.7799999999999998 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.937 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.02 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.02 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 0.87 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.76000000000000001 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.3700000000000001 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.817 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.46 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.1299999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.5800000000000001 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 2.6699999999999999 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . 0.618 HD21 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 1.5900000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 2.9500000000000002 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.46 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.25 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.937 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.23 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HB3' HD21 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.52000000000000002 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.1200000000000001 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.02 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 1.78 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.05 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.3599999999999999 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.6499999999999999 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 4.3200000000000003 110.285 178.842 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 2.7599999999999998 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.0 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 2.8199999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.88 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 2.9900000000000002 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.3700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.0800000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 0.94999999999999996 113.907 -168.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.21 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.957 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.1800000000000002 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.02 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 1.78 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.04 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 2.6899999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.957 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.71999999999999997 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.78000000000000003 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.71999999999999997 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.1899999999999999 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.47 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.1399999999999999 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.498 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.1299999999999999 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 2.7799999999999998 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.972 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.02 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.02 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 0.87 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.76000000000000001 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.3700000000000001 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.46 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.1299999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.5800000000000001 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 2.6699999999999999 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.2999999999999998 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 1.5900000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 169' ' ' LYS . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 108.941 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 2.9500000000000002 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.46 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.6 HD21 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.25 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.972 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.23 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.52000000000000002 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 160' ' ' THR . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.1200000000000001 110.541 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.02 110.325 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.78 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.05 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.3599999999999999 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.6499999999999999 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 4.3200000000000003 110.818 -177.261 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.0 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 2.8199999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.88 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 2.9900000000000002 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.0800000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.493 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 0.94999999999999996 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.21 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.1800000000000002 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 140' ' ' TRP . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.02 108.478 165.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 1.78 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.04 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 2.6899999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.71999999999999997 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.71999999999999997 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.1899999999999999 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 1.47 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.1399999999999999 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.1299999999999999 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.821 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 2.7799999999999998 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.02 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.02 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 0.87 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.76000000000000001 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.3700000000000001 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.46 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.1299999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.5800000000000001 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 2.6699999999999999 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.2999999999999998 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 1.5900000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.1599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 2.9500000000000002 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.46 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.25 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.23 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.52000000000000002 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.1200000000000001 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.02 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 1.78 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.05 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.3599999999999999 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.6499999999999999 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 4.3200000000000003 112.59 -178.961 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 2.7599999999999998 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 119' ' ' LYS . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.0 112.455 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.598 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 2.8199999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.88 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.561 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 2.9900000000000002 110.063 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.3700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.0800000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 0.94999999999999996 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.21 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.1800000000000002 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 140' ' ' TRP . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.02 108.577 167.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 1.78 113.35 -168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.04 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 2.6899999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.71999999999999997 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.585 ' HZ3' ' HG2' ' A' ' 122' ' ' ARG . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 28.8 m80 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.71999999999999997 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 1.47 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.1399999999999999 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.1299999999999999 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 2.7799999999999998 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.02 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.02 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 0.87 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.76000000000000001 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.46 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.731 HD21 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.5800000000000001 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 2.6699999999999999 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.2999999999999998 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 1.5900000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.1599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.803 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 2.9500000000000002 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.46 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . 0.493 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.25 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.23 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.52000000000000002 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.1200000000000001 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.02 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . 0.803 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.78 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.05 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.3599999999999999 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.6499999999999999 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 4.3200000000000003 111.661 -175.655 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 2.7599999999999998 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.0 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 2.8199999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.88 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.771 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 2.9900000000000002 110.054 -170.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.3700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 0.80000000000000004 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.0800000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 0.94999999999999996 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.21 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.1800000000000002 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.02 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 1.78 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.04 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 2.6899999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.71999999999999997 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.517 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.78000000000000003 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 36.5 m80 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.71999999999999997 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.1899999999999999 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 1.47 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.1399999999999999 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.1299999999999999 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 2.7799999999999998 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.02 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.712 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.02 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.916 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 0.87 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.76000000000000001 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.916 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.3700000000000001 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.46 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.1299999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.5800000000000001 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 2.6699999999999999 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.2999999999999998 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 1.5900000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.1599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 2.9500000000000002 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.46 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.849 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.23 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' CYS . . . . . 0.59 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.52000000000000002 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.1200000000000001 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.02 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.05 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.3599999999999999 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.6499999999999999 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 4.3200000000000003 114.209 177.608 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.553 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.8 mtpp . . . . . 0 N--CA 1.455 -0.178 0 N-CA-C 110.571 -0.159 . . . . 2.7599999999999998 110.571 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 42.7 t -75.12 107.66 4.31 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 108.334 -0.987 . . . . 0.80000000000000004 108.334 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -70.76 -9.36 25.6 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.723 2.282 . . . . 1.0 112.483 -174.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -83.6 -39.9 19.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.062 -0.517 . . . . 2.8199999999999998 109.62 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 59.3 m -99.19 -22.98 15.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.627 -0.715 . . . . 0.88 111.154 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.79 30.48 52.2 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.218 -0.753 . . . . 0.84999999999999998 111.218 -174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 59.9 tptt -121.58 127.46 50.94 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.651 0.262 . . . . 2.9900000000000002 110.784 -174.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.553 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 29.8 m -63.2 138.21 58.47 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.147 -0.478 . . . . 1.3700000000000001 111.545 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.0 t -124.82 143.95 36.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.966 -0.561 . . . . 0.80000000000000004 109.497 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.402 ' C ' ' HB2' ' A' ' 132' ' ' LYS . 1.3 t80 -129.41 -170.14 2.23 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.634 -0.426 . . . . 5.0800000000000001 110.835 177.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -45.25 -36.39 3.95 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.319 1.229 . . . . 0.94999999999999996 114.319 -167.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.79 -49.28 71.33 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.945 0.35 . . . . 1.21 111.945 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -114.14 16.46 18.08 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 2.4399999999999999 110.283 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.932 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 68.5 tttt -67.92 90.75 0.31 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.661 0.743 . . . . 2.1800000000000002 112.31 -173.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.9 m -109.28 112.81 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 108.284 -1.006 . . . . 1.02 108.284 168.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.8 mtp -85.03 98.65 10.53 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.785 -0.643 . . . . 1.78 112.562 -166.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -102.32 126.31 8.82 Favored Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 110.265 -1.134 . . . . 0.77000000000000002 110.265 167.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 66.85 28.52 73.82 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.31 -0.948 . . . . 1.72 112.203 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 81.89 7.46 87.92 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.581 -0.342 . . . . 1.04 113.598 176.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -136.77 142.76 40.05 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 117.484 0.642 . . . . 2.6899999999999999 110.81 -178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.932 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 29.7 Cg_endo -64.36 121.62 9.29 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.781 2.321 . . . . 0.71999999999999997 112.989 175.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 166' ' ' LEU . 12.6 m0 -101.12 170.33 8.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.479 -0.934 . . . . 0.78000000000000003 108.479 172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.509 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 32.7 m170 -67.96 136.18 53.53 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.459 -1.311 . . . . 0.71999999999999997 107.459 167.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -56.17 -27.79 55.68 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 120.323 -0.551 . . . . 3.1899999999999999 110.731 177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.683 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 24.8 p -68.13 -33.99 75.52 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.903 -0.59 . . . . 1.47 111.052 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.509 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 7.5 m -99.79 -8.37 24.27 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.776 -0.647 . . . . 1.1399999999999999 110.959 -176.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.678 ' CZ ' ' HB ' ' A' ' 159' ' ' VAL . 24.9 t80 -70.11 73.12 0.45 Allowed 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.602 -1.629 . . . . 1.1299999999999999 106.602 166.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.683 ' HD2' ' O ' ' A' ' 143' ' ' THR . 8.1 ptm180 -153.61 179.51 8.76 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.326 -1.307 . . . . 2.7799999999999998 107.956 -164.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.71 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.2 OUTLIER -117.45 136.37 53.25 Favored 'General case' 0 C--O 1.254 1.328 0 C-N-CA 118.976 -1.09 . . . . 0.68000000000000005 108.682 159.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -0.7 18.16 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 113.174 -1.83 . . . . 1.02 111.986 -177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 68.1 mt -73.75 -46.58 46.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.923 0.392 . . . . 1.02 110.001 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.759 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.6 p -104.83 -29.5 10.48 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-O 121.465 0.65 . . . . 0.87 109.959 -175.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.48 29.14 12.66 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 114.962 -1.017 . . . . 0.76000000000000001 111.241 -174.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 27.4 tttp -107.06 124.58 49.86 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.85 -0.34 . . . . 2.3700000000000001 111.681 -172.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -80.51 144.77 32.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.504 -0.771 . . . . 1.46 110.306 176.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.434 HD21 ' CB ' ' A' ' 168' ' ' CYS . 17.5 mt -107.43 131.33 54.39 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.901 -0.59 . . . . 1.1299999999999999 110.884 -173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 68.4 mm-40 -75.71 83.64 2.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.735 -0.666 . . . . 3.54 112.352 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 m 72.0 -50.13 0.69 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.582 0.753 . . . . 3.5800000000000001 112.42 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.602 HG22 ' H ' ' A' ' 158' ' ' ASN . 1.5 m -112.01 -149.27 0.44 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.77 -0.826 . . . . 2.6699999999999999 108.77 176.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.602 ' H ' HG22 ' A' ' 157' ' ' THR . 32.5 m-80 68.28 22.02 8.24 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.15 0.5 . . . . 2.2999999999999998 109.951 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.678 ' HB ' ' CZ ' ' A' ' 145' ' ' PHE . 1.3 p -94.43 130.73 42.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.466 -0.788 . . . . 1.5900000000000001 111.932 -173.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 21.6 m -138.54 120.81 15.86 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.803 -0.635 . . . . 1.1599999999999999 109.838 170.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -88.8 137.54 32.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.915 0.388 . . . . 2.27 111.273 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.68 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 8.0 tmtm? -139.33 97.99 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.202 -0.666 . . . . 2.9500000000000002 109.202 174.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 64.53 37.08 8.22 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.185 -0.916 . . . . 2.9700000000000002 111.961 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 89.53 -5.18 83.98 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.545 -0.836 . . . . 1.46 112.735 175.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -109.57 135.35 50.7 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.449 -0.574 . . . . 2.21 109.449 179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.525 ' HB3' ' O ' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -83.85 136.72 34.01 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 1.25 110.066 -175.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.71 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 95.4 m-85 -134.05 141.38 47.18 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 116.245 -0.434 . . . . 1.23 110.675 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.66 ' H ' ' HB3' ' A' ' 147' ' ' CYS . 4.6 m -61.85 143.83 55.78 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.699 -0.682 . . . . 0.52000000000000002 109.982 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -59.48 -25.9 64.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.928 0.394 . . . . 3.1200000000000001 110.525 174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.1 t -74.91 -48.79 31.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.967 -0.56 . . . . 1.02 110.247 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 60.8 m -69.78 -29.81 67.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 0.80000000000000004 110.802 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -60.31 -48.57 81.19 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.565 . . . . 1.78 109.958 174.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.64 -24.7 67.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 1.05 111.275 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 18.3 tppt? -81.04 -46.17 15.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.252 -0.431 . . . . 3.3599999999999999 111.069 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -80.61 -41.65 23.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.461 . . . . 2.6499999999999999 111.886 -174.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.498 ' CZ ' ' HG3' ' A' ' 162' ' ' LYS . 88.8 m-85 . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.989 0.423 . . . . 4.3200000000000003 111.199 -177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 35.8 tttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.607 0.242 . . . . 2.7599999999999998 110.984 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.632 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 9.0 t -83.12 112.85 41.79 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 116.043 -0.526 . . . . 0.80000000000000004 110.201 174.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -75.72 -6.16 17.26 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 123.112 2.541 . . . . 1.0 112.166 177.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.777 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 tpm_? -78.56 -45.11 22.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.212 -0.449 . . . . 2.8199999999999998 109.895 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 7.8 m -107.74 -11.84 15.33 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.748 -0.66 . . . . 0.88 111.063 -178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 75.15 28.67 61.76 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 111.379 -0.688 . . . . 0.84999999999999998 111.379 -176.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.779 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 28.4 mmmt -120.44 132.52 55.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.722 0.296 . . . . 2.9900000000000002 110.638 -174.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 4.2 m -68.34 144.5 54.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.996 -0.547 . . . . 1.3700000000000001 110.625 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.567 HG22 ' NE2' ' A' ' 141' ' ' HIS . 11.1 t -126.97 149.73 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 120.668 0.27 . . . . 0.80000000000000004 110.766 -176.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -131.92 -171.02 2.52 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 110.012 -0.366 . . . . 5.0800000000000001 110.012 172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.47 -35.92 53.67 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.946 0.721 . . . . 0.94999999999999996 112.946 -172.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -35.53 64.4 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.443 0.535 . . . . 1.21 112.443 -176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.507 ' OE1' ' HG2' ' A' ' 142' ' ' LYS . 7.0 tp10 -120.99 5.4 10.4 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.205 0.526 . . . . 2.4399999999999999 110.649 -178.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.465 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 2.1 tmmt? -60.64 102.18 0.17 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.918 0.71 . . . . 2.1800000000000002 112.918 -172.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 140' ' ' TRP . 17.2 m -106.92 151.05 8.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 108.344 -0.984 . . . . 1.02 108.344 163.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 93.9 mmm -91.76 85.17 5.55 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.037 0.754 . . . . 1.78 113.037 -165.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 140' ' ' TRP . . . -83.87 86.19 1.53 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.413 -0.898 . . . . 0.77000000000000002 110.989 166.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.55 -103.29 1.83 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.999 -0.62 . . . . 1.72 111.672 -177.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -124.38 14.66 7.75 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 121.068 -0.587 . . . . 1.04 111.868 177.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 67.3 mttm -126.85 141.83 41.67 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.178 -0.304 . . . . 2.6899999999999999 110.178 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HB3' ' CG ' ' A' ' 132' ' ' LYS . 33.8 Cg_endo -66.56 129.9 22.31 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.658 2.239 . . . . 0.71999999999999997 112.438 170.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.556 ' CZ3' HD21 ' A' ' 166' ' ' LEU . 20.6 m95 -114.42 -173.24 2.25 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.493 -0.776 . . . . 0.78000000000000003 109.286 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.813 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.7 m170 -102.74 129.21 49.3 Favored 'General case' 0 C--O 1.222 -0.383 0 N-CA-C 109.532 -0.544 . . . . 0.71999999999999997 109.532 178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.507 ' HG2' ' OE1' ' A' ' 131' ' ' GLU . 19.4 pttm -60.38 -17.22 42.28 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.599 0.592 . . . . 3.1899999999999999 112.599 -176.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.8 m -85.02 -34.35 22.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.014 0.435 . . . . 1.47 111.274 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.813 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 29.9 p -99.63 -24.12 14.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.245 -0.434 . . . . 1.1399999999999999 110.745 -176.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 12.6 t80 -69.69 70.62 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.187 -0.915 . . . . 1.1299999999999999 109.753 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.455 ' HA ' ' HA ' ' A' ' 153' ' ' SER . 20.7 ptt180 -138.97 142.54 38.38 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.495 -1.23 . . . . 2.7799999999999998 109.282 -175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -77.17 136.49 38.58 Favored 'General case' 0 C--O 1.252 1.188 0 N-CA-C 108.623 -0.88 . . . . 0.68000000000000005 108.623 175.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.63 -3.14 29.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.748 -1.115 . . . . 1.02 112.072 -177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.0 mt -75.94 -41.72 39.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 1.02 110.223 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.888 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.9 p -115.24 -17.12 11.43 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.218 0.532 . . . . 0.87 110.164 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.91 62.17 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.384 -0.825 . . . . 0.76000000000000001 111.332 -177.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.888 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 17.5 ttpp -112.35 139.86 47.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.902 0.382 . . . . 2.3700000000000001 111.827 -172.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 146' ' ' ARG . 12.9 p -73.02 163.76 27.7 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.379 -0.828 . . . . 1.46 112.167 -175.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.479 HD21 ' SG ' ' A' ' 168' ' ' CYS . 88.5 mt -125.73 -179.71 4.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.789 -1.096 . . . . 1.1299999999999999 109.345 178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -137.37 -77.14 0.4 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.956 0.408 . . . . 3.54 111.199 -175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.0 t -162.31 146.67 12.18 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.921 -0.581 . . . . 3.5800000000000001 109.519 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.9 p 52.5 25.7 3.76 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.584 0.754 . . . . 2.6699999999999999 112.59 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -144.21 27.2 1.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.505 0.669 . . . . 2.2999999999999998 109.573 176.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.491 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 21.8 t -122.83 128.46 75.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.026 -0.988 . . . . 1.5900000000000001 110.587 -174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.9 m -139.12 116.39 11.14 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.614 -0.513 . . . . 1.1599999999999999 109.614 174.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -105.22 166.18 10.59 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.415 0.626 . . . . 2.27 111.945 -173.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 28.3 tptp -129.99 100.95 5.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.126 -0.943 . . . . 2.9500000000000002 108.925 173.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 65.18 29.7 11.74 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.635 -0.711 . . . . 2.9700000000000002 110.972 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.82 -16.96 53.97 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.457 -0.878 . . . . 1.46 113.465 178.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -85.58 113.36 21.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 117.26 0.53 . . . . 2.21 109.595 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.656 HD22 ' H ' ' A' ' 166' ' ' LEU . 1.4 mm? -72.85 140.3 47.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.751 -0.659 . . . . 1.25 111.359 -172.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.995 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 60.1 m-85 -132.57 145.0 50.78 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.532 -0.758 . . . . 1.23 109.179 172.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.479 ' SG ' HD21 ' A' ' 154' ' ' LEU . 20.9 m -65.96 152.25 44.97 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.982 -0.377 . . . . 0.52000000000000002 109.982 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -59.14 -28.01 66.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.309 0.576 . . . . 3.1200000000000001 110.002 176.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 62.9 t -78.55 -47.79 23.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.69 . . . . 1.02 110.517 177.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.799 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 82.2 m -69.59 -34.11 73.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.297 -0.41 . . . . 0.80000000000000004 111.895 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -62.0 -36.48 81.65 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.739 0.304 . . . . 1.78 110.273 177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -67.99 -38.54 82.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.958 -0.565 . . . . 1.05 110.826 178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.799 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 49.2 mtmt -68.97 -47.75 64.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.311 0.577 . . . . 3.3599999999999999 110.568 178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -74.23 -43.07 58.53 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.713 -0.676 . . . . 2.6499999999999999 111.922 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 121.302 0.572 . . . . 4.3200000000000003 111.711 -178.508 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.575 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 55.4 mtmt . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.887 0.375 . . . . 2.7599999999999998 111.282 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.544 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.6 OUTLIER -77.76 113.92 36.76 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.367 -0.833 . . . . 0.80000000000000004 108.756 169.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.46 ' HG2' ' CH2' ' A' ' 140' ' ' TRP . 51.5 Cg_endo -73.61 8.91 1.73 Allowed 'Trans proline' 0 CA--C 1.531 0.363 0 C-N-CA 122.823 2.348 . . . . 1.0 112.944 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.792 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 18.7 mmt180 -86.91 -33.8 19.6 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.171 -1.048 . . . . 2.8199999999999998 108.171 172.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 56.4 m -115.22 -27.78 7.15 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 114.585 -1.188 . . . . 0.88 111.75 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.89 27.42 50.31 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.362 -1.095 . . . . 0.84999999999999998 110.362 -170.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.456 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 50.5 mttm -120.57 133.05 55.43 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.255 -0.472 . . . . 2.9900000000000002 111.726 -172.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.575 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 74.0 m -58.76 148.02 31.13 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.372 0.508 . . . . 1.3700000000000001 112.372 -177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.759 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 18.5 t -127.64 139.0 53.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.84 -0.618 . . . . 0.80000000000000004 110.104 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -130.96 -175.63 3.74 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.658 -0.417 . . . . 5.0800000000000001 110.945 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -47.17 -35.93 7.96 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 113.618 0.97 . . . . 0.94999999999999996 113.618 -169.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.13 -35.69 62.46 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.278 0.474 . . . . 1.21 112.278 -176.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -136.65 22.23 3.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.983 0.42 . . . . 2.4399999999999999 110.759 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.5 ttpt -71.04 91.06 0.87 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.022 -0.536 . . . . 2.1800000000000002 112.003 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.414 HG21 ' HB2' ' A' ' 145' ' ' PHE . 3.3 m -95.14 129.74 44.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.693 -0.854 . . . . 1.02 108.693 166.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 89.9 mmm -83.77 90.63 7.36 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.266 -0.424 . . . . 1.78 111.76 -169.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -93.65 118.26 5.66 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.546 -0.835 . . . . 0.77000000000000002 111.053 170.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.41 18.96 73.99 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.644 -0.788 . . . . 1.72 112.655 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 90.76 14.25 58.34 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.995 -0.622 . . . . 1.04 113.311 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.444 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -145.27 157.5 53.01 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 117.306 0.553 . . . . 2.6899999999999999 111.26 178.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.38 133.25 56.83 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.774 2.983 . . . . 0.71999999999999997 113.972 177.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.46 ' CH2' ' HG2' ' A' ' 121' ' ' PRO . 26.2 m95 -131.04 164.72 24.8 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.76 -1.109 . . . . 0.78000000000000003 108.452 172.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.654 ' CD2' HG22 ' A' ' 127' ' ' VAL . 44.7 m170 -75.33 145.35 41.82 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 109.066 -0.716 . . . . 0.71999999999999997 109.066 173.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.454 ' CE ' ' HG2' ' A' ' 155' ' ' GLU . 22.3 tptm -69.25 -24.19 63.96 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.098 0.475 . . . . 3.1899999999999999 110.352 -179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 5.8 p -79.54 -21.22 45.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.646 -0.706 . . . . 1.47 111.105 177.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.792 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 4.0 m -111.31 -1.57 15.98 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.085 -0.507 . . . . 1.1399999999999999 110.946 -175.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.594 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 3.9 t80 -76.56 54.51 0.95 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.113 -0.949 . . . . 1.1299999999999999 108.895 176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.55 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 57.2 mtm180 -123.36 159.01 29.8 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.979 -1.01 . . . . 2.7799999999999998 109.178 -174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.912 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -92.85 139.06 30.93 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.995 -1.113 . . . . 0.68000000000000005 107.995 166.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -4.57 38.88 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 124.379 1.049 . . . . 1.02 112.23 -177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.64 HD12 ' HB3' ' A' ' 171' ' ' CYS . 70.0 mt -75.23 -48.19 32.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.925 0.393 . . . . 1.02 110.15 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.727 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -109.03 -10.96 15.01 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.423 0.63 . . . . 0.87 109.532 -178.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.53 29.11 71.67 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.125 -0.943 . . . . 0.76000000000000001 111.324 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.727 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.0 OUTLIER -115.64 140.06 49.54 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.669 -0.412 . . . . 2.3700000000000001 111.511 -171.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.55 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 12.9 p -77.59 144.37 37.57 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.327 -0.851 . . . . 1.46 113.041 -173.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.761 HD21 ' SG ' ' A' ' 168' ' ' CYS . 91.3 mt -106.41 163.73 12.61 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.601 -1.181 . . . . 1.1299999999999999 109.768 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.454 ' HG2' ' CE ' ' A' ' 142' ' ' LYS . 29.1 mt-10 -141.37 -84.38 0.2 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 120.79 -0.364 . . . . 3.54 111.959 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 17.0 p -110.3 -81.17 0.58 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.414 0.524 . . . . 3.5800000000000001 112.414 -173.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -70.74 -15.95 62.73 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.065 0.46 . . . . 2.6699999999999999 111.904 -174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.675 ' O ' ' HB3' ' A' ' 154' ' ' LEU . 42.6 m-80 -114.84 94.91 4.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.52 -0.309 . . . . 2.2999999999999998 111.232 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.747 ' HA ' HD13 ' A' ' 154' ' ' LEU . 2.6 p -168.6 120.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.151 0.501 . . . . 1.5900000000000001 110.549 166.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 29.1 m -139.13 121.51 16.04 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 116.07 -0.513 . . . . 1.1599999999999999 110.075 174.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -93.1 146.37 23.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.011 -0.54 . . . . 2.27 111.36 -176.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.732 ' HB2' ' HE1' ' A' ' 172' ' ' TYR . 25.6 tptp -146.19 118.89 8.59 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.879 -0.601 . . . . 2.9500000000000002 109.704 176.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 63.71 23.97 13.69 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.952 -0.567 . . . . 2.9700000000000002 111.189 177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.5 -14.65 64.81 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.76 -0.733 . . . . 1.46 112.532 -179.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -91.04 146.87 23.48 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.756 -0.461 . . . . 2.21 109.756 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -98.34 139.18 34.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.833 0.349 . . . . 1.25 110.181 -179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.912 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 82.0 m-85 -137.69 142.45 41.08 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.715 -0.675 . . . . 1.23 109.934 177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.761 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.7 m -69.48 157.73 36.57 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.426 -0.583 . . . . 0.52000000000000002 109.426 173.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -54.18 -43.92 71.08 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 118.024 0.374 . . . . 3.1200000000000001 110.871 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.27 -47.39 74.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.075 -0.511 . . . . 1.02 111.229 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 149' ' ' ILE . 39.8 m -65.98 -41.4 91.18 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 116.071 -0.513 . . . . 0.80000000000000004 111.068 -178.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.732 ' HE1' ' HB2' ' A' ' 162' ' ' LYS . 71.9 t80 -66.6 -41.53 88.31 Favored 'General case' 0 C--O 1.216 -0.69 0 CA-C-N 116.195 -0.457 . . . . 1.78 111.091 178.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.77 -24.96 67.06 Favored 'General case' 0 C--N 1.318 -0.796 0 C-N-CA 120.44 -0.504 . . . . 1.05 110.917 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -70.77 -64.58 0.87 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.879 -0.6 . . . . 3.3599999999999999 111.868 -176.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -98.29 -20.46 17.2 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.307 0.484 . . . . 2.6499999999999999 112.307 -178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.552 ' HA ' ' O ' ' A' ' 172' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.86 0 C-N-CA 124.802 1.241 . . . . 4.3200000000000003 111.522 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 70.7 mttt . . . . . 0 C--O 1.232 0.166 0 N-CA-C 113.0 0.741 . . . . 2.7599999999999998 113.0 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 3.1 t -98.5 114.44 65.3 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 114.641 -1.163 . . . . 0.80000000000000004 109.22 172.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 11.5 Cg_exo -71.11 -8.3 23.25 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.366 2.711 . . . . 1.0 112.778 -178.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.488 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 36.0 mmt180 -78.39 -45.99 21.01 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.162 -0.681 . . . . 2.8199999999999998 109.162 178.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -95.68 -25.12 16.24 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.319 -0.855 . . . . 0.88 111.377 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.55 28.49 59.42 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.511 -1.035 . . . . 0.84999999999999998 110.511 -172.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -116.51 173.33 6.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.01 -0.595 . . . . 2.9900000000000002 110.156 -173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.8 m -93.65 156.13 16.88 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.932 0.396 . . . . 1.3700000000000001 111.055 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.71 HG22 ' CD2' ' A' ' 141' ' ' HIS . 16.1 t -130.92 157.74 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.663 -0.699 . . . . 0.80000000000000004 109.556 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.9 t80 -131.95 -177.0 4.24 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 120.435 -0.506 . . . . 5.0800000000000001 110.79 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -55.63 -40.61 72.38 Favored 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 113.273 0.842 . . . . 0.94999999999999996 113.273 -169.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.32 -28.84 63.44 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.886 0.328 . . . . 1.21 111.886 -178.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -109.58 -2.8 17.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.386 -0.37 . . . . 2.4399999999999999 110.549 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.831 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttmt -60.9 93.45 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.792 0.806 . . . . 2.1800000000000002 112.865 -171.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG21 ' HB2' ' A' ' 145' ' ' PHE . 1.6 m -108.14 111.11 34.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 114.83 -1.077 . . . . 1.02 108.272 166.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 97.4 mmm -71.97 88.29 1.06 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.93 -0.577 . . . . 1.78 112.179 -170.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -96.36 114.82 5.04 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.826 -0.702 . . . . 0.77000000000000002 111.929 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.86 16.86 72.83 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.91 -0.662 . . . . 1.72 112.923 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.92 0.77 42.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.516 -0.85 . . . . 1.04 113.377 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.1 pttm -143.72 148.68 43.9 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 117.559 0.679 . . . . 2.6899999999999999 111.243 177.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.831 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 37.3 Cg_endo -64.56 124.73 13.71 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.37 2.713 . . . . 0.71999999999999997 113.422 179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.461 ' CZ2' HD23 ' A' ' 166' ' ' LEU . 22.8 m0 -103.94 172.93 6.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.026 -0.731 . . . . 0.78000000000000003 109.026 172.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.71 ' CD2' HG22 ' A' ' 127' ' ' VAL . 31.4 m170 -74.17 139.6 44.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.66 -0.867 . . . . 0.71999999999999997 108.66 172.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 40.6 tptt -58.45 -22.77 55.65 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 121.026 0.441 . . . . 3.1899999999999999 110.886 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 m -71.76 -40.82 69.07 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.195 -0.457 . . . . 1.47 110.817 177.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -112.88 9.04 18.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.1399999999999999 112.18 -170.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.492 ' HB2' HG21 ' A' ' 133' ' ' VAL . 27.6 t80 -69.45 75.71 0.39 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.413 -1.329 . . . . 1.1299999999999999 107.413 168.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.872 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.7 ptt180 -157.66 166.73 32.06 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 114.855 -1.066 . . . . 2.7799999999999998 109.959 -166.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.918 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -88.56 135.2 33.61 Favored 'General case' 0 C--O 1.252 1.223 0 C-N-CA 120.05 -0.66 . . . . 0.68000000000000005 109.5 175.325 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.09 -8.99 58.11 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 113.781 -1.554 . . . . 1.02 111.605 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.665 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 62.6 mt -66.1 -45.83 89.41 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 CA-C-O 120.878 0.371 . . . . 1.02 110.048 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 21.7 p -113.52 -29.09 7.29 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.192 0.52 . . . . 0.87 109.878 -177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 93.28 25.38 19.23 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.376 -0.829 . . . . 0.76000000000000001 111.379 -175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 61.9 tttp -104.08 129.89 51.76 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 120.849 -0.34 . . . . 2.3700000000000001 111.833 -173.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.872 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 18.4 p -72.19 143.56 48.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.378 -0.828 . . . . 1.46 112.245 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.61 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 57.9 mt -98.74 143.68 28.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.341 -0.845 . . . . 1.1299999999999999 109.777 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 34.1 mm-40 -103.25 -77.46 0.56 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.024 -0.535 . . . . 3.54 111.09 -177.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.3 m -147.16 -54.54 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.042 0.449 . . . . 3.5800000000000001 111.191 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -81.89 -14.06 56.72 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.343 -0.389 . . . . 2.6699999999999999 111.902 -174.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.425 ' HA ' ' HB2' ' A' ' 169' ' ' LYS . 30.5 p-10 -106.47 14.55 27.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.721 0.296 . . . . 2.2999999999999998 110.967 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.528 ' HA ' HD13 ' A' ' 154' ' ' LEU . 99.5 t -79.48 102.51 5.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.815 0.341 . . . . 1.5900000000000001 110.372 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -123.98 152.35 42.64 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.599 -0.519 . . . . 1.1599999999999999 109.599 178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -141.6 152.48 44.05 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.931 0.396 . . . . 2.27 110.167 176.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.551 ' HB2' ' HE2' ' A' ' 172' ' ' TYR . 33.3 ttpt -150.48 124.21 9.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.887 -0.597 . . . . 2.9500000000000002 109.722 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.416 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 14.1 m-20 62.26 30.11 17.5 Favored 'General case' 0 C--N 1.328 -0.341 0 O-C-N 123.632 0.583 . . . . 2.9700000000000002 110.836 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 87.15 -7.57 80.08 Favored Glycine 0 N--CA 1.451 -0.365 0 CA-C-N 115.799 -0.637 . . . . 1.46 113.307 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -100.57 134.72 43.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.904 0.352 . . . . 2.21 110.051 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.461 HD23 ' CZ2' ' A' ' 140' ' ' TRP . 4.1 mm? -80.76 135.91 36.06 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.033 -0.531 . . . . 1.25 110.603 -179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.918 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 54.7 m-85 -135.94 146.02 46.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.711 -0.677 . . . . 1.23 110.216 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.479 ' HA ' ' CD2' ' A' ' 154' ' ' LEU . 9.9 m -67.22 152.81 45.07 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.396 -0.594 . . . . 0.52000000000000002 109.396 173.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.425 ' HB2' ' HA ' ' A' ' 158' ' ' ASN . 44.1 tttp -59.1 -35.95 74.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.009 0.433 . . . . 3.1200000000000001 110.059 178.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 47.4 t -70.92 -44.43 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.69 -0.686 . . . . 1.02 110.616 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.988 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 75.5 m -69.65 -30.38 68.06 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 111.715 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' ' ND2' ' A' ' 175' ' ' ASN . 36.8 t80 -71.17 -34.8 71.27 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.05 -0.352 . . . . 1.78 110.05 175.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.31 -24.55 63.4 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.323 -0.399 . . . . 1.05 110.861 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.988 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 56.8 mtmt -78.86 -37.06 41.25 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.207 -0.452 . . . . 3.3599999999999999 111.934 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.668 ' ND2' ' HA ' ' A' ' 172' ' ' TYR . 9.6 p30 -97.71 -23.85 15.75 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.851 0.685 . . . . 2.6499999999999999 112.851 -178.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 N--CA 1.48 1.032 0 C-N-CA 123.817 0.847 . . . . 4.3200000000000003 112.761 175.083 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 6.5 ttpm? . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 112.348 0.499 . . . . 2.7599999999999998 112.348 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 1.3 t -81.57 110.9 21.43 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-N 115.13 -0.941 . . . . 0.80000000000000004 109.145 171.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 15.9 Cg_exo -68.68 -7.76 21.39 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 123.22 2.613 . . . . 1.0 112.518 -177.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.487 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 9.4 mmp_? -78.27 -43.2 28.76 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.178 -0.675 . . . . 2.8199999999999998 109.178 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 80.3 m -91.11 -29.82 17.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.422 -0.808 . . . . 0.88 111.198 177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 76.89 34.86 41.32 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 109.954 -1.259 . . . . 0.84999999999999998 109.954 -170.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -132.22 134.72 45.67 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.632 -0.784 . . . . 2.9900000000000002 109.957 -170.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.539 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 69.5 m -72.55 143.36 48.33 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.831 0.348 . . . . 1.3700000000000001 110.972 -178.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 34.6 t -123.89 143.9 35.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.106 -0.497 . . . . 0.80000000000000004 110.046 -176.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -122.52 -172.26 2.44 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.819 -0.352 . . . . 5.0800000000000001 110.419 178.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -45.69 -34.69 3.69 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 114.212 1.19 . . . . 0.94999999999999996 114.212 -170.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.2 -47.97 71.5 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.021 0.378 . . . . 1.21 112.021 -176.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -110.52 9.07 23.2 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.475 -0.329 . . . . 2.4399999999999999 110.608 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.862 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 50.0 tttt -64.11 91.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.689 0.757 . . . . 2.1800000000000002 113.02 -169.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 139' ' ' PRO . 3.7 m -109.42 140.14 29.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 114.919 -1.037 . . . . 1.02 109.026 169.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.8 mmt -80.22 84.59 5.87 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 112.779 0.659 . . . . 1.78 112.779 -169.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' CE1' ' A' ' 145' ' ' PHE . . . -74.14 90.74 0.71 Allowed Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 110.789 -0.924 . . . . 0.77000000000000002 110.789 169.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.43 -6.25 46.09 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 121.073 -0.584 . . . . 1.72 111.992 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 132.26 -12.98 5.22 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.04 -0.6 . . . . 1.04 112.225 -178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -118.63 141.44 29.89 Favored Pre-proline 0 C--N 1.327 -0.392 0 C-N-CA 121.198 -0.201 . . . . 2.6899999999999999 110.531 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.862 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 15.5 Cg_endo -57.89 119.89 7.43 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.561 2.841 . . . . 0.71999999999999997 114.38 -178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 17.9 m0 -105.15 171.72 7.17 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 167.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.856 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 64.5 m80 -77.47 140.34 39.8 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.276 -1.009 . . . . 0.71999999999999997 108.276 171.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -63.74 -17.83 63.43 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.099 0.476 . . . . 3.1899999999999999 110.406 176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.3 p -76.23 -17.72 59.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.009 -0.541 . . . . 1.47 111.602 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.856 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -123.33 -23.89 4.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.342 -0.39 . . . . 1.1399999999999999 111.318 -175.036 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.511 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 39.9 t80 -70.18 74.43 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.967 0.889 . . . . 1.1299999999999999 108.675 174.103 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.429 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 11.0 ptm180 -147.91 139.71 23.94 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.292 -1.322 . . . . 2.7799999999999998 108.619 -173.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -72.15 134.57 45.79 Favored 'General case' 0 C--O 1.25 1.081 0 C-N-CA 119.554 -0.858 . . . . 0.68000000000000005 108.897 178.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.95 -7.79 53.66 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.959 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 58.8 mt -72.02 -36.86 58.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.013 0.435 . . . . 1.02 110.196 -178.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.585 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -121.47 -32.31 3.87 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 121.252 0.548 . . . . 0.87 110.33 -178.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 98.06 26.82 9.26 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.285 -0.87 . . . . 0.76000000000000001 111.373 -174.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.585 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 54.2 tptt -98.64 122.29 41.67 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.649 0.611 . . . . 2.3700000000000001 112.649 -173.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 66.4 m -67.66 128.08 35.16 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.677 -0.692 . . . . 1.46 110.992 175.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.643 HD21 ' HA ' ' A' ' 168' ' ' CYS . 82.1 mt -94.22 148.39 22.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.833 -0.621 . . . . 1.1299999999999999 112.21 -175.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 157' ' ' THR . 9.7 tp10 -87.02 145.49 26.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.357 -0.979 . . . . 3.54 108.357 169.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.3 t -63.75 -11.23 24.7 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.397 -0.365 . . . . 3.5800000000000001 111.861 -170.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.478 ' H ' ' HG3' ' A' ' 155' ' ' GLU . 6.1 m -101.45 -2.25 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.082 0.468 . . . . 2.6699999999999999 111.276 -179.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -132.26 59.68 1.71 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.963 0.411 . . . . 2.2999999999999998 110.054 -178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 38.3 t -117.76 140.63 40.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.952 -0.567 . . . . 1.5900000000000001 111.176 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 25.3 m -137.12 110.78 8.07 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.858 -0.423 . . . . 1.1599999999999999 109.858 170.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -98.24 147.85 24.2 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.954 0.407 . . . . 2.27 110.432 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -137.7 102.44 4.74 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.339 -0.615 . . . . 2.9500000000000002 109.339 178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 57.2 43.19 24.28 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 115.432 -0.804 . . . . 2.9700000000000002 111.397 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 93.85 -20.19 48.63 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.72 -0.752 . . . . 1.46 113.559 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -93.33 136.22 33.81 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 117.222 0.511 . . . . 2.21 109.77 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.511 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 3.6 mm? -93.44 133.48 36.67 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.069 -0.514 . . . . 1.25 110.526 -176.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.954 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.0 m-85 -133.94 148.64 51.2 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 116.169 -0.468 . . . . 1.23 110.517 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.643 ' HA ' HD21 ' A' ' 154' ' ' LEU . 8.1 m -68.33 151.14 47.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.7 -0.682 . . . . 0.52000000000000002 109.887 174.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -61.17 -25.61 67.14 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.202 -0.453 . . . . 3.1200000000000001 110.51 176.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.445 ' O ' ' HG3' ' A' ' 174' ' ' LYS . 40.4 t -79.32 -47.75 21.99 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 116.133 -0.485 . . . . 1.02 110.775 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 61.0 m -68.81 -37.66 79.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.80000000000000004 111.028 -178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -61.7 -38.79 89.16 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.386 -0.598 . . . . 1.78 109.386 174.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.37 -25.24 62.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.352 -0.84 . . . . 1.05 111.32 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 170' ' ' VAL . 54.8 mtpt -76.41 -45.33 32.07 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.957 0.408 . . . . 3.3599999999999999 110.338 176.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -65.81 -40.24 91.69 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.846 -0.615 . . . . 2.6499999999999999 111.274 -176.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 C--N 1.327 -0.39 0 N-CA-C 112.179 0.436 . . . . 4.3200000000000003 112.179 -177.491 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm . . . . . 0 N--CA 1.451 -0.391 0 CA-C-O 121.148 0.499 . . . . 2.7599999999999998 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -86.7 123.94 70.04 Favored Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.307 -0.861 . . . . 0.80000000000000004 110.554 177.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -86.61 -0.68 8.16 Favored 'Trans proline' 0 N--CA 1.46 -0.443 0 C-N-CA 122.923 2.415 . . . . 1.0 112.402 177.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 12.8 tpt180 -86.39 -34.03 20.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.405 -0.591 . . . . 2.8199999999999998 109.405 -178.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 15.4 m -113.4 -29.04 7.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.683 -0.689 . . . . 0.88 111.035 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 85.83 38.02 8.99 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.578 -1.009 . . . . 0.84999999999999998 110.578 -171.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.567 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 67.2 mttm -133.58 158.77 42.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.475 0.179 . . . . 2.9900000000000002 110.526 -173.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.6 m -79.03 154.72 29.23 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.504 -0.316 . . . . 1.3700000000000001 110.787 177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.534 HG22 ' CD2' ' A' ' 141' ' ' HIS . 37.7 t -114.4 143.24 24.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.409 -0.36 . . . . 0.80000000000000004 110.093 178.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.815 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -99.88 175.47 5.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.59 -0.277 . . . . 5.0800000000000001 110.916 175.662 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.51 -37.51 80.11 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 112.134 0.42 . . . . 0.94999999999999996 112.134 -176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.97 74.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.941 0.719 . . . . 1.21 112.941 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.815 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 42.6 mt-10 -119.65 31.8 6.38 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.095 0.474 . . . . 2.4399999999999999 111.104 -176.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.951 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.7 ttmt -68.7 90.35 0.4 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.249 -0.887 . . . . 2.1800000000000002 111.021 175.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 47.1 t -84.97 126.21 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 N-CA-C 109.057 -0.72 . . . . 1.02 109.057 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 79.5 mtp -75.54 84.43 2.6 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 121.05 -0.26 . . . . 1.78 111.685 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -87.67 110.52 3.6 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.796 -0.716 . . . . 0.77000000000000002 111.773 173.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.25 -77.87 1.15 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.165 -0.541 . . . . 1.72 111.951 -178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -159.73 20.39 0.26 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 121.075 -0.583 . . . . 1.04 111.918 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -150.4 160.53 32.81 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 122.839 -0.212 . . . . 2.6899999999999999 110.736 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.951 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.3 Cg_endo -55.78 133.61 59.08 Favored 'Trans proline' 0 CA--C 1.531 0.352 0 C-N-CA 123.52 2.813 . . . . 0.71999999999999997 114.168 174.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.439 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 17.0 m95 -126.85 175.52 7.97 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.533 -1.212 . . . . 0.78000000000000003 108.792 173.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.839 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 27.8 m170 -100.29 136.49 40.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 110.069 -0.345 . . . . 0.71999999999999997 110.069 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -60.92 -19.31 60.45 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.952 -0.567 . . . . 3.1899999999999999 111.306 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.0 p -85.97 -30.82 22.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.102 0.408 . . . . 1.47 112.102 -177.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.839 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.3 p -109.11 -17.66 13.83 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.692 0.256 . . . . 1.1399999999999999 111.692 -173.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.571 ' CE1' ' HG ' ' A' ' 166' ' ' LEU . 10.5 t80 -71.44 65.14 0.43 Allowed 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.22 -1.029 . . . . 1.1299999999999999 108.22 176.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.469 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 11.7 ptm180 -135.71 144.59 46.01 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 114.59 -1.186 . . . . 2.7799999999999998 109.534 -170.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.891 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.08 135.38 34.85 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.848 -0.797 . . . . 0.68000000000000005 108.848 174.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.37 -7.93 54.55 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.027 -1.442 . . . . 1.02 111.93 -176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.53 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 65.8 mt -71.01 -39.51 75.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.766 0.317 . . . . 1.02 110.441 -178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.959 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.6 p -113.02 -24.6 9.39 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 121.293 0.568 . . . . 0.87 110.185 -178.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.9 29.75 28.0 Favored Glycine 0 N--CA 1.441 -0.985 0 CA-C-N 115.124 -0.944 . . . . 0.76000000000000001 110.937 -175.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.959 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 1.0 OUTLIER -118.19 139.78 50.77 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.899 0.38 . . . . 2.3700000000000001 111.037 -173.251 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.469 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 36.0 p -83.11 140.08 32.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.466 -0.788 . . . . 1.46 111.968 -175.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.459 HD21 ' HA ' ' A' ' 168' ' ' CYS . 33.3 mt -82.27 86.82 6.61 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.05 -0.977 . . . . 1.1299999999999999 109.024 176.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -50.91 -54.11 26.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.792 -1.095 . . . . 3.54 112.24 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 51.1 m -154.24 -89.63 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.704 0.288 . . . . 3.5800000000000001 111.656 176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.2 p -88.86 83.34 6.65 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.238 0.459 . . . . 2.6699999999999999 112.238 -173.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.538 HD22 ' N ' ' A' ' 158' ' ' ASN . 0.1 OUTLIER -176.2 34.01 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.259 0.552 . . . . 2.2999999999999998 110.116 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 33.8 t -97.22 119.62 45.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.58 -0.736 . . . . 1.5900000000000001 111.51 -171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.5 p -128.67 116.46 19.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.01 0.434 . . . . 1.1599999999999999 110.315 173.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.95 137.44 32.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.957 -0.565 . . . . 2.27 110.875 -177.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -127.26 97.04 4.77 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.181 -0.463 . . . . 2.9500000000000002 110.545 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 73.02 -29.94 0.21 Allowed 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.736 0.815 . . . . 2.9700000000000002 112.485 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.45 -19.82 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 121.102 -0.571 . . . . 1.46 112.348 -177.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -95.36 141.66 28.66 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.291 0.567 . . . . 2.21 110.855 176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.571 ' HG ' ' CE1' ' A' ' 145' ' ' PHE . 1.9 mm? -89.13 123.31 33.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.003 -0.998 . . . . 1.25 109.393 -179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.891 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 44.9 m-85 -125.84 150.57 47.75 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.773 0.32 . . . . 1.23 110.606 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.459 ' HA ' HD21 ' A' ' 154' ' ' LEU . 3.9 m -71.0 148.17 47.91 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 0.52000000000000002 110.39 178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -58.43 -25.75 62.54 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.718 -0.674 . . . . 3.1200000000000001 110.866 178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 43.9 t -78.61 -47.42 23.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 1.02 110.683 177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 56.0 m -69.6 -32.34 71.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.047 -0.524 . . . . 0.80000000000000004 111.03 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 47.5 t80 -65.28 -33.26 75.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.006 -0.543 . . . . 1.78 109.822 175.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.62 -24.58 60.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.451 -0.795 . . . . 1.05 110.963 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -70.03 -41.72 73.89 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.996 0.426 . . . . 3.3599999999999999 110.488 178.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -87.51 -51.95 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.961 -0.563 . . . . 2.6499999999999999 111.596 -174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.285 0.564 . . . . 4.3200000000000003 110.831 178.092 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 63.0 mtpt . . . . . 0 N--CA 1.46 0.069 0 N-CA-C 111.936 0.347 . . . . 2.7599999999999998 111.936 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.523 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 22.4 t -68.48 114.51 22.38 Favored Pre-proline 0 C--O 1.235 0.315 0 N-CA-C 108.603 -0.888 . . . . 0.80000000000000004 108.603 170.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.45 -1.88 11.32 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.789 2.326 . . . . 1.0 112.345 -178.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.523 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.7 mmt85 -87.52 -44.22 11.44 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.086 -0.506 . . . . 2.8199999999999998 109.779 176.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 35.5 m -103.21 -14.68 16.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.774 -0.648 . . . . 0.88 111.58 -176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.27 36.97 80.09 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.227 -0.749 . . . . 0.84999999999999998 111.227 -176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -131.48 135.69 47.31 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.643 0.259 . . . . 2.9900000000000002 111.139 -173.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.437 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 5.0 m -60.62 136.38 58.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.707 -0.678 . . . . 1.3700000000000001 111.431 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.992 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 47.6 t -116.35 124.34 72.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.333 0.587 . . . . 0.80000000000000004 111.274 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.542 ' HD1' ' H ' ' A' ' 130' ' ' ALA . 47.8 p90 -73.37 164.1 27.14 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.976 -1.011 . . . . 5.0800000000000001 110.474 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 132' ' ' LYS . . . -71.3 -17.28 62.47 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.582 0.956 . . . . 0.94999999999999996 113.582 -169.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.542 ' H ' ' HD1' ' A' ' 128' ' ' TYR . . . -79.75 -15.84 56.74 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 111.842 0.312 . . . . 1.21 111.842 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.581 ' HG2' ' HB2' ' A' ' 142' ' ' LYS . 6.9 tt0 -118.94 2.05 11.51 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.959 -0.756 . . . . 2.4399999999999999 108.959 175.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.792 ' HE2' ' HB3' ' A' ' 139' ' ' PRO . 38.2 ttmt -68.49 94.26 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.512 -1.222 . . . . 2.1800000000000002 112.612 -173.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 140' ' ' TRP . 0.2 OUTLIER -92.59 101.08 12.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.621 -0.881 . . . . 1.02 108.621 168.271 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.524 ' SD ' ' HD3' ' A' ' 132' ' ' LYS . 74.8 mmm -69.38 89.83 0.5 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.342 -0.845 . . . . 1.78 112.66 -170.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -91.66 107.53 3.51 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.25 -0.976 . . . . 0.77000000000000002 111.358 170.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 71.48 21.21 78.71 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.908 -0.663 . . . . 1.72 112.926 176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 94.49 9.22 59.14 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.825 -0.702 . . . . 1.04 113.0 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.548 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 0.0 OUTLIER -120.47 137.38 26.12 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 122.408 -0.466 . . . . 2.6899999999999999 111.295 179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.992 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 20.5 Cg_endo -62.28 109.11 0.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.975 2.45 . . . . 0.71999999999999997 111.844 167.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.548 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 32.1 m95 -97.91 156.96 16.37 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.829 -0.804 . . . . 0.78000000000000003 108.829 173.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.572 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 33.1 m170 -69.49 147.34 51.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.073 -0.714 . . . . 0.71999999999999997 109.073 172.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.581 ' HB2' ' HG2' ' A' ' 131' ' ' GLU . 37.2 ttmt -57.99 -24.8 59.64 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.359 -0.837 . . . . 3.1899999999999999 110.581 -179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.456 ' O ' ' HD3' ' A' ' 146' ' ' ARG . 4.6 t -93.69 -19.11 21.41 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.637 -0.71 . . . . 1.47 112.137 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 34.1 m -101.65 -25.11 13.98 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 112.254 0.465 . . . . 1.1399999999999999 112.254 -172.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 159' ' ' VAL . 9.3 t80 -74.25 69.24 1.55 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 107.824 -1.176 . . . . 1.1299999999999999 107.824 172.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 33.9 ptt180 -143.15 171.87 13.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 114.92 -1.036 . . . . 2.7799999999999998 110.148 -169.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.884 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -107.11 139.29 41.76 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 121.265 0.555 . . . . 0.68000000000000005 110.36 175.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.83 -10.71 59.76 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 114.525 -1.216 . . . . 1.02 112.139 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.636 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 40.7 mm -69.26 -44.41 80.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.729 0.299 . . . . 1.02 110.584 -177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.783 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.2 p -110.59 -18.24 13.23 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.368 -0.533 . . . . 0.87 109.889 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 81.65 24.62 55.69 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.386 -0.825 . . . . 0.76000000000000001 111.264 -178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.783 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 47.0 tttp -105.57 130.11 53.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.821 0.343 . . . . 2.3700000000000001 111.458 -171.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.742 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 49.2 m -75.7 135.6 40.38 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.396 -0.82 . . . . 1.46 110.49 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.696 HD21 ' SG ' ' A' ' 168' ' ' CYS . 81.2 mt -109.3 175.98 5.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.431 0.634 . . . . 1.1299999999999999 111.776 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -130.81 137.53 49.46 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.667 -1.234 . . . . 3.54 107.667 173.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.6 t -63.17 93.79 0.07 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.592 0.59 . . . . 3.5800000000000001 112.592 -169.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 10.2 t -171.8 -33.7 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.579 -0.737 . . . . 2.6699999999999999 110.429 174.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -122.74 24.45 9.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.136 0.493 . . . . 2.2999999999999998 110.243 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.59 HG21 ' CE2' ' A' ' 145' ' ' PHE . 13.8 t -97.9 141.39 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.612 . . . . 1.5900000000000001 110.962 -174.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 28.7 p -122.66 153.95 38.69 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.344 -0.389 . . . . 1.1599999999999999 110.41 177.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -117.3 144.73 44.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.733 0.301 . . . . 2.27 110.983 -175.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 162' ' ' LYS . 27.2 mmtm -150.49 94.32 2.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.238 -0.437 . . . . 2.9500000000000002 111.409 176.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 58.93 42.06 20.15 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.577 -0.738 . . . . 2.9700000000000002 112.196 170.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.89 -24.34 32.55 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.836 -0.697 . . . . 1.46 112.161 177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.475 ' HA ' ' NH2' ' A' ' 122' ' ' ARG . 8.8 tp10 -93.54 153.58 18.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.255 -0.646 . . . . 2.21 109.255 177.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' A' ' 146' ' ' ARG . 3.3 mm? -115.57 154.81 28.72 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.353 -0.61 . . . . 1.25 109.353 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.884 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 96.7 m-85 -139.74 138.91 36.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.302 -0.408 . . . . 1.23 110.558 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.696 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.4 m -67.56 157.02 35.37 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.732 -0.667 . . . . 0.52000000000000002 109.788 173.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -57.17 -31.83 65.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.758 0.313 . . . . 3.1200000000000001 111.11 -179.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.2 t -79.27 -47.55 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.262 -0.426 . . . . 1.02 111.028 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.5 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 13.7 m -70.04 -29.85 66.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.086 -0.506 . . . . 0.80000000000000004 111.252 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -64.71 -29.08 70.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.485 -0.325 . . . . 1.78 110.67 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.14 66.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.916 0.388 . . . . 1.05 111.031 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.5 ' HE2' ' HA ' ' A' ' 171' ' ' CYS . 61.6 mttm -73.73 -51.95 14.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.881 -0.599 . . . . 3.3599999999999999 111.355 -178.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -87.13 -46.75 9.48 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.067 0.395 . . . . 2.6499999999999999 112.067 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 38.2 p90 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 126.417 1.887 . . . . 4.3200000000000003 115.229 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 51.8 mttp . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 121.382 0.61 . . . . 2.7599999999999998 112.232 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.52 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.9 t -89.97 109.84 35.7 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 114.459 -1.246 . . . . 0.80000000000000004 108.776 167.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -72.53 -4.35 15.13 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.857 2.371 . . . . 1.0 112.277 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.52 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 6.8 tpt180 -80.68 -57.45 3.56 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.595 -0.52 . . . . 2.8199999999999998 109.595 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 18.5 m -89.22 -31.16 18.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.693 -0.685 . . . . 0.88 111.146 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 91.24 41.16 5.28 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.369 -0.693 . . . . 0.84999999999999998 111.369 -176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.52 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 99.4 mttt -133.1 163.82 28.39 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.965 -0.383 . . . . 2.9900000000000002 109.965 -175.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.7 m -85.0 135.21 34.12 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.809 0.338 . . . . 1.3700000000000001 111.023 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.74 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 16.9 t -125.34 127.63 72.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.668 -0.493 . . . . 0.80000000000000004 109.668 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.427 ' HD1' ' HA ' ' A' ' 128' ' ' TYR . 1.2 t80 -116.97 -179.25 3.64 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 119.957 -0.697 . . . . 5.0800000000000001 110.921 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.746 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.76 -33.03 21.54 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 114.321 1.23 . . . . 0.94999999999999996 114.321 -165.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.9 -50.54 68.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.658 0.266 . . . . 1.21 111.646 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -115.02 8.71 15.84 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.443 -0.344 . . . . 2.4399999999999999 110.799 -176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.746 ' HE2' ' HA ' ' A' ' 129' ' ' ALA . 30.8 ttpt -64.19 104.02 0.69 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.244 -0.434 . . . . 2.1800000000000002 111.541 -178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.6 m -105.93 140.33 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.818 -0.808 . . . . 1.02 108.818 168.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' MET . 21.7 ptp -81.39 83.43 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.441 0.639 . . . . 1.78 112.288 -172.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -82.3 93.55 1.64 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.1 -0.8 . . . . 0.77000000000000002 111.1 173.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.47 15.9 77.41 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.824 -0.703 . . . . 1.72 112.086 -178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 106.27 -13.52 44.03 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.116 -0.564 . . . . 1.04 112.502 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -106.52 139.48 20.38 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 110.54 -0.17 . . . . 2.6899999999999999 110.54 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.74 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 19.4 Cg_endo -57.3 112.52 1.14 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 123.212 2.608 . . . . 0.71999999999999997 112.96 173.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -106.87 172.08 7.02 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.694 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 38.3 m80 -90.76 134.14 34.65 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.701 -0.851 . . . . 0.71999999999999997 108.701 178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -58.81 -17.91 27.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.303 -0.408 . . . . 3.1899999999999999 111.859 -178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.409 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 17.0 p -94.81 -15.38 23.82 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.139 -0.482 . . . . 1.47 112.248 -178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 22.3 p -117.51 -21.05 8.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.906 -0.133 . . . . 1.1399999999999999 110.939 -177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.435 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 9.9 t80 -59.2 81.46 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 124.145 0.903 . . . . 1.1299999999999999 109.164 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.462 HH11 ' HD2' ' A' ' 146' ' ' ARG . 15.2 mtp180 -141.67 153.1 44.48 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.203 -0.908 . . . . 2.7799999999999998 109.815 -169.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 1.047 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -90.99 139.74 30.49 Favored 'General case' 0 C--O 1.252 1.23 0 N-CA-C 108.769 -0.826 . . . . 0.68000000000000005 108.769 170.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.9 -12.43 60.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.491 -1.231 . . . . 1.02 112.055 -175.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.509 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 56.2 mt -66.57 -37.52 79.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 N-CA-C 110.168 -0.308 . . . . 1.02 110.168 -178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.3 p -118.23 -30.32 5.31 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-O 121.339 0.59 . . . . 0.87 110.216 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.38 39.59 9.73 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.216 -1.154 . . . . 0.76000000000000001 110.216 -171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.605 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 69.8 tttt -116.71 140.48 49.36 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.605 -0.438 . . . . 2.3700000000000001 111.489 -177.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 22.2 m -70.47 134.07 47.41 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.727 -0.67 . . . . 1.46 111.127 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.53 HD22 ' O ' ' A' ' 158' ' ' ASN . 50.5 mt -79.66 98.22 6.86 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.122 -0.696 . . . . 1.1299999999999999 109.122 176.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 155' ' ' GLU . 8.6 pt-20 -79.14 48.1 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.503 -0.771 . . . . 3.54 111.582 -174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.1 m 71.31 -30.22 0.2 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.793 0.837 . . . . 3.5800000000000001 112.807 175.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 16.6 p -91.77 -20.06 21.93 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.409 0.522 . . . . 2.6699999999999999 112.409 -175.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.617 HD22 ' HB3' ' A' ' 168' ' ' CYS . 15.9 p-10 -117.21 48.29 1.36 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.702 0.287 . . . . 2.2999999999999998 111.144 -178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 98.1 t -95.57 116.35 36.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 120.72 0.295 . . . . 1.5900000000000001 111.218 -177.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 53.5 m -140.15 140.67 36.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.013 -0.366 . . . . 1.1599999999999999 110.013 174.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -117.14 141.74 47.89 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.776 0.322 . . . . 2.27 111.205 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.608 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 24.1 ttpp -131.45 105.64 7.72 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.475 -0.565 . . . . 2.9500000000000002 109.475 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 3.8 p30 46.24 34.91 2.36 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.238 1.015 . . . . 2.9700000000000002 113.164 177.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.54 -17.3 21.09 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.241 -0.981 . . . . 1.46 113.841 174.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -102.7 146.72 27.79 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 117.362 0.581 . . . . 2.21 110.451 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.497 ' HB3' HD11 ' A' ' 154' ' ' LEU . 4.3 mm? -96.44 139.72 32.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.01 -0.541 . . . . 1.25 110.782 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.4 m-85 -140.06 145.72 38.06 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.642 -0.708 . . . . 1.23 109.629 177.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' HB3' HD22 ' A' ' 158' ' ' ASN . 5.1 m -70.96 155.83 40.35 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.975 -0.38 . . . . 0.52000000000000002 109.975 175.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.532 ' H ' ' HB2' ' A' ' 158' ' ' ASN . 29.6 tptp -55.98 -42.05 75.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.021 0.439 . . . . 3.1200000000000001 110.165 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 24.3 t -67.36 -47.52 80.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.623 -0.717 . . . . 1.02 111.057 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 35.3 m -69.52 -34.93 74.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.304 -0.407 . . . . 0.80000000000000004 111.328 -178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -65.42 -34.19 77.72 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.558 -0.534 . . . . 1.78 109.558 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.19 -23.81 63.96 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.811 -0.631 . . . . 1.05 110.878 176.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.3 ttmm -84.52 -20.4 31.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.324 0.583 . . . . 3.3599999999999999 110.434 178.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -94.05 -54.3 3.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.581 -0.736 . . . . 2.6499999999999999 110.76 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 24.9 p90 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 124.379 1.072 . . . . 4.3200000000000003 112.751 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 54.2 mtmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.531 0.205 . . . . 2.7599999999999998 110.807 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 16.1 t -84.24 115.2 59.07 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.167 176.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -75.09 -9.08 20.5 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.081 2.521 . . . . 1.0 112.141 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.578 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 8.5 tpt180 -79.56 -54.9 5.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.147 0.499 . . . . 2.8199999999999998 109.814 -178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 11.2 m -92.7 -19.06 22.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.539 -0.755 . . . . 0.88 110.788 -177.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.85 31.03 36.92 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 111.413 -0.675 . . . . 0.84999999999999998 111.413 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.552 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 80.5 tttt -131.29 138.4 49.25 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.522 -0.339 . . . . 2.9900000000000002 110.144 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 10.2 m -59.37 150.51 26.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.951 0.405 . . . . 1.3700000000000001 111.542 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.797 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 11.7 t -132.0 138.4 52.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.08 -0.509 . . . . 0.80000000000000004 109.745 177.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -125.68 -168.25 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.932 -0.707 . . . . 5.0800000000000001 110.89 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -51.11 -37.03 43.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.497 0.925 . . . . 0.94999999999999996 113.497 -169.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.04 -42.63 69.41 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.324 0.49 . . . . 1.21 112.324 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.966 ' HG2' ' HE2' ' A' ' 142' ' ' LYS . 44.8 mt-10 -125.18 15.85 8.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.065 -0.254 . . . . 2.4399999999999999 111.665 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.716 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.7 ttmt -63.8 90.47 0.06 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 121.362 0.601 . . . . 2.1800000000000002 111.76 -176.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' A' ' 140' ' ' TRP . 3.9 m -100.14 125.23 53.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.394 -0.965 . . . . 1.02 108.394 168.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.4 mtp -88.6 88.92 7.78 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 112.746 0.646 . . . . 1.78 112.746 -166.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.21 113.68 4.08 Favored Glycine 0 N--CA 1.444 -0.806 0 N-CA-C 110.56 -1.016 . . . . 0.77000000000000002 110.56 168.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 68.71 27.36 73.9 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.786 . . . . 1.72 112.176 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 78.86 14.85 81.57 Favored Glycine 0 CA--C 1.517 0.195 0 C-N-CA 120.994 -0.622 . . . . 1.04 113.0 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.5 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 25.7 mtmm -128.06 144.58 52.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.842 0.321 . . . . 2.6899999999999999 110.62 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.797 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 30.3 Cg_endo -64.24 121.99 9.81 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.062 2.508 . . . . 0.71999999999999997 113.345 174.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.578 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 30.2 m95 -112.07 178.27 4.37 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.494 -0.928 . . . . 0.78000000000000003 108.494 172.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.765 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 35.8 m80 -97.56 139.07 34.02 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.67 -0.493 . . . . 0.71999999999999997 109.67 -179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.966 ' HE2' ' HG2' ' A' ' 131' ' ' GLU . 54.9 mtmt -62.84 -17.04 60.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.719 0.295 . . . . 3.1899999999999999 111.49 -178.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.6 t -93.75 -11.49 31.27 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.245 0.461 . . . . 1.47 112.245 -178.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.765 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 30.9 p -121.18 -24.16 5.58 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.214 -0.304 . . . . 1.1399999999999999 110.834 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.466 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 17.9 t80 -68.41 75.86 0.26 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.652 -0.704 . . . . 1.1299999999999999 109.721 178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.938 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 24.3 ptt180 -158.02 149.39 21.33 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.143 -0.935 . . . . 2.7799999999999998 109.728 -177.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -83.99 139.47 32.52 Favored 'General case' 0 C--O 1.251 1.16 0 C-N-CA 120.423 -0.511 . . . . 0.68000000000000005 109.732 -178.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.94 -6.61 50.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.405 -1.27 . . . . 1.02 112.262 -177.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.604 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 37.7 mt -70.73 -46.12 70.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 120.697 -0.401 . . . . 1.02 109.939 178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.822 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 31.4 p -109.68 -24.71 10.78 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.612 0.72 . . . . 0.87 109.59 -177.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 84.5 24.74 45.53 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.932 -1.031 . . . . 0.76000000000000001 111.105 -175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.822 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 79.7 tttt -111.99 138.64 48.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.89 0.376 . . . . 2.3700000000000001 111.614 -170.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.938 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 14.0 m -62.69 135.04 57.17 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 115.0 -1.0 . . . . 1.46 112.344 -175.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.709 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 73.1 mt -84.83 140.4 31.2 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.986 -1.006 . . . . 1.1299999999999999 110.699 -178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.424 ' OE1' HG22 ' A' ' 157' ' ' THR . 0.5 OUTLIER -86.93 152.49 22.38 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.349 -1.352 . . . . 3.54 107.349 169.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 9.4 t -67.56 -6.59 20.73 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.961 0.356 . . . . 3.5800000000000001 111.961 -170.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.424 HG22 ' OE1' ' A' ' 155' ' ' GLU . 15.1 t -113.66 -5.51 13.36 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.379 0.609 . . . . 2.6699999999999999 110.449 175.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -111.46 23.78 13.57 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 116.054 -0.521 . . . . 2.2999999999999998 110.799 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.7 p -104.02 125.04 58.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.257 0.551 . . . . 1.5900000000000001 111.558 -178.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -133.19 122.02 23.39 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.609 -0.723 . . . . 1.1599999999999999 110.078 173.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.93 149.43 21.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.197 0.523 . . . . 2.27 110.019 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.577 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 27.6 tptp -125.92 89.1 2.97 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 109.061 -0.718 . . . . 2.9500000000000002 109.061 176.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 62.81 32.56 15.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.281 -0.872 . . . . 2.9700000000000002 111.485 177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 113.03 -26.56 10.4 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.5 -0.857 . . . . 1.46 113.439 176.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.47 137.29 32.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 117.229 0.515 . . . . 2.21 110.075 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.532 HD21 ' CH2' ' A' ' 140' ' ' TRP . 3.3 mm? -90.51 135.89 33.41 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.308 -0.405 . . . . 1.25 110.904 -173.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 1.001 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 66.4 m-85 -138.87 150.29 45.82 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.824 -0.626 . . . . 1.23 109.962 178.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 21.6 m -74.44 162.5 28.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.101 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -52.69 -46.12 67.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.085 0.469 . . . . 3.1200000000000001 110.304 175.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 52.6 t -74.04 -46.31 45.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.778 -0.646 . . . . 1.02 111.442 -177.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 59.8 m -64.88 -34.13 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.794 0.331 . . . . 0.80000000000000004 111.093 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -67.85 -35.92 79.39 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.973 0.416 . . . . 1.78 110.019 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.44 -25.41 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.909 -0.587 . . . . 1.05 111.134 178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.699 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 11.0 mmpt? -69.49 -22.89 63.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.004 0.431 . . . . 3.3599999999999999 109.909 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -94.17 -53.51 3.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.681 -0.69 . . . . 2.6499999999999999 110.623 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 4.3200000000000003 110.648 -177.576 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 N--CA 1.451 -0.394 0 CA-C-O 120.755 0.312 . . . . 2.7599999999999998 110.186 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 19.5 t -73.21 117.72 62.55 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.776 -0.647 . . . . 0.80000000000000004 110.235 177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -75.92 -7.06 18.06 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.057 2.505 . . . . 1.0 111.776 178.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.522 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.9 tpp180 -86.25 -54.35 4.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.815 -0.63 . . . . 2.8199999999999998 110.216 -177.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 14.1 m -91.42 -18.79 23.67 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.025 0.44 . . . . 0.88 111.036 -179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.46 38.47 28.54 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.347 -0.701 . . . . 0.84999999999999998 111.347 -177.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -133.71 141.66 47.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.493 0.187 . . . . 2.9900000000000002 110.83 -174.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.3 m -71.8 138.2 48.18 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.893 -0.41 . . . . 1.3700000000000001 109.893 175.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.746 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.5 t -122.04 146.92 26.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 120.704 0.287 . . . . 0.80000000000000004 110.475 -176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -128.6 177.8 6.77 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 110.166 -0.309 . . . . 5.0800000000000001 110.166 177.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.742 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -46.46 -45.52 18.3 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.175 1.176 . . . . 0.94999999999999996 114.175 -168.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.82 -18.76 35.28 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 112.713 0.634 . . . . 1.21 112.713 -176.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.529 ' OE2' ' HB3' ' A' ' 142' ' ' LYS . 10.7 tp10 -130.36 6.93 4.91 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.491 -0.559 . . . . 2.4399999999999999 109.491 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.82 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 35.7 ttpt -78.94 100.67 7.36 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.32 0.581 . . . . 2.1800000000000002 112.412 -170.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.8 m -115.29 98.46 6.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.898 -1.149 . . . . 1.02 107.898 166.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 20.3 ptp -78.75 111.72 15.15 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.105 0.78 . . . . 1.78 113.105 -166.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.8 122.66 7.26 Favored Glycine 0 N--CA 1.445 -0.743 0 N-CA-C 110.116 -1.193 . . . . 0.77000000000000002 110.116 169.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 73.78 11.45 80.83 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 120.777 -0.725 . . . . 1.72 111.86 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.02 -4.98 65.75 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.985 -0.626 . . . . 1.04 112.557 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' A' ' 138' ' ' LYS . 0.1 OUTLIER -114.12 131.27 23.28 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 122.651 -0.323 . . . . 2.6899999999999999 110.188 179.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.82 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.8 Cg_endo -54.5 120.84 8.71 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.684 2.923 . . . . 0.71999999999999997 114.439 -177.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.438 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 13.0 m95 -101.57 -174.64 2.64 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 107.688 -1.227 . . . . 0.78000000000000003 107.688 168.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 79.8 m80 -98.4 144.72 27.47 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.99 -0.744 . . . . 0.71999999999999997 108.99 178.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.545 ' HB3' ' NZ ' ' A' ' 142' ' ' LYS . 6.1 ttpm? -68.56 -21.79 64.52 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.996 -0.742 . . . . 3.1899999999999999 108.996 174.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.3 m -71.48 -42.59 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.129 -0.942 . . . . 1.47 110.837 175.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 28.6 p -96.77 8.9 43.24 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.026 -0.361 . . . . 1.1399999999999999 110.026 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.502 ' HB2' ' HA ' ' A' ' 142' ' ' LYS . 0.3 OUTLIER -75.48 55.23 0.8 Allowed 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 122.296 1.046 . . . . 1.1299999999999999 109.064 178.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.497 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 22.3 ptt180 -139.54 127.52 22.25 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 113.816 -1.538 . . . . 2.7799999999999998 108.202 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.883 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -63.81 141.34 58.8 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.067 0.461 . . . . 0.68000000000000005 109.791 -178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.61 59.74 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 114.661 -1.154 . . . . 1.02 112.472 -175.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 28.3 mt -86.67 -45.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 C-N-CA 120.821 -0.351 . . . . 1.02 110.971 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 11.3 m -91.09 -20.32 22.17 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.586 0.708 . . . . 0.87 109.327 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 24.37 76.08 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 109.65 -1.38 . . . . 0.76000000000000001 109.65 -170.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.627 ' HE3' ' SG ' ' A' ' 168' ' ' CYS . 22.4 ttpp -106.75 131.12 54.24 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 115.35 -0.425 . . . . 2.3700000000000001 112.107 -166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.497 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 48.9 m -68.26 135.42 51.92 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.494 -0.776 . . . . 1.46 109.911 178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.6 118.63 21.62 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.48 0.657 . . . . 1.1299999999999999 109.811 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.513 ' CD ' ' H ' ' A' ' 155' ' ' GLU . 0.1 OUTLIER -102.68 -12.38 17.73 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.833 -1.076 . . . . 3.54 111.14 -170.234 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 37.2 m -143.77 179.48 7.13 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.767 -0.651 . . . . 3.5800000000000001 109.355 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.2 p -77.62 48.58 0.68 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.305 0.574 . . . . 2.6699999999999999 111.692 -176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.95 ' HB2' ' HB2' ' A' ' 169' ' ' LYS . 8.3 p30 -104.78 34.29 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.69 0.757 . . . . 2.2999999999999998 109.082 174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 22.0 t -79.47 121.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 114.746 -1.115 . . . . 1.5900000000000001 110.266 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.8 m -134.39 117.11 15.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.517 -0.31 . . . . 1.1599999999999999 110.386 178.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -102.13 156.34 17.62 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.592 -0.521 . . . . 2.27 109.592 178.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.461 ' HB3' ' HE1' ' A' ' 167' ' ' TYR . 25.1 ttmm -160.66 108.04 1.55 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.331 -0.395 . . . . 2.9500000000000002 110.636 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.6 t70 56.72 55.34 6.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.46 -0.791 . . . . 2.9700000000000002 111.221 174.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 84.52 -24.33 6.57 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.865 -0.683 . . . . 1.46 112.713 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -80.73 178.39 8.4 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.477 0.656 . . . . 2.21 111.682 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.423 HD22 ' HA ' ' A' ' 166' ' ' LEU . 0.3 OUTLIER -149.25 129.55 13.74 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.645 -1.162 . . . . 1.25 108.18 -175.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.883 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 32.1 m-85 -133.67 169.3 17.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.313 0.383 . . . . 1.23 110.767 -174.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.627 ' SG ' ' HE3' ' A' ' 152' ' ' LYS . 2.4 m -93.1 -172.2 2.9 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.211 -1.033 . . . . 0.52000000000000002 108.211 170.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.95 ' HB2' ' HB2' ' A' ' 158' ' ' ASN . 62.9 tttm -68.29 -42.82 78.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.164 0.507 . . . . 3.1200000000000001 111.282 174.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.5 t -72.48 -48.96 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.846 -0.616 . . . . 1.02 112.414 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 2.6 p -69.83 -38.92 76.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.886 0.374 . . . . 0.80000000000000004 110.638 -176.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.518 ' HB3' ' O ' ' A' ' 168' ' ' CYS . 0.0 OUTLIER -59.0 -42.4 89.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.973 -0.558 . . . . 1.78 111.037 176.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.33 -25.68 59.69 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.709 0.262 . . . . 1.05 111.709 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 14.2 tppt? -88.62 -38.16 15.05 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.762 0.315 . . . . 3.3599999999999999 111.471 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -93.52 -58.52 2.26 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.892 0.33 . . . . 2.6499999999999999 111.892 -175.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 113.665 0.987 . . . . 4.3200000000000003 113.665 -178.101 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.112 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.535 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 6.1 t -69.78 116.88 48.02 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.419 -0.809 . . . . 0.80000000000000004 109.099 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.98 -6.98 19.37 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.683 2.256 . . . . 1.0 112.011 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.535 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 13.2 mmt180 -78.86 -38.61 37.4 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.068 -0.716 . . . . 2.8199999999999998 109.068 178.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 53.9 m -107.58 -19.77 13.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.3 -0.864 . . . . 0.88 111.672 -177.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.01 42.03 92.77 Favored Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 110.272 -1.131 . . . . 0.84999999999999998 110.272 -171.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.421 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 48.1 tttp -132.46 143.64 49.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.463 -0.369 . . . . 2.9900000000000002 110.403 -170.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.9 m -64.02 149.68 46.92 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.964 -0.562 . . . . 1.3700000000000001 111.467 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.568 HG22 ' CD2' ' A' ' 141' ' ' HIS . 24.6 t -122.76 146.71 27.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.768 -0.651 . . . . 0.80000000000000004 109.99 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HE1' ' HG2' ' A' ' 131' ' ' GLU . 0.4 OUTLIER -110.74 169.44 8.75 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.275 -0.42 . . . . 5.0800000000000001 110.134 176.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 132' ' ' LYS . . . -57.14 -39.2 74.72 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.653 0.612 . . . . 0.94999999999999996 112.653 -174.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.32 -51.44 66.73 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.255 0.835 . . . . 1.21 113.255 -172.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.47 ' HG2' ' HE1' ' A' ' 128' ' ' TYR . 9.4 mm-40 -102.15 13.83 33.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.284 0.564 . . . . 2.4399999999999999 110.748 -176.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.706 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 32.7 tttm -71.31 114.41 9.35 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.128 -0.942 . . . . 2.1800000000000002 112.601 -177.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.496 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.0 m -108.7 147.55 13.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.003 -0.999 . . . . 1.02 109.452 168.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 98.3 mmm -87.3 88.88 7.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.919 0.39 . . . . 1.78 111.892 -171.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -79.82 89.71 1.26 Allowed Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 110.895 -0.882 . . . . 0.77000000000000002 110.895 171.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 77.04 -71.25 2.23 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 111.647 -0.581 . . . . 1.72 111.647 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -155.44 12.25 0.41 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.262 -0.494 . . . . 1.04 111.93 177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -129.81 140.96 40.21 Favored Pre-proline 0 C--N 1.329 -0.322 0 N-CA-C 110.18 -0.304 . . . . 2.6899999999999999 110.18 -177.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.706 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.8 Cg_endo -58.6 121.66 10.34 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.113 2.542 . . . . 0.71999999999999997 112.957 170.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.0 m0 -110.73 172.49 6.84 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.37 -0.832 . . . . 0.78000000000000003 108.992 172.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.782 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 18.2 m170 -86.53 135.28 33.51 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.056 -1.09 . . . . 0.71999999999999997 108.056 170.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 153' ' ' SER . 42.8 mtmt -55.36 -24.54 30.05 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.823 0.675 . . . . 3.1899999999999999 112.823 -176.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 4.1 p -77.59 -48.96 15.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.008 0.432 . . . . 1.47 111.724 -177.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.782 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -87.79 -14.41 39.68 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.841 -0.618 . . . . 1.1399999999999999 111.642 -174.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -71.13 65.21 0.37 Allowed 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.789 -1.189 . . . . 1.1299999999999999 107.789 168.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.3 ptm180 -130.94 158.49 40.09 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 114.69 -1.141 . . . . 2.7799999999999998 109.744 -169.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -100.57 134.36 43.66 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 109.174 -0.676 . . . . 0.68000000000000005 109.174 174.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.32 -5.73 43.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.8 -1.091 . . . . 1.02 111.989 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.584 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 45.4 mt -72.58 -36.29 53.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.768 -0.373 . . . . 1.02 110.286 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.897 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 28.0 p -115.59 -18.13 10.98 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.389 0.614 . . . . 0.87 110.093 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 71.71 37.62 61.44 Favored Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 110.514 -1.034 . . . . 0.76000000000000001 110.514 -173.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.897 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 3.9 tmtt? -125.81 142.64 51.42 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.29 0.566 . . . . 2.3700000000000001 111.558 -176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.56 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 17.8 m -74.84 139.48 43.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.139 -0.937 . . . . 1.46 112.048 -175.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 168' ' ' CYS . 57.2 mt -86.26 135.48 33.53 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.758 -0.655 . . . . 1.1299999999999999 109.625 175.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 156' ' ' SER . 25.3 mt-10 -63.25 -52.07 63.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.669 -0.696 . . . . 3.54 110.856 -177.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 155' ' ' GLU . 21.1 t 167.51 -33.04 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 107.804 -1.184 . . . . 3.5800000000000001 107.804 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.7 p -100.94 -174.14 2.55 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.634 -1.166 . . . . 2.6699999999999999 109.842 175.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 9.6 p30 47.49 33.33 2.78 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.79 0.836 . . . . 2.2999999999999998 111.52 -176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 59.0 t -93.01 128.48 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 CA-C-N 115.239 -0.891 . . . . 1.5900000000000001 109.544 178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.1 m -120.44 134.51 55.26 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.853 179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.25 133.51 41.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.02 -0.536 . . . . 2.27 110.426 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -160.78 123.11 3.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.688 0.28 . . . . 2.9500000000000002 110.797 175.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 64.29 24.37 13.29 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.655 -0.702 . . . . 2.9700000000000002 111.025 179.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 76.7 13.98 82.98 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.928 -0.653 . . . . 1.46 112.017 -178.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -118.97 149.36 41.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.919 0.39 . . . . 2.21 110.074 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 166' ' ' LEU . 3.5 mm? -93.35 130.59 39.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.741 -0.663 . . . . 1.25 110.211 -177.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 69.8 m-85 -134.03 150.63 51.23 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.044 -0.525 . . . . 1.23 109.907 178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' HA ' HD21 ' A' ' 154' ' ' LEU . 4.3 m -70.19 150.65 46.25 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.717 -0.475 . . . . 0.52000000000000002 109.717 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -56.34 -37.39 69.92 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.079 0.466 . . . . 3.1200000000000001 110.415 177.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.5 -47.14 78.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.814 -0.63 . . . . 1.02 111.041 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 58.5 m -69.42 -33.31 72.8 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.037 -0.529 . . . . 0.80000000000000004 111.246 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.668 ' HA ' HD21 ' A' ' 175' ' ' ASN . 74.6 t80 -67.45 -37.79 83.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.171 -0.468 . . . . 1.78 110.201 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.86 67.86 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.073 -0.512 . . . . 1.05 110.69 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -74.54 -34.9 63.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.994 -0.548 . . . . 3.3599999999999999 111.222 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.668 HD21 ' HA ' ' A' ' 172' ' ' TYR . 9.9 p30 -93.78 -40.34 10.26 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.518 -0.473 . . . . 2.6499999999999999 111.819 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 29.7 p90 . . . . . 0 N--CA 1.476 0.825 0 C-N-CA 124.07 0.948 . . . . 4.3200000000000003 112.743 178.344 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.515 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 56.9 pttt . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 120.617 0.246 . . . . 2.7599999999999998 111.454 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 43.7 t -68.5 111.58 8.52 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.475 -0.784 . . . . 0.80000000000000004 109.165 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 3.0 Cg_exo -75.25 -2.33 12.42 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 123.182 2.588 . . . . 1.0 112.312 -175.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 14.3 mmt85 -91.38 -28.01 17.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.017 0.437 . . . . 2.8199999999999998 110.171 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 23.3 m -116.39 -12.61 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.791 -0.64 . . . . 0.88 111.098 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 69.0 36.37 81.12 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.48 -0.782 . . . . 0.84999999999999998 111.904 -179.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.0 tptm -126.05 128.89 48.1 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.544 0.211 . . . . 2.9900000000000002 110.445 -174.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.515 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 6.0 p -72.1 135.5 46.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.064 0.459 . . . . 1.3700000000000001 111.324 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -121.47 141.21 42.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.979 -0.555 . . . . 0.80000000000000004 109.97 -175.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.425 ' CG ' ' N ' ' A' ' 129' ' ' ALA . 6.5 t80 -114.22 -171.99 2.01 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 121.135 -0.226 . . . . 5.0800000000000001 110.802 -178.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.425 ' N ' ' CG ' ' A' ' 128' ' ' TYR . . . -48.2 -47.44 35.4 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.809 1.04 . . . . 0.94999999999999996 113.809 -169.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.4 -40.13 67.94 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.026 0.38 . . . . 1.21 112.026 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.536 ' HA ' ' HE3' ' A' ' 142' ' ' LYS . 7.0 mm-40 -113.68 10.55 17.97 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.723 -0.217 . . . . 2.4399999999999999 110.846 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.884 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 3.0 ttmp? -71.09 104.35 3.01 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.492 0.663 . . . . 2.1800000000000002 111.624 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.55 HG21 ' HB2' ' A' ' 145' ' ' PHE . 5.0 m -115.08 108.55 25.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.527 -0.916 . . . . 1.02 108.527 169.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.522 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 87.4 mtp -78.08 81.8 4.45 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.483 0.549 . . . . 1.78 112.483 -166.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -76.95 104.86 1.95 Allowed Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.942 -0.863 . . . . 0.77000000000000002 110.942 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 72.0 6.52 64.31 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.097 -0.573 . . . . 1.72 112.684 179.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 121.63 -23.76 7.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.816 -0.707 . . . . 1.04 112.544 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 134' ' ' MET . 1.3 mptp? -94.98 138.43 22.05 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 122.65 -0.323 . . . . 2.6899999999999999 110.532 -178.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.884 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 27.6 Cg_endo -63.85 101.46 0.33 Allowed 'Trans proline' 0 N--CA 1.463 -0.27 0 C-N-CA 122.5 2.133 . . . . 0.71999999999999997 111.685 167.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.498 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 11.8 m95 -84.99 -176.91 6.41 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.061 -0.718 . . . . 0.78000000000000003 109.061 174.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.522 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 26.0 m170 -83.01 150.92 26.06 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 110.299 -0.259 . . . . 0.71999999999999997 110.299 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 131' ' ' GLU . 33.8 mmtp -58.96 -31.09 68.41 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.461 0.648 . . . . 3.1899999999999999 109.264 169.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 37.6 p -82.67 -0.3 46.65 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.15 -0.932 . . . . 1.47 111.202 177.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.522 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 63.2 m -130.36 7.32 4.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.976 0.417 . . . . 1.1399999999999999 111.216 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.642 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -81.12 54.94 2.36 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.913 -1.514 . . . . 1.1299999999999999 106.913 170.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.949 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 65.0 mtm180 -139.1 162.28 35.32 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 113.952 -1.476 . . . . 2.7799999999999998 109.159 -169.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.853 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -94.06 138.47 32.11 Favored 'General case' 0 C--O 1.254 1.296 0 N-CA-C 107.822 -1.177 . . . . 0.68000000000000005 107.822 168.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.98 -9.42 58.51 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.36 1.037 . . . . 1.02 112.132 -176.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.505 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 51.5 mt -67.92 -40.49 83.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 121.002 0.429 . . . . 1.02 110.028 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 32.1 p -113.53 -25.52 8.71 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.76 0.79 . . . . 0.87 109.391 -178.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 77.66 39.3 25.58 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 114.488 -1.233 . . . . 0.76000000000000001 110.745 -173.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.435 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 0.1 OUTLIER -123.0 148.0 46.01 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 120.013 -0.675 . . . . 2.3700000000000001 111.449 -176.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.949 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 3.8 p -77.63 151.52 34.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.029 -0.987 . . . . 1.46 113.429 -168.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.708 HD13 ' HA ' ' A' ' 159' ' ' VAL . 68.7 mt -106.38 142.15 36.52 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.945 -1.025 . . . . 1.1299999999999999 109.45 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . 0.45 ' CD ' ' H ' ' A' ' 157' ' ' THR . 0.0 OUTLIER -75.53 -53.72 8.18 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 116.164 -0.471 . . . . 3.54 111.503 -177.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 48.2 t 172.91 -55.95 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.131 0.572 . . . . 3.5800000000000001 109.605 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.45 ' H ' ' CD ' ' A' ' 155' ' ' GLU . 0.3 OUTLIER -84.82 -19.62 32.21 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.57 0.7 . . . . 2.6699999999999999 109.621 178.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.677 ' HA ' ' HZ2' ' A' ' 169' ' ' LYS . 17.5 m-80 -75.35 -0.49 19.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.168 -0.924 . . . . 2.2999999999999998 111.685 174.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.708 ' HA ' HD13 ' A' ' 154' ' ' LEU . 61.7 t -81.5 118.54 29.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.165 -0.471 . . . . 1.5900000000000001 110.041 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -125.35 110.78 14.39 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.39 -0.596 . . . . 1.1599999999999999 109.39 176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -92.64 143.61 26.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.244 0.545 . . . . 2.27 111.016 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.475 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 6.6 tmtm? -134.77 101.79 5.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.437 -0.802 . . . . 2.9500000000000002 108.954 178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 69.91 -75.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.578 0 O-C-N 123.801 0.688 . . . . 2.9700000000000002 111.164 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -151.02 29.89 0.99 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.524 -0.63 . . . . 1.46 111.524 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.465 ' HB3' ' CE2' ' A' ' 167' ' ' TYR . 22.6 tp10 -136.63 140.48 42.83 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 2.21 109.67 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -94.05 135.83 34.99 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.051 -0.722 . . . . 1.25 109.051 175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.853 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 89.2 m-85 -133.4 147.98 51.79 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 120.925 0.393 . . . . 1.23 111.048 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . . . . . . . . . 3.3 m -76.19 160.03 30.1 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.78 -0.646 . . . . 0.52000000000000002 110.448 174.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.677 ' HZ2' ' HA ' ' A' ' 158' ' ' ASN . 55.8 mttp -51.6 -52.18 49.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.71 0.29 . . . . 3.1200000000000001 111.435 176.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 44.5 t -60.79 -47.92 91.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.975 -0.557 . . . . 1.02 111.167 -176.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 8.4 m -70.29 -43.7 69.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.715 -0.675 . . . . 0.80000000000000004 111.46 -177.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.494 ' O ' ' HD1' ' A' ' 176' ' ' PHE . 87.8 t80 -66.47 -29.28 69.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.35 -0.386 . . . . 1.78 111.074 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.662 ' HA ' ' HE1' ' A' ' 176' ' ' PHE . . . -58.06 -31.59 67.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.049 0.452 . . . . 1.05 111.315 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -88.55 -9.69 51.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.241 0.543 . . . . 3.3599999999999999 110.845 178.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -95.98 -36.58 11.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 113.146 0.795 . . . . 2.6499999999999999 113.146 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.662 ' HE1' ' HA ' ' A' ' 173' ' ' ALA . 33.1 p90 . . . . . 0 N--CA 1.468 0.428 0 N-CA-C 113.583 0.957 . . . . 4.3200000000000003 113.583 -166.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.63 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 53.9 pttt . . . . . 0 N--CA 1.455 -0.208 0 N-CA-C 113.16 0.8 . . . . 2.7599999999999998 113.16 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 0.5 OUTLIER -75.69 119.42 77.04 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-N 114.257 -1.338 . . . . 0.80000000000000004 109.448 172.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -73.24 -4.45 15.45 Favored 'Trans proline' 0 CA--C 1.529 0.231 0 C-N-CA 122.916 2.411 . . . . 1.0 112.72 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.755 ' HG3' ' HB3' ' A' ' 144' ' ' CYS . 14.3 mmt180 -79.75 -45.87 18.07 Favored 'General case' 0 CA--C 1.518 -0.276 0 N-CA-C 108.833 -0.803 . . . . 2.8199999999999998 108.833 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 57.4 m -97.75 -25.77 14.96 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.112 -0.949 . . . . 0.88 111.32 -178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.07 27.7 55.52 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 110.762 -0.935 . . . . 0.84999999999999998 110.762 -172.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -123.06 130.54 52.91 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 115.63 -0.285 . . . . 2.9900000000000002 111.136 -172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 13.7 m -62.03 138.66 58.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.947 -0.57 . . . . 1.3700000000000001 110.774 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.93 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 88.3 t -104.25 140.12 23.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.262 0.553 . . . . 0.80000000000000004 110.617 179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.65 ' HE1' ' HB2' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -88.32 158.62 18.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.439 -0.801 . . . . 5.0800000000000001 110.383 179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.76 -14.19 57.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.838 -0.619 . . . . 0.94999999999999996 112.609 -174.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.53 -43.84 75.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.816 0.341 . . . . 1.21 111.409 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.65 ' HB2' ' HE1' ' A' ' 128' ' ' TYR . 63.9 mt-10 -122.51 35.58 4.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.637 0.732 . . . . 2.4399999999999999 110.128 -176.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.528 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 23.3 ttpp -85.37 107.89 17.57 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.806 -1.088 . . . . 2.1800000000000002 111.806 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.576 HG21 ' HB2' ' A' ' 145' ' ' PHE . 2.4 m -98.61 136.22 30.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 108.767 -0.827 . . . . 1.02 108.767 168.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 90.1 mmm -85.35 91.94 8.33 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.186 0.439 . . . . 1.78 112.186 -167.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -95.99 96.98 2.01 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.945 -0.645 . . . . 0.77000000000000002 111.516 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 61.49 49.25 79.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.068 -0.587 . . . . 1.72 112.596 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 73.74 2.37 60.74 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 121.464 -0.398 . . . . 1.04 112.885 178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 139' ' ' PRO . 35.0 mtmm -118.67 131.65 24.2 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 122.779 -0.247 . . . . 2.6899999999999999 110.754 -175.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.93 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 11.9 Cg_endo -56.59 113.95 1.69 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.982 2.455 . . . . 0.71999999999999997 112.732 170.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -107.11 169.15 8.73 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.688 -0.687 . . . . 0.78000000000000003 109.547 174.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.531 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 9.8 m80 -76.23 144.47 40.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.832 0.349 . . . . 0.71999999999999997 110.646 176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -52.51 -26.44 13.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.209 -0.905 . . . . 3.1899999999999999 111.895 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.495 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 12.0 p -94.1 -40.68 9.93 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.368 -0.378 . . . . 1.47 111.61 178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.755 ' HB3' ' HG3' ' A' ' 122' ' ' ARG . 9.4 m -81.6 -7.89 59.64 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 112.312 0.486 . . . . 1.1399999999999999 112.312 -174.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.576 ' HB2' HG21 ' A' ' 133' ' ' VAL . 4.9 t80 -71.0 63.04 0.3 Allowed 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 107.92 -1.141 . . . . 1.1299999999999999 107.92 171.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 143' ' ' THR . 9.8 ptm180 -142.88 148.67 37.39 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.707 -1.133 . . . . 2.7799999999999998 109.454 -167.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.947 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -81.41 133.79 35.46 Favored 'General case' 0 C--O 1.248 0.989 0 C-N-CA 120.402 -0.519 . . . . 0.68000000000000005 109.602 176.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.26 -12.01 60.43 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 114.466 -1.243 . . . . 1.02 111.946 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 63.8 mt -68.2 -41.31 83.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.714 0.292 . . . . 1.02 110.509 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.516 ' SG ' ' CB ' ' A' ' 152' ' ' LYS . 21.1 p -119.04 -27.47 5.72 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-O 121.268 0.556 . . . . 0.87 110.784 -178.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 95.84 23.88 16.86 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.564 -0.744 . . . . 0.76000000000000001 111.469 -175.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.671 ' HB3' ' SG ' ' A' ' 168' ' ' CYS . 26.3 tptp -87.04 118.51 26.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 111.885 0.328 . . . . 2.3700000000000001 111.885 -174.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 7.9 p -69.39 121.53 17.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.823 -0.626 . . . . 1.46 110.341 176.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.751 HD13 ' HA ' ' A' ' 159' ' ' VAL . 55.4 mt -96.56 141.36 29.92 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.244 -0.435 . . . . 1.1299999999999999 110.734 -174.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -110.25 -164.55 0.93 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.974 -0.557 . . . . 3.54 110.735 -178.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 14.5 m -52.96 111.91 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.418 0.449 . . . . 3.5800000000000001 112.181 -175.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.1 m 67.35 13.46 9.36 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.643 -0.708 . . . . 2.6699999999999999 111.564 174.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -96.1 -6.7 37.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 122.157 0.98 . . . . 2.2999999999999998 108.923 176.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.751 ' HA ' HD13 ' A' ' 154' ' ' LEU . 7.4 p -92.07 148.28 4.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 114.371 -1.286 . . . . 1.5900000000000001 111.263 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.5 m -126.59 143.42 51.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.141 -0.481 . . . . 1.1599999999999999 109.72 172.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -102.75 130.73 49.8 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.362 -0.236 . . . . 2.27 110.362 -177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.57 ' HE2' ' HZ ' ' A' ' 176' ' ' PHE . 23.2 tptp -139.76 97.6 3.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.722 0.296 . . . . 2.9500000000000002 110.606 177.042 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.09 28.88 18.55 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.924 -0.58 . . . . 2.9700000000000002 111.792 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 103.88 -17.63 48.6 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.444 -0.884 . . . . 1.46 112.871 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -101.51 144.09 30.7 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 2.21 109.76 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.33 133.63 44.46 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.295 -0.411 . . . . 1.25 110.324 -176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.947 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 37.7 m-85 -130.15 152.51 49.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.07 -0.514 . . . . 1.23 110.778 -179.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.709 ' SG ' HD21 ' A' ' 154' ' ' LEU . 29.4 m -66.21 162.9 18.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.995 -0.548 . . . . 0.52000000000000002 110.984 177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -66.77 -31.39 72.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.131 0.491 . . . . 3.1200000000000001 110.285 174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 49.4 t -76.42 -46.78 31.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.615 . . . . 1.02 110.448 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.409 ' H ' ' HB2' ' A' ' 168' ' ' CYS . 66.5 m -68.51 -29.49 68.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.076 -0.511 . . . . 0.80000000000000004 110.89 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -59.78 -38.14 81.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.059 -0.519 . . . . 1.78 110.77 172.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.82 -25.37 67.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.088 -0.505 . . . . 1.05 111.063 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 17.2 tppt? -70.95 -40.26 72.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.932 0.396 . . . . 3.3599999999999999 110.326 177.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -72.88 -43.29 62.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 2.6499999999999999 110.517 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.57 ' HZ ' ' HE2' ' A' ' 162' ' ' LYS . 75.5 m-85 . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 4.3200000000000003 110.385 -178.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 38.8 ttpt . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.908 -0.405 . . . . 2.7599999999999998 109.908 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 122' ' ' ARG . 3.7 t -78.41 118.14 70.53 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 115.359 -0.837 . . . . 0.80000000000000004 111.225 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.76 4.42 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.12 2.547 . . . . 1.0 112.087 176.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.433 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 20.5 tpt180 -89.62 -58.49 2.5 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.784 -0.45 . . . . 2.8199999999999998 109.784 178.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.6 m -90.25 -29.08 18.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.13 -0.486 . . . . 0.88 110.135 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 94.02 44.91 3.46 Favored Glycine 0 C--N 1.333 0.362 0 CA-C-N 115.898 -0.592 . . . . 0.84999999999999998 112.226 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.696 ' HB2' ' HE1' ' A' ' 141' ' ' HIS . 73.6 mmtt -139.64 137.8 35.58 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.251 -0.277 . . . . 2.9900000000000002 110.251 -174.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 50.5 m -65.46 144.81 56.8 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.667 0.27 . . . . 1.3700000000000001 110.842 178.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.484 HG22 ' CD2' ' A' ' 141' ' ' HIS . 15.8 t -127.26 136.79 59.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-O 120.763 0.315 . . . . 0.80000000000000004 110.973 -174.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.26 -168.06 1.95 Allowed 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 120.999 -0.28 . . . . 5.0800000000000001 111.654 173.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -45.86 -42.75 12.86 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.717 1.006 . . . . 0.94999999999999996 113.717 -168.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.17 -37.9 67.62 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 111.987 0.366 . . . . 1.21 111.987 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.0 -2.1 14.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.423 -0.353 . . . . 2.4399999999999999 111.606 -177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.838 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.0 ttmt -61.77 91.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.876 0.695 . . . . 2.1800000000000002 112.876 -169.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.8 m -113.13 106.59 21.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 107.997 -1.112 . . . . 1.02 107.997 165.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 49.8 mtt -69.82 103.92 2.32 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.596 0.591 . . . . 1.78 112.596 -169.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.43 112.7 4.12 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 110.228 -1.149 . . . . 0.77000000000000002 110.228 170.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 78.8 -26.59 2.35 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 121.15 -0.548 . . . . 1.72 112.636 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.91 -12.17 1.27 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 121.199 -0.524 . . . . 1.04 111.927 -178.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.4 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 75.0 mmtt -114.57 140.7 25.59 Favored Pre-proline 0 C--N 1.327 -0.406 0 N-CA-C 110.022 -0.362 . . . . 2.6899999999999999 110.022 178.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.838 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 12.3 Cg_endo -55.87 118.64 5.45 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 123.006 2.471 . . . . 0.71999999999999997 113.216 176.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 10.0 m95 -103.79 -176.53 3.11 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.863 -0.791 . . . . 0.78000000000000003 108.863 171.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.716 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m170 -90.46 147.27 23.51 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.334 -0.617 . . . . 0.71999999999999997 109.334 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.1 mttp -56.18 -32.39 64.31 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 120.636 -0.426 . . . . 3.1899999999999999 110.378 176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.624 ' O ' ' HD2' ' A' ' 146' ' ' ARG . 62.3 m -70.1 -53.08 18.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.833 -0.621 . . . . 1.47 111.681 -178.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.716 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.7 p -87.61 -1.99 58.32 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.758 0.281 . . . . 1.1399999999999999 111.758 -174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.472 ' CZ ' HG21 ' A' ' 159' ' ' VAL . 9.4 t80 -65.73 77.33 0.08 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.434 -1.321 . . . . 1.1299999999999999 107.434 170.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HA ' ' HG ' ' A' ' 154' ' ' LEU . 10.3 ptm180 -167.71 172.95 8.81 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 114.84 -1.073 . . . . 2.7799999999999998 109.164 -164.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.718 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -108.37 129.13 55.25 Favored 'General case' 0 C--O 1.245 0.841 0 C-N-CA 120.211 -0.595 . . . . 0.68000000000000005 109.421 171.122 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.98 3.48 10.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.843 -1.072 . . . . 1.02 111.793 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.649 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 54.0 mt -74.48 -39.91 48.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.815 -0.439 . . . . 1.02 109.815 178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.587 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.1 p -108.4 -29.55 8.77 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 121.825 0.821 . . . . 0.87 108.932 177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.55 34.75 8.3 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-N 114.284 -1.325 . . . . 0.76000000000000001 111.201 -174.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.722 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 82.8 tttt -115.4 135.99 53.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 111.678 0.251 . . . . 2.3700000000000001 111.678 -177.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.67 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 35.3 p -76.15 153.05 36.51 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.998 -0.546 . . . . 1.46 111.785 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.742 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 94.4 mt -114.16 154.03 28.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.681 -0.69 . . . . 1.1299999999999999 111.451 -175.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -102.61 -178.24 3.62 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-N 115.626 -0.715 . . . . 3.54 110.111 176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 20.0 m -67.04 -23.33 65.88 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 114.48 1.289 . . . . 3.5800000000000001 114.48 -161.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 14.8 t -119.31 -26.31 5.89 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 120.176 -0.61 . . . . 2.6699999999999999 112.601 -175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -82.91 4.63 24.88 Favored 'General case' 0 C--N 1.33 -0.254 0 O-C-N 121.826 -0.546 . . . . 2.2999999999999998 110.608 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.472 HG21 ' CZ ' ' A' ' 145' ' ' PHE . 6.3 p -81.56 135.56 24.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.817 -0.629 . . . . 1.5900000000000001 111.303 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.9 m -130.35 152.58 49.61 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.781 -0.645 . . . . 1.1599999999999999 109.281 172.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -128.95 156.05 44.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.974 0.416 . . . . 2.27 110.779 -177.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.584 ' HB3' ' HE2' ' A' ' 167' ' ' TYR . 53.0 tttm -143.92 106.6 4.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.562 -0.744 . . . . 2.9500000000000002 109.817 172.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 11.4 m-20 71.2 -81.18 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.49 -0.777 . . . . 2.9700000000000002 111.084 177.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -134.76 -8.62 1.88 Allowed Glycine 0 C--O 1.227 -0.327 0 C-N-CA 120.845 -0.693 . . . . 1.46 112.893 -177.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -106.97 148.07 29.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.918 0.39 . . . . 2.21 111.206 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -99.12 143.88 28.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.675 . . . . 1.25 109.203 174.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.718 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 80.5 m-85 -137.92 140.74 40.48 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.575 -0.284 . . . . 1.23 110.666 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.623 ' SG ' HD21 ' A' ' 154' ' ' LEU . 3.2 m -63.52 148.35 48.96 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.945 -0.761 . . . . 0.52000000000000002 108.945 170.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt -62.56 -31.66 72.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.902 0.382 . . . . 3.1200000000000001 110.521 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 60.7 t -67.65 -47.7 79.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.145 -0.48 . . . . 1.02 110.463 178.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 34.1 m -70.27 -31.61 69.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.82 -0.627 . . . . 0.80000000000000004 110.924 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 58.5 t80 -68.37 -44.9 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.866 -0.606 . . . . 1.78 110.129 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.9 -25.16 68.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.966 -0.561 . . . . 1.05 111.229 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -61.15 -41.88 97.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.885 -0.598 . . . . 3.3599999999999999 110.506 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -93.04 -43.01 9.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 2.6499999999999999 111.501 -174.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 C--N 1.323 -0.58 0 CA-C-O 121.086 0.47 . . . . 4.3200000000000003 110.79 -175.361 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 121.32 0.581 . . . . 2.7599999999999998 111.894 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 4.1 t -84.33 122.62 75.43 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.79 -1.095 . . . . 0.80000000000000004 110.534 177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 4.4 Cg_exo -81.32 3.92 7.42 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.638 2.892 . . . . 1.0 112.859 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.606 ' HE ' ' HA ' ' A' ' 122' ' ' ARG . 1.3 mmp_? -97.38 -35.97 10.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.899 0.38 . . . . 2.8199999999999998 110.689 177.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 20.4 m -108.35 -12.06 15.1 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.141 -0.481 . . . . 0.88 111.244 -179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.96 74.55 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 111.451 -0.659 . . . . 0.84999999999999998 111.451 -177.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -129.93 148.21 51.77 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.162 -0.31 . . . . 2.9900000000000002 110.162 -171.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.2 m -64.63 150.99 45.98 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.02 0.438 . . . . 1.3700000000000001 110.859 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.639 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 27.7 t -123.99 131.49 72.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.018 -0.537 . . . . 0.80000000000000004 110.464 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 130' ' ' ALA . 2.4 p90 -95.22 -176.67 3.88 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.793 -0.64 . . . . 5.0800000000000001 110.174 176.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.87 -43.37 98.97 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.779 0.659 . . . . 0.94999999999999996 112.779 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HB3' ' CE1' ' A' ' 128' ' ' TYR . . . -57.35 -45.61 84.17 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.621 0.6 . . . . 1.21 112.621 -173.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -94.79 0.21 54.72 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 111.613 0.227 . . . . 2.4399999999999999 111.613 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.954 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 36.9 ttmt -65.67 96.77 0.29 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.31 0.576 . . . . 2.1800000000000002 112.245 -172.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 75.0 t -100.04 101.39 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 108.139 -1.06 . . . . 1.02 108.139 167.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 66.6 mtp -75.22 93.9 2.9 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.495 0.554 . . . . 1.78 112.495 -169.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -73.44 97.13 0.85 Allowed Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.051 -1.22 . . . . 0.77000000000000002 110.051 167.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 75.97 -111.32 3.28 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.88 -0.888 . . . . 1.72 110.88 -173.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -114.41 15.79 19.95 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.62 -0.8 . . . . 1.04 112.498 176.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 93.0 mttt -121.82 127.67 25.9 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.588 0.194 . . . . 2.6899999999999999 110.984 -177.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.954 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 18.9 Cg_endo -59.7 120.38 8.16 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.807 2.338 . . . . 0.71999999999999997 113.24 166.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.495 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 8.1 m95 -107.63 175.64 5.42 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 107.11 -1.441 . . . . 0.78000000000000003 107.11 168.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.832 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 25.4 m80 -97.28 158.92 15.21 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.0 -0.741 . . . . 0.71999999999999997 109.0 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 153' ' ' SER . 58.0 mttp -61.62 -43.48 98.78 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.392 0.516 . . . . 3.1899999999999999 112.392 -174.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.5 p -73.98 -35.31 64.46 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.02 0.748 . . . . 1.47 113.02 -171.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.832 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 1.8 p -90.48 -28.86 18.3 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.562 -0.29 . . . . 1.1399999999999999 111.25 -174.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.565 ' HD1' ' HB2' ' A' ' 154' ' ' LEU . 48.1 t80 -66.74 80.02 0.11 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 108.364 -0.976 . . . . 1.1299999999999999 108.364 172.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 152' ' ' LYS . 7.4 ptm180 -135.61 145.15 46.6 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.459 -0.791 . . . . 2.7799999999999998 110.26 -171.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 1.081 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -78.57 135.41 37.27 Favored 'General case' 0 C--O 1.248 0.974 0 N-CA-C 108.928 -0.767 . . . . 0.68000000000000005 108.928 175.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.45 -9.55 58.8 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.777 1.298 . . . . 1.02 112.197 -175.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.525 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 60.2 mt -70.79 -39.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 110.094 -0.336 . . . . 1.02 110.094 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 152' ' ' LYS . 27.2 p -120.46 -27.72 5.12 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 121.181 0.515 . . . . 0.87 111.028 -177.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 91.15 27.83 17.18 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.428 -0.806 . . . . 0.76000000000000001 111.407 -174.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 150' ' ' CYS . 39.8 tttp -93.1 122.79 35.84 Favored 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 112.087 0.403 . . . . 2.3700000000000001 112.087 -173.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 142' ' ' LYS . 7.1 m -66.84 128.36 36.01 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.543 -0.753 . . . . 1.46 109.982 174.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.565 ' HB2' ' HD1' ' A' ' 145' ' ' PHE . 85.6 mt -110.53 -171.41 1.83 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.183 -0.462 . . . . 1.1299999999999999 110.7 -175.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.78 -157.62 0.79 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.574 . . . . 3.54 109.802 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.7 m -63.21 -37.0 85.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.859 0.362 . . . . 3.5800000000000001 111.389 -178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 44.0 p -111.58 172.54 6.83 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.686 -0.234 . . . . 2.6699999999999999 111.027 178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.589 ' HA ' ' HD3' ' A' ' 169' ' ' LYS . 31.6 m-80 73.11 29.47 1.74 Allowed 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.552 0.741 . . . . 2.2999999999999998 110.632 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 29.1 t -126.8 149.6 31.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.23 0.538 . . . . 1.5900000000000001 111.434 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.4 m -133.78 122.02 22.7 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.65 -0.705 . . . . 1.1599999999999999 109.298 172.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -100.52 137.77 38.48 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.819 0.342 . . . . 2.27 111.156 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -132.27 91.57 2.96 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.852 -0.613 . . . . 2.9500000000000002 110.433 174.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 60.17 30.86 20.24 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.341 -0.845 . . . . 2.9700000000000002 112.095 173.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 105.56 -10.47 45.91 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.619 -0.8 . . . . 1.46 112.475 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -95.47 117.06 29.7 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.484 -0.562 . . . . 2.21 109.484 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 166' ' ' LEU . 1.8 mm? -89.87 136.26 33.14 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.19 -0.459 . . . . 1.25 110.301 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 1.081 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 86.9 m-85 -135.95 141.84 44.52 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.147 -0.478 . . . . 1.23 109.813 176.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.55 ' SG ' HD21 ' A' ' 154' ' ' LEU . 4.9 m -62.95 144.08 57.11 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.872 -0.788 . . . . 0.52000000000000002 108.872 171.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 158' ' ' ASN . 21.4 pttp -62.88 -25.57 68.36 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.543 -0.54 . . . . 3.1200000000000001 109.543 177.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 21.3 t -69.03 -48.12 71.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.857 -0.611 . . . . 1.02 110.29 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 74.1 m -69.8 -41.81 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.657 -0.701 . . . . 0.80000000000000004 111.753 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -66.4 -42.77 87.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.685 0.279 . . . . 1.78 110.257 -179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.59 -24.94 61.16 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.834 0.35 . . . . 1.05 110.811 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 26.9 ttpp -62.81 -41.71 99.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.133 -0.485 . . . . 3.3599999999999999 110.115 177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -86.63 -45.16 11.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.844 -0.617 . . . . 2.6499999999999999 110.948 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 116.055 -0.521 . . . . 4.3200000000000003 110.217 -178.805 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 51.1 tttp . . . . . 0 N--CA 1.451 -0.385 0 CA-C-O 121.1 0.476 . . . . 2.7599999999999998 110.83 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 1.7 t -76.65 122.39 86.5 Favored Pre-proline 0 C--O 1.24 0.601 0 CA-C-N 115.254 -0.884 . . . . 0.80000000000000004 110.815 178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 1.1 Cg_endo -84.17 2.48 8.16 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 123.776 2.984 . . . . 1.0 112.143 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HB3' ' SG ' ' A' ' 120' ' ' CYS . 19.5 tpt180 -88.45 -59.91 2.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.375 -0.602 . . . . 2.8199999999999998 109.375 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 3.9 m -92.34 -17.79 24.2 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.571 -0.74 . . . . 0.88 110.821 -177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.46 36.13 15.17 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.892 -0.671 . . . . 0.84999999999999998 112.213 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -139.79 150.07 44.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.444 0.164 . . . . 2.9900000000000002 110.562 -175.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.697 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 49.5 m -68.12 157.32 35.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.938 0.399 . . . . 1.3700000000000001 111.455 -176.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.772 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 12.3 t -132.64 144.15 37.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.336 -0.616 . . . . 0.80000000000000004 109.336 177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -130.87 -179.27 5.21 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 120.325 -0.55 . . . . 5.0800000000000001 110.498 177.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -46.72 -41.34 14.93 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.877 1.066 . . . . 0.94999999999999996 113.877 -168.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.14 -35.31 64.58 Favored 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.161 0.43 . . . . 1.21 112.161 -175.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -123.89 12.0 9.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.568 -0.287 . . . . 2.4399999999999999 110.888 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.85 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 38.9 ttmt -66.79 90.86 0.18 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.298 0.571 . . . . 2.1800000000000002 112.095 -175.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.64 111.24 30.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.716 -0.846 . . . . 1.02 108.716 168.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.44 ' HA ' ' O ' ' A' ' 138' ' ' LYS . 90.7 mtp -81.67 88.87 6.23 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.797 -0.638 . . . . 1.78 112.602 -166.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -78.49 109.94 2.94 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.96 -0.856 . . . . 0.77000000000000002 110.96 170.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 81.05 -16.5 15.8 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.136 -0.554 . . . . 1.72 112.462 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.71 -4.01 6.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 121.008 -0.615 . . . . 1.04 111.961 -177.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 1.3 ptpm? -115.09 142.66 28.86 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 110.06 -0.348 . . . . 2.6899999999999999 110.06 178.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.85 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.2 Cg_endo -61.57 123.69 13.21 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.972 2.448 . . . . 0.71999999999999997 113.199 176.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.466 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 29.3 m95 -108.8 177.92 4.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.267 -0.879 . . . . 0.78000000000000003 108.788 171.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.752 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 34.5 m80 -96.03 137.47 35.05 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.967 -0.753 . . . . 0.71999999999999997 108.967 176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -57.44 -16.83 10.48 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.141 0.496 . . . . 3.1899999999999999 111.864 -179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 4.8 m -92.09 -20.46 21.25 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 116.231 -0.44 . . . . 1.47 112.1 -179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.752 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 26.4 p -115.1 -22.05 9.69 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.752 0.311 . . . . 1.1399999999999999 111.154 -177.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 154' ' ' LEU . 33.6 t80 -65.2 84.08 0.05 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.671 -0.863 . . . . 1.1299999999999999 108.671 173.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.817 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 12.7 ptm180 -163.49 157.87 20.22 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 115.228 -0.896 . . . . 2.7799999999999998 109.127 -170.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.937 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -97.65 138.66 34.71 Favored 'General case' 0 C--O 1.246 0.901 0 C-N-CA 120.426 -0.509 . . . . 0.68000000000000005 109.674 178.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.4 -10.06 59.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.027 -0.988 . . . . 1.02 112.12 -178.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 49.7 mt -67.63 -47.85 78.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.581 0.229 . . . . 1.02 110.401 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.865 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.1 p -104.62 -12.22 16.53 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.477 0.656 . . . . 0.87 109.292 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 69.35 29.11 71.94 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 114.836 -1.075 . . . . 0.76000000000000001 111.003 -177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.865 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 86.4 tttt -117.75 140.97 48.94 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.938 0.399 . . . . 2.3700000000000001 111.295 -171.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.817 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 4.2 p -74.91 142.72 44.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 115.304 -0.862 . . . . 1.46 112.403 -175.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.582 ' HG ' ' HA ' ' A' ' 146' ' ' ARG . 45.3 mt -91.88 136.14 33.38 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.064 -0.971 . . . . 1.1299999999999999 109.424 177.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -75.48 -70.52 0.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.976 0.417 . . . . 3.54 111.001 -177.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 13.6 p -169.65 -47.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.776 -0.647 . . . . 3.5800000000000001 110.839 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 1.1 m -88.78 29.63 1.0 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.111 0.481 . . . . 2.6699999999999999 110.943 -176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . 0.618 HD21 ' HB3' ' A' ' 168' ' ' CYS . 33.4 t30 -154.72 103.57 2.46 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.09 -0.504 . . . . 2.2999999999999998 110.231 -176.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 2.1 p -166.87 129.92 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 1.5900000000000001 111.32 178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.7 m -133.02 149.24 52.22 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.999 -0.546 . . . . 1.1599999999999999 109.763 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -117.31 131.29 56.84 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.023 0.44 . . . . 2.27 110.846 -179.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -129.54 95.62 4.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.622 -0.717 . . . . 2.9500000000000002 109.656 173.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 63.26 26.24 15.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.758 -0.655 . . . . 2.9700000000000002 111.595 176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 102.98 -8.35 53.92 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.608 -0.806 . . . . 1.46 112.191 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 24.9 mt-10 -92.29 123.17 35.42 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.119 0.485 . . . . 2.21 110.869 176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -86.3 129.57 34.81 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.33 -0.85 . . . . 1.25 109.578 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.937 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 19.7 m-85 -133.71 150.44 51.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.378 -0.374 . . . . 1.23 110.876 -179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.618 ' HB3' HD21 ' A' ' 158' ' ' ASN . 2.8 m -74.59 157.88 34.66 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 109.466 -0.568 . . . . 0.52000000000000002 109.466 171.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -54.44 -41.53 69.51 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 111.978 0.362 . . . . 3.1200000000000001 111.978 -179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 55.9 t -69.14 -47.04 76.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.074 0.464 . . . . 1.02 111.031 -177.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 9.7 m -67.1 -32.17 73.15 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.886 -0.597 . . . . 0.80000000000000004 110.517 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -65.45 -36.28 83.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.629 -0.714 . . . . 1.78 110.454 174.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.76 -25.12 67.13 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.833 -0.621 . . . . 1.05 111.733 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -70.57 -50.12 40.78 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.761 0.315 . . . . 3.3599999999999999 110.724 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -71.29 -32.54 68.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 2.6499999999999999 111.092 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 . . . . . 0 C--N 1.323 -0.56 0 CA-C-O 121.206 0.527 . . . . 4.3200000000000003 110.285 178.842 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.652 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 97.0 mttt . . . . . 0 C--O 1.233 0.229 0 CA-C-O 121.207 0.527 . . . . 2.7599999999999998 111.324 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 140' ' ' TRP . 0.6 OUTLIER -95.78 129.29 34.81 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.063 -0.971 . . . . 0.80000000000000004 110.058 175.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -84.04 -1.25 9.85 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 123.062 2.508 . . . . 1.0 112.828 -178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.605 ' HB2' ' CZ3' ' A' ' 140' ' ' TRP . 13.1 tpt180 -90.92 -45.04 8.99 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.638 -0.505 . . . . 2.8199999999999998 109.638 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 13.1 m -97.22 -16.41 20.4 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.854 -0.612 . . . . 0.88 110.778 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 73.34 33.75 58.49 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.406 -0.816 . . . . 0.84999999999999998 111.988 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -140.9 153.35 45.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.625 0.25 . . . . 2.9900000000000002 110.814 -173.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.652 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 8.6 m -73.48 145.29 45.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.967 -0.561 . . . . 1.3700000000000001 111.647 -174.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.82 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 21.4 t -125.67 138.75 53.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.055 -0.52 . . . . 0.80000000000000004 110.203 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -117.11 173.82 6.45 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.695 -0.402 . . . . 5.0800000000000001 109.937 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 132' ' ' LYS . . . -49.36 -37.11 23.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 113.907 1.077 . . . . 0.94999999999999996 113.907 -168.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.89 -32.29 60.82 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.415 0.524 . . . . 1.21 112.415 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -127.46 14.76 7.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.943 0.401 . . . . 2.4399999999999999 110.121 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.957 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 37.2 ttmt -73.41 90.39 1.69 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.147 0.499 . . . . 2.1800000000000002 111.612 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.5 m -98.32 112.98 31.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 108.571 -0.9 . . . . 1.02 108.571 168.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 83.5 mtp -83.5 93.27 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.607 0.595 . . . . 1.78 112.607 -167.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -74.09 105.14 1.77 Allowed Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.527 -1.029 . . . . 0.77000000000000002 110.527 168.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 74.86 -95.63 0.92 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.747 -0.74 . . . . 1.72 111.299 -175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -136.89 21.74 3.34 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.797 -0.715 . . . . 1.04 112.333 178.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.445 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 57.7 mttp -134.07 138.94 31.71 Favored Pre-proline 0 C--N 1.327 -0.396 0 O-C-N 123.014 -0.109 . . . . 2.6899999999999999 110.718 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.957 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 28.6 Cg_endo -62.5 125.46 16.25 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.918 2.412 . . . . 0.71999999999999997 112.747 170.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.605 ' CZ3' ' HB2' ' A' ' 122' ' ' ARG . 26.8 m95 -108.8 -174.21 2.46 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 108.638 -0.875 . . . . 0.78000000000000003 108.638 172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.603 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 72.9 m80 -105.23 141.57 36.53 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.61 -0.885 . . . . 0.71999999999999997 108.61 177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -60.58 -16.86 42.18 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.85 0.357 . . . . 3.1899999999999999 110.76 176.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.7 m -81.8 -32.45 31.31 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.99 -0.55 . . . . 1.47 111.534 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.603 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 19.9 p -100.71 -26.57 13.75 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.92 0.39 . . . . 1.1399999999999999 110.492 -178.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.498 ' CD1' ' HG ' ' A' ' 166' ' ' LEU . 7.3 t80 -75.33 68.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.451 -0.795 . . . . 1.1299999999999999 109.93 -179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -148.47 128.11 13.28 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 114.952 -1.022 . . . . 2.7799999999999998 109.449 -178.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.972 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -71.26 132.8 45.46 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 109.925 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.12 -8.95 58.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 114.457 -1.247 . . . . 1.02 111.845 -176.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.631 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 57.5 mt -69.26 -41.65 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 110.031 -0.359 . . . . 1.02 110.031 -179.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 30.7 p -117.09 -23.68 7.85 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.417 0.627 . . . . 0.87 110.616 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.02 29.67 22.38 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.256 -0.884 . . . . 0.76000000000000001 111.144 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.688 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 62.9 tttp -107.94 135.04 49.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 2.3700000000000001 111.945 -174.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 20.7 p -81.31 142.91 32.63 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.711 . . . . 1.46 110.633 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.689 HD21 ' SG ' ' A' ' 168' ' ' CYS . 63.3 mt -116.88 171.52 7.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.786 0.327 . . . . 1.1299999999999999 111.486 -173.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -101.84 -91.57 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 3.54 111.239 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.0 m -149.55 -42.62 0.14 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 120.885 0.374 . . . . 3.5800000000000001 110.918 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 m -83.74 -33.71 25.01 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.225 0.536 . . . . 2.6699999999999999 111.096 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.0 p-10 -90.3 23.96 2.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.794 -0.639 . . . . 2.2999999999999998 112.14 -171.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.489 HG11 ' HZ ' ' A' ' 145' ' ' PHE . 6.1 p -127.45 139.34 52.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.305 0.574 . . . . 1.5900000000000001 111.83 -177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.4 ' OG1' ' HG2' ' A' ' 169' ' ' LYS . 49.7 m -137.51 111.0 7.99 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.48 -0.782 . . . . 1.1599999999999999 108.941 170.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -92.54 152.46 19.62 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.069 0.461 . . . . 2.27 110.754 -176.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -124.4 105.58 9.54 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.609 -0.723 . . . . 2.9500000000000002 109.46 177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 61.21 35.65 18.26 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.747 -0.66 . . . . 2.9700000000000002 112.068 176.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 99.01 -3.05 58.34 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.421 -0.895 . . . . 1.46 113.592 174.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -111.55 130.54 55.7 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 117.296 0.548 . . . . 2.21 110.693 176.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.6 HD21 ' CZ3' ' A' ' 140' ' ' TRP . 1.0 OUTLIER -84.02 135.4 34.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.502 -0.772 . . . . 1.25 110.567 -170.824 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.972 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 83.2 m-85 -134.7 133.72 40.3 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.68 -0.489 . . . . 1.23 109.68 174.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.689 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.3 m -58.3 141.78 49.96 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.359 -0.608 . . . . 0.52000000000000002 109.359 174.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . 0.4 ' HG2' ' OG1' ' A' ' 160' ' ' THR . 29.3 mtpp -59.03 -25.47 63.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.762 0.315 . . . . 3.1200000000000001 110.541 177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.415 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 59.0 t -74.86 -47.78 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.251 0 CA-C-N 116.058 -0.519 . . . . 1.02 110.325 176.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 80.0 m -67.94 -30.14 69.37 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.032 0.444 . . . . 0.80000000000000004 110.809 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 30.5 t80 -70.35 -32.4 70.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.974 -0.557 . . . . 1.78 109.939 177.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.75 -24.06 59.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.058 0.456 . . . . 1.05 110.541 176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 174' ' ' LYS . 10.1 mmpt? -84.97 -60.79 1.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.938 -0.573 . . . . 3.3599999999999999 111.185 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -97.29 -28.57 13.99 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 113.338 0.866 . . . . 2.6499999999999999 113.338 -172.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 . . . . . 0 N--CA 1.473 0.719 0 C-N-CA 123.106 0.562 . . . . 4.3200000000000003 110.818 -177.261 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 126' ' ' SER . 29.4 ttpp . . . . . 0 N--CA 1.454 -0.237 0 CA-C-O 120.848 0.356 . . . . 2.7599999999999998 111.072 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HA ' ' HD3' ' A' ' 121' ' ' PRO . 11.4 t -60.07 117.43 23.65 Favored Pre-proline 0 C--O 1.234 0.276 0 CA-C-N 115.387 -0.824 . . . . 0.80000000000000004 110.32 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 120' ' ' CYS . 5.8 Cg_exo -77.96 -3.73 13.76 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 123.213 2.609 . . . . 1.0 112.21 -178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.431 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 10.8 tpt85 -92.14 -36.69 13.16 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-N 116.548 -0.296 . . . . 2.8199999999999998 110.306 -178.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 36.7 m -100.04 -27.73 13.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.135 0.493 . . . . 0.88 110.728 175.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 86.18 31.17 20.64 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.475 -0.784 . . . . 0.84999999999999998 111.492 -176.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -133.94 140.64 46.91 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.777 0.323 . . . . 2.9900000000000002 111.088 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.755 ' HA ' ' HA ' ' A' ' 119' ' ' LYS . 14.1 m -74.91 134.93 41.5 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.865 -0.607 . . . . 1.3700000000000001 111.008 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.406 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 4.6 t -126.51 147.38 31.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.792 -0.64 . . . . 0.80000000000000004 109.389 -178.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.85 -164.64 1.48 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.84 -0.744 . . . . 5.0800000000000001 111.674 178.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.493 ' HA ' ' HE3' ' A' ' 132' ' ' LYS . . . -44.76 -38.48 4.5 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 114.5 1.296 . . . . 0.94999999999999996 114.5 -166.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.2 -50.63 68.88 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.031 0.382 . . . . 1.21 112.031 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 30.0 mm-40 -114.05 6.55 16.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.69 -0.232 . . . . 2.4399999999999999 110.996 -175.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.666 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 25.7 ttpp -60.73 102.9 0.21 Allowed 'General case' 0 C--O 1.235 0.326 0 CA-C-O 121.324 0.583 . . . . 2.1800000000000002 112.176 -174.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 140' ' ' TRP . 6.2 m -113.08 121.87 66.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.083 -0.962 . . . . 1.02 108.478 165.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 87.3 mtp -76.87 88.37 3.46 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 112.485 0.55 . . . . 1.78 112.485 -169.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -94.59 117.17 5.49 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.968 -0.853 . . . . 0.77000000000000002 110.968 171.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 65.67 18.42 65.98 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.629 -0.796 . . . . 1.72 112.576 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 86.87 12.35 68.77 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.0 -0.619 . . . . 1.04 112.367 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.406 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 37.5 mttm -124.86 135.14 26.34 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.899 -0.408 . . . . 2.6899999999999999 109.899 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 11.9 Cg_endo -56.8 103.58 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.868 2.379 . . . . 0.71999999999999997 112.937 170.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 138' ' ' LYS . 10.9 m0 -90.06 -176.79 4.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.88 -0.6 . . . . 0.78000000000000003 109.418 172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.785 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 73.2 m80 -97.23 131.18 44.2 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.426 -0.953 . . . . 0.71999999999999997 108.426 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.447 ' HB2' ' HE3' ' A' ' 142' ' ' LYS . 18.1 ptmt -66.57 -16.63 64.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.234 0.54 . . . . 3.1899999999999999 110.128 177.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 30.4 m -76.97 -35.03 57.51 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.406 -0.815 . . . . 1.47 111.277 177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.785 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 24.7 p -99.59 -9.39 23.28 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.866 -0.42 . . . . 1.1399999999999999 109.866 -179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.557 ' HB2' ' O ' ' A' ' 141' ' ' HIS . 1.4 t80 -70.89 63.97 0.31 Allowed 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 115.039 -0.982 . . . . 1.1299999999999999 109.423 -179.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.821 ' HG2' ' HA ' ' A' ' 153' ' ' SER . 48.0 mtp180 -133.89 127.21 32.04 Favored 'General case' 0 C--N 1.309 -1.184 0 CA-C-N 114.228 -1.351 . . . . 2.7799999999999998 108.138 -176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 1.068 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.0 OUTLIER -83.06 141.66 31.87 Favored 'General case' 0 C--N 1.31 -1.138 0 C-N-CA 119.589 -0.844 . . . . 0.68000000000000005 109.772 -179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -73.85 -19.29 60.77 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 114.159 -1.382 . . . . 1.02 112.659 -172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.461 HG13 ' CE1' ' A' ' 167' ' ' TYR . 64.4 mt -66.63 -31.96 55.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.844 0.354 . . . . 1.02 110.454 -176.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.622 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.9 p -122.63 -31.31 3.75 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-O 121.144 0.497 . . . . 0.87 110.578 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 90.33 28.5 17.03 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.923 -0.871 . . . . 0.76000000000000001 110.923 -175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.624 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 56.8 tttp -101.08 136.28 41.18 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.54 0.57 . . . . 2.3700000000000001 112.54 -169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.821 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 39.9 m -74.16 120.6 19.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.525 -0.761 . . . . 1.46 110.324 174.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.617 HD21 ' SG ' ' A' ' 168' ' ' CYS . 78.8 mt -90.39 107.5 19.19 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.041 -0.527 . . . . 1.1299999999999999 111.521 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -84.41 58.25 4.74 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.947 -0.76 . . . . 3.54 108.947 175.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 44.0 p 51.06 -159.96 0.09 Allowed 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.045 -0.979 . . . . 3.5800000000000001 111.573 -176.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 56.0 m 74.04 -71.66 0.13 Allowed 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 112.34 0.496 . . . . 2.6699999999999999 112.34 176.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -100.32 65.69 1.24 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.453 0.644 . . . . 2.2999999999999998 111.584 -175.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 61.8 t -108.12 140.26 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.646 -0.706 . . . . 1.5900000000000001 111.219 -175.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 m -144.79 137.7 26.61 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.728 0.299 . . . . 1.1599999999999999 110.542 175.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -93.56 144.3 25.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.593 -0.276 . . . . 2.27 110.906 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -127.11 86.37 2.49 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.19 -0.67 . . . . 2.9500000000000002 109.19 170.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 16.1 t70 58.95 -84.32 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.271 -0.877 . . . . 2.9700000000000002 111.427 -174.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -128.52 7.42 6.61 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 121.05 -0.595 . . . . 1.46 112.134 -178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -112.36 150.23 31.35 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.563 -0.532 . . . . 2.21 109.563 178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.41 127.21 52.05 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.994 -0.548 . . . . 1.25 110.167 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 1.068 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 61.0 m-85 -134.34 156.81 47.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.558 -0.292 . . . . 1.23 110.854 178.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.617 ' SG ' HD21 ' A' ' 154' ' ' LEU . 5.0 m -71.62 156.31 39.53 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.427 -0.352 . . . . 0.52000000000000002 110.523 176.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 6.6 tmtm? -54.12 -46.58 72.19 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.661 -0.496 . . . . 3.1200000000000001 109.661 174.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.98 -48.47 88.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 115.755 -0.657 . . . . 1.02 111.186 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LYS . 56.1 m -70.6 -32.97 70.53 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.222 -0.445 . . . . 0.80000000000000004 111.861 -175.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 60.7 t80 -68.02 -42.5 80.54 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.764 -0.375 . . . . 1.78 110.019 175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -69.48 -24.34 63.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.561 0.695 . . . . 1.05 109.968 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 171' ' ' CYS . 65.9 tttp -67.1 -45.93 75.74 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.163 -0.926 . . . . 3.3599999999999999 110.952 178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -94.68 -37.55 11.25 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.917 -0.313 . . . . 2.6499999999999999 111.811 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 4.3200000000000003 112.59 -178.961 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 126' ' ' SER . 3.0 ptpp? . . . . . 0 N--CA 1.451 -0.418 0 N-CA-C 112.501 0.556 . . . . 2.7599999999999998 112.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 122' ' ' ARG . 2.9 t -78.41 107.84 6.55 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.831 -1.077 . . . . 0.80000000000000004 109.059 174.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 119' ' ' LYS . 39.3 Cg_endo -69.36 -5.82 16.88 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.766 2.311 . . . . 1.0 112.455 -179.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.598 ' HB2' ' SG ' ' A' ' 120' ' ' CYS . 31.4 mmt180 -75.28 -30.77 60.53 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.265 -0.642 . . . . 2.8199999999999998 109.265 176.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 60.2 m -110.82 -26.24 9.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.047 -0.979 . . . . 0.88 110.908 177.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 79.15 20.14 70.63 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.238 -1.145 . . . . 0.84999999999999998 110.238 -172.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.561 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 88.2 tttt -114.01 135.49 53.95 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.719 -0.74 . . . . 2.9900000000000002 110.063 -172.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.409 ' HA ' ' HB3' ' A' ' 119' ' ' LYS . 33.6 m -79.24 140.03 37.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.981 -0.554 . . . . 1.3700000000000001 111.309 -174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.535 ' HB ' ' O ' ' A' ' 139' ' ' PRO . 13.5 t -124.43 150.34 29.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.668 -0.696 . . . . 0.80000000000000004 109.276 178.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -132.42 -163.89 1.4 Allowed 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.91 -0.316 . . . . 5.0800000000000001 110.392 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.16 -33.04 17.77 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 113.72 1.008 . . . . 0.94999999999999996 113.72 -170.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.35 -30.42 60.28 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.493 0.553 . . . . 1.21 112.493 -177.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -142.82 21.13 1.98 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 2.4399999999999999 110.462 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.585 ' HG3' ' HB3' ' A' ' 139' ' ' PRO . 27.5 ttpp -64.36 111.76 2.79 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.466 0.651 . . . . 2.1800000000000002 112.529 -175.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' HB2' ' A' ' 140' ' ' TRP . 2.2 m -120.29 121.18 65.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.006 -0.997 . . . . 1.02 108.577 167.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 18.9 mmt -75.68 89.78 2.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.35 0.87 . . . . 1.78 113.35 -168.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -80.75 94.91 1.58 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 110.836 -0.906 . . . . 0.77000000000000002 110.836 167.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 76.98 -74.5 1.83 Allowed Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 111.895 -0.482 . . . . 1.72 111.895 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -154.27 23.4 0.67 Allowed Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 111.019 -0.833 . . . . 1.04 111.019 176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.579 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 45.1 mttp -126.09 132.65 24.39 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.549 -0.325 . . . . 2.6899999999999999 111.132 -177.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HB3' ' HG3' ' A' ' 132' ' ' LYS . 14.8 Cg_endo -61.41 99.7 0.17 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.217 1.945 . . . . 0.71999999999999997 111.371 161.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.585 ' HZ3' ' HG2' ' A' ' 122' ' ' ARG . 26.4 m95 -88.41 171.24 10.27 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.099 -0.501 . . . . 0.78000000000000003 110.145 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.61 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 28.8 m80 -74.73 140.95 44.46 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 109.118 -0.697 . . . . 0.71999999999999997 109.118 172.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -59.51 -25.85 64.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.067 -0.515 . . . . 3.1899999999999999 110.915 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 14.6 p -77.17 -52.34 9.42 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.92 -0.582 . . . . 1.47 111.372 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 0.0 OUTLIER -88.58 -2.33 58.54 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.007 -0.542 . . . . 1.1399999999999999 112.119 -172.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.02 64.4 0.71 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 107.26 -1.385 . . . . 1.1299999999999999 107.26 168.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.571 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 36.6 ptt180 -145.8 164.09 32.98 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.818 -1.083 . . . . 2.7799999999999998 110.012 -167.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.629 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.5 OUTLIER -103.32 146.35 28.6 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 109.115 -0.698 . . . . 0.68000000000000005 109.115 173.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.71 -6.61 52.86 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.041 -0.981 . . . . 1.02 111.77 178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 56.3 mt -83.19 -52.55 12.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.528 0.204 . . . . 1.02 110.76 -175.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 5.2 m -92.13 -11.03 36.78 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.482 -0.933 . . . . 0.87 108.482 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 62.08 39.88 98.19 Favored Glycine 0 N--CA 1.443 -0.844 0 CA-C-N 114.27 -1.332 . . . . 0.76000000000000001 110.179 -174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -126.8 134.54 50.55 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 112.393 0.516 . . . . 2.3700000000000001 112.393 -168.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.571 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 32.7 m -73.55 143.57 46.43 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.567 -0.742 . . . . 1.46 110.077 176.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.731 HD21 ' SG ' ' A' ' 168' ' ' CYS . 65.9 mt -110.1 148.1 32.38 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.157 0.503 . . . . 1.1299999999999999 111.823 -171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -91.87 167.2 12.3 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.617 -0.72 . . . . 3.54 109.25 173.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 21.4 m -73.59 62.02 0.75 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.094 0.473 . . . . 3.5800000000000001 111.384 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.7 t -175.59 -16.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.632 -0.713 . . . . 2.6699999999999999 110.562 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -126.03 70.57 1.22 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.779 -0.452 . . . . 2.2999999999999998 109.779 -178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 4.6 p -156.63 139.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.004 0.431 . . . . 1.5900000000000001 111.613 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 48.7 m -138.57 135.6 35.16 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.029 -0.532 . . . . 1.1599999999999999 109.973 172.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -97.24 129.99 44.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 2.27 110.992 -176.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.803 ' HD3' ' HE1' ' A' ' 172' ' ' TYR . 20.6 ttpp -135.62 105.3 6.12 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.295 -0.411 . . . . 2.9500000000000002 109.997 176.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.428 ' OD2' ' HG2' ' A' ' 162' ' ' LYS . 23.1 m-20 65.48 24.09 11.87 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.655 0.597 . . . . 2.9700000000000002 111.17 176.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 95.31 -9.14 69.63 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.703 -0.76 . . . . 1.46 111.941 -178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . 0.493 ' HG2' HH22 ' A' ' 122' ' ' ARG . 35.7 mt-10 -93.55 134.88 35.37 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.022 0.439 . . . . 2.21 110.835 177.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.506 HD21 ' CH2' ' A' ' 140' ' ' TRP . 2.8 mm? -95.5 137.35 34.68 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.749 -0.66 . . . . 1.25 109.84 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 72.8 m-85 -136.73 149.3 47.78 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.976 -0.75 . . . . 1.23 108.976 175.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.731 ' SG ' HD21 ' A' ' 154' ' ' LEU . 2.7 m -66.53 160.52 24.98 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.721 -0.844 . . . . 0.52000000000000002 108.721 173.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -63.96 -26.78 68.74 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.856 0.36 . . . . 3.1200000000000001 110.459 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.4 t -80.5 -50.51 17.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.266 -0.425 . . . . 1.02 112.137 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . . . . . . . . . 19.1 p -71.24 -34.5 70.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 120.809 0.338 . . . . 0.80000000000000004 110.762 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . 0.803 ' HE1' ' HD3' ' A' ' 162' ' ' LYS . 80.7 t80 -64.95 -41.76 95.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 1.78 110.654 176.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -72.14 -29.43 64.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.423 . . . . 1.05 110.679 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -76.07 -55.11 5.9 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.835 -0.621 . . . . 3.3599999999999999 111.413 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -93.58 -31.79 14.38 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 112.23 0.456 . . . . 2.6499999999999999 112.23 -173.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 32.6 p90 . . . . . 0 N--CA 1.475 0.823 0 CA-C-O 121.58 0.705 . . . . 4.3200000000000003 111.661 -175.655 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' HE3' ' HB3' ' A' ' 119' ' ' LYS . 10.6 mmmt . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 110.327 -0.249 . . . . 2.7599999999999998 110.327 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 12.5 t -80.79 117.83 69.71 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.34 -0.391 . . . . 0.80000000000000004 110.024 174.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -84.23 7.52 5.14 Favored 'Trans proline' 0 N--CA 1.456 -0.691 0 C-N-CA 122.996 2.464 . . . . 1.0 111.995 176.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.422 ' HD2' ' HA ' ' A' ' 122' ' ' ARG . 12.9 tpt180 -98.14 -37.94 9.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 2.8199999999999998 110.493 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' CYS . . . . . . . . . . . . . 8.5 m -112.38 -11.32 13.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.41 -0.359 . . . . 0.88 111.428 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 71.09 45.64 48.79 Favored Glycine 0 C--N 1.331 0.27 0 N-CA-C 111.163 -0.775 . . . . 0.84999999999999998 111.163 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.771 ' HB3' ' HE1' ' A' ' 141' ' ' HIS . 54.6 tptt -134.08 153.35 51.86 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.054 -0.351 . . . . 2.9900000000000002 110.054 -170.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 37.5 t -74.81 145.36 42.95 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.389 -0.226 . . . . 1.3700000000000001 110.389 178.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.573 ' HB ' ' HB2' ' A' ' 139' ' ' PRO . 19.6 t -135.96 139.11 46.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 110.129 -0.323 . . . . 0.80000000000000004 110.129 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -132.76 -179.13 5.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 110.146 -0.316 . . . . 5.0800000000000001 110.146 172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 132' ' ' LYS . . . -50.41 -32.98 19.14 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.919 1.081 . . . . 0.94999999999999996 113.919 -166.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -54.88 -28.62 51.75 Favored 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.433 0.531 . . . . 1.21 112.433 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -140.48 15.78 2.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.645 -0.422 . . . . 2.4399999999999999 110.608 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.538 ' HD3' ' HB3' ' A' ' 139' ' ' PRO . 31.8 ttpt -68.47 92.72 0.45 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 2.1800000000000002 111.495 -179.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.517 HG23 ' HB2' ' A' ' 140' ' ' TRP . 5.3 m -89.38 127.45 42.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.376 -0.972 . . . . 1.02 108.376 168.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . . . . . . . . . 24.9 mmt -77.41 84.27 3.83 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.148 0.425 . . . . 1.78 112.148 -169.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -77.53 83.71 1.11 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.732 -0.947 . . . . 0.77000000000000002 110.732 169.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 69.81 36.39 74.38 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 121.229 -0.51 . . . . 1.72 112.208 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 88.03 -12.17 64.93 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.941 -0.647 . . . . 1.04 112.267 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.428 ' O ' ' HD1' ' A' ' 140' ' ' TRP . 97.2 mttt -96.08 129.42 33.95 Favored Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 109.961 -0.385 . . . . 2.6899999999999999 109.961 179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HB2' ' HB ' ' A' ' 127' ' ' VAL . 18.8 Cg_endo -60.8 113.42 1.7 Allowed 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.609 2.206 . . . . 0.71999999999999997 112.604 172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.517 ' HB2' HG23 ' A' ' 133' ' ' VAL . 12.2 m95 -106.8 -179.15 3.85 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.982 -0.747 . . . . 0.78000000000000003 108.982 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.809 ' HB2' ' SG ' ' A' ' 144' ' ' CYS . 36.5 m80 -98.13 148.82 23.17 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.707 -0.479 . . . . 0.71999999999999997 109.707 179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -76.32 -19.79 57.89 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.977 -0.749 . . . . 3.1899999999999999 108.977 176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.1 m -78.28 -29.07 47.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.273 -0.876 . . . . 1.47 110.893 176.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' CYS . . . . . 0.809 ' SG ' ' HB2' ' A' ' 141' ' ' HIS . 21.6 p -112.41 9.86 19.75 Favored 'General case' 0 CA--C 1.517 -0.314 0 C-N-CA 121.037 -0.265 . . . . 1.1399999999999999 111.065 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PHE . . . . . 0.596 ' CZ ' HG11 ' A' ' 159' ' ' VAL . 0.1 OUTLIER -72.12 68.79 0.73 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.804 -1.184 . . . . 1.1299999999999999 107.804 174.208 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.572 ' HB3' ' HA ' ' A' ' 153' ' ' SER . 2.6 ptm180 -157.41 135.65 11.1 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.24 -1.346 . . . . 2.7799999999999998 108.919 -170.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' CYS . . . . . 0.849 ' HB2' ' HA ' ' A' ' 167' ' ' TYR . 0.1 OUTLIER -85.39 140.19 30.95 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 119.883 -0.727 . . . . 0.68000000000000005 109.336 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -74.78 -3.97 34.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.929 -1.032 . . . . 1.02 112.377 -177.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.712 ' HB ' ' SG ' ' A' ' 147' ' ' CYS . 35.7 mm -71.86 -37.8 62.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.097 0.475 . . . . 1.02 109.891 178.193 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.916 ' SG ' ' HB3' ' A' ' 152' ' ' LYS . 29.4 p -116.95 -22.61 8.39 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.679 0.752 . . . . 0.87 109.701 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 80.93 22.17 61.88 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.005 -0.998 . . . . 0.76000000000000001 111.074 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.916 ' HB3' ' SG ' ' A' ' 150' ' ' CYS . 11.9 ttpp -111.51 140.89 45.74 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.234 0.457 . . . . 2.3700000000000001 112.234 -170.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.572 ' HA ' ' HB3' ' A' ' 146' ' ' ARG . 12.5 m -65.91 163.65 16.61 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.249 -0.887 . . . . 1.46 111.521 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.59 HD21 ' CB ' ' A' ' 168' ' ' CYS . 28.5 mt -127.97 171.17 12.08 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.578 0.704 . . . . 1.1299999999999999 112.604 -173.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.65 142.85 50.9 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 114.283 -1.326 . . . . 3.54 107.636 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.1 m -49.17 -35.81 17.87 Favored 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 113.463 0.912 . . . . 3.5800000000000001 113.463 -167.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 36.6 p -57.69 -37.53 73.63 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.512 0.56 . . . . 2.6699999999999999 112.512 -177.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -120.17 41.89 3.09 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.393 0.516 . . . . 2.2999999999999998 112.393 -171.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.982 ' HB ' HD11 ' A' ' 166' ' ' LEU . 6.7 m -95.94 144.32 10.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.727 -0.472 . . . . 1.5900000000000001 109.727 174.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 32.2 p -133.15 133.86 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.987 0.422 . . . . 1.1599999999999999 111.147 177.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -92.86 133.71 35.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.99 -0.55 . . . . 2.27 110.406 -178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.421 ' HD2' ' HA ' ' A' ' 162' ' ' LYS . 17.3 mmmt -142.94 84.13 1.83 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.15 0.5 . . . . 2.9500000000000002 111.861 171.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 49.03 46.3 22.54 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 114.919 -1.037 . . . . 2.9700000000000002 113.56 167.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 121.08 -26.07 6.87 Favored Glycine 0 CA--C 1.512 -0.136 0 C-N-CA 120.162 -1.018 . . . . 1.46 112.759 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -106.68 148.58 28.21 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 2.21 110.598 177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.982 HD11 ' HB ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -111.15 110.8 21.49 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.075 -1.083 . . . . 1.25 108.075 173.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.849 ' HA ' ' HB2' ' A' ' 147' ' ' CYS . 73.0 m-85 -105.79 156.96 17.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.972 0.415 . . . . 1.23 110.911 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' CYS . . . . . 0.59 ' CB ' HD21 ' A' ' 154' ' ' LEU . 5.5 m -71.22 146.34 49.09 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.484 -0.78 . . . . 0.52000000000000002 109.395 172.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt -56.81 -33.87 67.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.135 0.493 . . . . 3.1200000000000001 110.119 176.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.3 t -69.07 -47.82 72.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.749 -0.66 . . . . 1.02 110.503 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' CYS . . . . . 0.526 ' HA ' ' HB3' ' A' ' 174' ' ' LYS . 60.9 m -69.72 -29.47 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.326 -0.397 . . . . 0.80000000000000004 111.061 178.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -62.03 -44.98 95.54 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 116.277 -0.42 . . . . 1.78 110.309 175.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -73.86 -25.24 59.95 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.394 0.616 . . . . 1.05 110.379 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.526 ' HB3' ' HA ' ' A' ' 171' ' ' CYS . 32.6 ttmt -69.27 -59.84 2.74 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.823 -1.081 . . . . 3.3599999999999999 111.725 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -94.94 -30.6 14.06 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.863 0.32 . . . . 2.6499999999999999 111.863 -176.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 37.0 p90 . . . . . 0 N--CA 1.479 1.021 0 C-N-CA 125.008 1.323 . . . . 4.3200000000000003 114.209 177.608 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_